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Abstract
Nerve section results in the rapid, Wallerian degeneration of distal axons and motor
nerve terminals. This process is normally complete within 24-48 hours in wild-type
rodents. By contrast, motor nerve terminals of the spontaneous mutant Wlds mouse
persist, both functionally and morphologically, for up to two weeks following nerve
injury. This thesis aims first, to extend knowledge and understanding of the fate of
neuromuscular junctions (NMJ) in normal and Wlds mice following axotomy; second,
to test the hypothesis that the Wlds phenotype is age-dependent; and third, to test the
hypothesis that the Wlds phenotype is produced as a result of the expression of a
Ube4b/Nmnat chimeric gene.
Immunocytochemical, confocal and vital staining experiments revealed marked
differences between the mechanisms of nerve terminal removal in axotomised wild-type
and Wlds preparations. Wild-type preparations endured a rapid, fragmentary type of
degeneration (the characteristics of classical Wallerian degeneration), whereas Wlds
nerve terminals appeared to be withdrawn from endplates in a piecemeal fashion.
Ultrastructural analysis confirmed that axotomised wild-type NMJs exhibited all of the
classical signs of Wallerian degeneration, including in-situ nerve terminal
fragmentation, mitochondrial swelling and lysis and phagocytosis by the terminal
Schwann cell. Electron micrographs of axotomised Wlds NMJs demonstrated a
retention of nerve terminal architecture, including synaptic vesicles and mitochondria.
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Together, these data suggest that when axonal degeneration is delayed, as in the Wlds
mouse, a novel form of synaptic withdrawal is unmasked, and that aspects of this
process resemble those which occur during the formation of mature innervation patterns
in postnatal development.
The effect of age on the phenotypic expression of the Wlds mutation was studied in 2, 4,
7 and 12 month old Wlds mice using morphological and ultrastructural techniques. As
the mice matured, the rate of nerve terminal loss progressively increased, with animals
of 7 months and older exhibiting wild-type characteristics (most terminals being lost
within 24-48 hours of axotomy). The nature of nerve terminal loss also changed from
apparent piecemeal withdrawal to classical Wallerian degeneration with increasing age.
In Wlds mice of 7 months and older, partial occupancy of an endplate was rarely
observed, whereas the incidence of fragmented, degenerating nerve terminals increased.
Ultrastructural analysis supported these findings: thus mainly degenerating nerve
terminal profiles were observed in Wlds mice of 7 months or older. Interestingly the
transition from withdrawal to degeneration appeared to be gradual with evidence of
both mechanisms operating at individual NMJs in 4 month old Wlds mice. These
studies suggest that the loss of nerve terminal withdrawal characteristics in older Wlds
mice may be accounted for by an age-related decline in the levels of a 'synaptic
maintenance factor' within a neuron. Such a factor may be responsible for initiating the
withdrawal of nerve terminals under conditions such as axotomy or disuse.
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Similar morphological and ultrastructural analyses were performed on nerve/muscle
preparations from transgenic mice expressing the candidate Wlds gene (Ube4b/Nmnat)
under a (3-actin promoter. Transgenic mice strongly expressing the Ube4b/Nmnat
chimeric gene also showed prolonged retention of axons and motor nerve terminals
following axotomy, at similar levels to those found in Wlds mice. Evidence of partially
occupied endplates suggested that piecemeal withdrawal of motor nerve terminals also
occurred in transgenic mice, and ultrastructural analysis reported a retention of nerve
terminal architecture. These findings support the hypothesis that the Ube4b/Nmnat
chimeric gene is responsible for the Wlds phenotype, and suggests that synapse specific
events unmasked when axonal Wallerian degeneration is delayed are not unique to the
Wlds mouse.
My studies provide evidence for a compartmental model of neurodegeneration.
Whereas it is widely acknowledged that the somatic and axonal portions of a neuron
have separate, compartmentalised mechanisms of degeneration, data presented here
suggest that degeneration of synaptic terminals is also controlled by at least one other,
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The vertebrate nervous system is the most complex assembly of cells found in any
living organism. It is a highly specialised unit, organised to continually receive, process
and act upon information produced from within the animal as well as its surrounding
environment. The central nervous system (CNS; comprising the brain and spinal cord)
is the division responsible for the majority of 'higher' functions such as decision
making, learning and multiple input integration. The peripheral nervous system (PNS;
comprising all neural tissue outside the CNS) is responsible for providing the sensory
input to and carrying the motor output from the CNS. Yet the connections within the
nervous system are not immutable. Some of the most fascinating scientific discoveries
of recent years have greatly enhanced our understanding of the role of plasticity within
these systems. Thus, it has become increasingly apparent that the nervous system is not
a 'hardwired', inflexible unit (as was originally thought by early neurobiologists; for
review see Albright et al., 2000), but rather a very dynamic entity, capable of altering
both its structure and function in response to a variety of circumstances. Whilst most
current research focuses on plasticity in the CNS (for example, the role of plastic
mechanisms in learning and memory; for review see Martin et al., 2000), there has been
a steady accumulation of literature over the past few decades concerning plasticity in
the PNS, not least with regard to the formation, development, stabilisation and repair of
neuromuscular connections (for general review see Grinnell, 1995).
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Neuronal degeneration has also been the subject of intensive study in recent years. Even
though degenerative processes underlie many common disorders of the nervous system,
including multiple sclerosis (Perry and Anthony, 1999), spinal cord injury (Zhang et ah,
1996), stroke and peripheral neuropathy (Wang et al., 2001), little is known with regard
to the underlying cellular and molecular control mechanisms. Recent advances have
suggested however that cell body degeneration and axonal degeneration occur via
separate and distinct pathways (Deckwerth and Johnson, 1994). However, most of
these studies have overlooked the specific involvement of synapses, regarding the
synaptic component of a neurone as a simple extension of the axon. As a result,
evidence of synapse specific events occurring during neuronal degeneration has, in the
majority of cases, gone unreported. It is only with the publication of recent studies,
which have focused on synaptic rather than axonal events, that evidence for direct
synaptic involvement in neuronal degeneration has emerged. For example, it has been
shown that apoptotic biochemical cascades can be activated locally in synapses
(Mattson et al., 1998a and 1998b).
Thus, a deeper understanding of the independent mechanisms involved in neuronal
degeneration is essential for producing specific preventative and therapeutic strategies
for those diseases where all, or only selective portions, of the neurone degenerate.
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1.2 Purpose and Overview of the Present Study
This thesis addresses current issues concerning the morphological events and
underlying mechanisms of synaptic plasticity and degeneration at axotomised peripheral
synapses. The main techniques I have used are electron microscopy, confocal
microscopy, conventional fluorescence microscopy and vital staining techniques. The
studies have focused on the naturally occurring C57B1/Wlds mutant mouse, in which
axonal Wallerian degeneration is significantly delayed. Evidence has accumulated that
a distinct form of synapse specific degeneration can be unmasked by axotomy in this
mutant. The studies described in this thesis suggest that synaptic responses to axotomy
are completely different and distinct from degeneration of the cell body and axon. On
the other hand, there are some remarkable similarities in morphology and time-course to
the processes of synapse elimination which occurs during development or following
reinnervation.
The controversy over the age dependence of the Wlds phenotype is also addressed
within this thesis. Experimental data I present unequivocally shows that at the synaptic
level, the expression of the Wlds phenotype at NMJs is lost with age, and that the
mechanism of motor nerve terminal loss is also fundamentally altered. Finally, a
contribution to the hypothesis that the Wlds phenotype results from the expression of a
novel gene is described. Experiments utilising transgenic mice suggest that the
Ube4b/Nmnat chimeric gene is both necessary and sufficient to confer slow
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degeneration of both axons and motor nerve terminals following nerve lesion. Finally,
taking all the data together, a model is proposed, in which synapses have their own
distinct and separate mechanisms of degeneration, independent of somatic and axonal
degeneration.
The remainder of this chapter introduces the mammalian NMJ, Wallerian degeneration
and the Wlds mutant mouse. The present view of neurodegenerative mechanisms and of
synapse elimination at the NMJ are also described. Chapter 2 contains information on
the materials and methods used throughout the current study. In chapter 3, experimental
data is presented comparing the morphological characteristics of control and
axotomised NMJs in wild-type and Wlds mutant mice. In chapter 4, data is presented to
address the effect of age on the phenotypic expression of the Wlds mutation at NMJs.
Chapter 5 contains results from experiments aimed at assessing the role of the
Ube4b/Nmnat chimeric gene in producing the Wlds phenotype at axotomised NMJs. In
the final chapter (chapter 6) I argue that the results of the previous chapters lead to the
proposal of a compartmental model of the neurone with regard to neurodegeneration as
well as differentiation, and specifically that the degeneration of synaptic terminals is
regulated by at least one and possibly several distinct cellular mechanisms.
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1.3 The Vertebrate Neuromuscular Junction
The neuromuscular junction (NMJ) is the best understood chemical synapse. It is
formed where axons of spinal motor neurones terminate and become morphologically
specialised to create synapses with their target skeletal muscle fibres. The vertebrate
NMJ is arguably the best preparation for analysis of synaptic development (Sanes and
Lichtman, 1999), refinement of synaptic connections and long-term morphological and
functional synaptic plasticity (Grinnell, 1995).
1.3.1 Historical Perspective
Santiago Ramon Y Cajal (1928) was one of the major innovators of, and subscribers to,
the 'neuronal doctrine'. This proposed that neurones are discreet, membrane bound
cells, which are not linked via a continuation of neurofibrils from one cell to another, as
had previously been argued by other neurobiologists including Camillo Golgi. Ramon
Y Cajal's findings suggested that nerves only contact other cells at specific points of
apposition: sites that were later named synapses by Charles Sherrington (Sherrington,
1897; 1906). Whilst NMJs were used experimentally as 'model synapses' throughout
the earlier part of the 20th century, it was only following the advent of electron
microscopy that they were unequivocally shown to be an apposition between a motor
axon terminal and a skeletal muscle fibre, separated from each other by a 50nm synaptic
cleft (Reger, 1954; Reger, 1955; Reger, 1958; Birks, Huxley and Katz, 1960).
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Whilst the existence of both electrical and chemical synaptic transmission in both
vertebrate and invertebrate nervous systems is now widely acknowledged (Bennett,
2000), it was the vertebrate NMJ which was the first synapse to be clearly shown to
release the chemical neurotransmitter acetylcholine (Dale et al., 1936). A couple of
decades later, the vertebrate NMJ was utilised in a classic series of experiments by Katz
and colleagues to demonstrate the precise nature of chemical synaptic transmission.
Fatt and Katz (Fatt and Katz, 1951; Fatt and Katz, 1952) showed that chemical synaptic
transmission is produced as a result of a change in the permeability of neural
membranes to ions, a situation summarised by the 'ionic hypothesis' (Hodgkin et al.,
1952). In these studies Fatt and Katz showed that the membrane permeability of a
muscle fibre is altered following the binding of acetylcholine. Subsequent work
revealed that neurotransmitter release from motor nerve terminals occurs not by the
release of single molecules, but rather by the release of multimolecular packets of
around 5000 molecules known as 'quanta' (Fatt and Katz, 1952; del Castillo and Katz,
1954; Katz, 1969; Kuffler and Yoshikami, 1975). It was also demonstrated using
these NMJ preparations that transmitter release occurs, not only by evoked means
(producing end plate potentials), but also as random, spontaneous events: as evidenced
by the occurrence of miniature end plate potentials (MEPPs; Fatt and Katz, 1952; Katz
and Miledi, 1969). The spontaneous events were shown, largely through the statistical
analysis of endplate recordings, to be equivalent to the unitary quanta underlying
stimulation-evoked endplate potentials.
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1.3.2 General Structure of the NMJ
Present understanding indicates that the vertebrate NMJ is constructed from highly
specialised portions of three cells: motor neurone, skeletal muscle fibre and a specific
class of Schwann cell known as the 'terminal', or 'perijunctional', Schwann cell
(Grinnell, 1995; Son and Thompson, 1995a). The synaptic area of each of these cells is
morphologically distinct from the rest of the cell due to higher or lower levels of
organelles and molecules which are not found extrasynaptically (Figure 1.1). The
detailed structure of the synaptic region in each of the cells is described below.
1.3.3 Structure of the Motor Nerve Terminal
The motor nerve terminal has a highly polarised ultrastructure. Clustered close to the
presynaptic membrane are clear, 50nm synaptic vesicles (Palade and Palay, 1954;
Robertson, 1956), each containing one 'quantum' (ca. 5000 molecules; see above) of
the neurotransmitter acetylcholine (Whittaker et al., 1964). So far, a direct
demonstration that exocytosis of synaptic vesicles is responsible for neurotransmitter
secretion which produces postsynaptic activation has only been possible using mouse
mast cells and adrenal chromaffin cells (Alvarez de Toledo et al., 1993; Chow et al.,
1992). However, the indirect evidence that neurotransmitter is released by exocytosis at
NMJs is none the less compelling (e.g. Betz and Angleson, 1998; Richards et al.,
2000). Synaptic vesicles often aggregate around hot spots of exocytosis on the
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presynaptic membrane, appearing as electron dense regions down the EM, known as
'active zones' (Hirokawa et ah, 1989). There is considerable evidence that the
population of vesicles within a nerve terminal is split into two functionally and spatially
distinct populations: a ready-releasable pool and a larger reserve pool, which is
available for release under more strenuous conditions such as during trains of stimuli
(Betz and Bewick, 1992; Kelly, 1993; Kuromi and Kidokoro, 1998; Delgado et ah,
2000; Richards et ah, 2000). Sometimes 'omega' (Q) figures can be detected on the
presynaptic membrane. These are thought to form by vesicular membrane fusion with
the presynaptic membrane (Heuser et al., 1979).
Within, or in close proximity to active zones is the molecular machinery responsible for
regulating and driving the synaptic vesicle cycle (docking, fusion, endocytosis and
subsequent recycling; Betz and Angleson, 1998). P-type calcium channels are
distributed widely throughout the presynaptic membrane to allow Ca2+ entry (Uchitel et
al., 1992) which is essential for calcium-dependent vesicle exocytosis. To enhance the
secretion of neurotransmitter, voltage-gated potassium and calcium channels are also
heavily localised within active zones (Robitaille et al., 1993; Day et al., 1997).
Syntaxins have been identified in the presynaptic membrane and are thought to play a
major role in vesicle docking at the presynaptic membrane (Pevsner et al., 1994).
Specific integrins are also present in active zones, one example being a3pl (Cohen et
al., 2000). Integrins securely attach the nerve terminal to the basal lamina, thereby
keeping neurotransmitter release sites firmly anchored opposite postsynaptic receptors.
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Fig. 1.1 Diagrammatical Representation of the Neuromuscular Junction.
(A) The cellular organisation of a motor neurone, skeletal muscle fibre and Schwann
cells.
(B) Distal to the last myelin sheath, the presynaptic axon diversifies into numerous
varicosities called synaptic boutons.
(C) Each nerve terminal bouton is separated from the skeletal muscle fibre by a ~50nm
synaptic cleft, in which the synaptic basal lamina lies. The postsynaptic area of a
skeletal muscle fibre is convoluted into junctional folds, at the top of which can be
found the AchRs .
Figure adapted from Kandel, E.R., Schwartz, J.H. & Jessell, T.M. (1991) 'Principles of
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Integrins are also thought to assist in facilitating neurotransmitter release (Chen and
Grinnell, 1995). The membranes of vesicles themselves contain many of the interactive
molecules required for anchoring, docking, fusion, release and recycling. Some
examples include synaptophysin and synaptobrevins (Elferink and Scheller, 1993),
Synapsins I and II (Sudhof and Jahn, 1991) and the vesicular Ach transporter (Erickson
et al., 1994).
Distal from the presynaptic membrane are numerous nerve terminal mitochondria,
intermingled between which can be found a few sparse microtubules and
neurofilaments. Whilst microtubules and neurofilaments exist in abundance pre-
terminally, their incidence decreases markedly within the nerve terminal itself (Yee et
al., 1988).
Each nerve terminal is split up into many individual boutons, each of which contain all
of the ultrastructural features described above. Although the gross structure of a motor
nerve terminal may be subdivided, it has been shown that all boutons function as a
single unit. For example, when an action potential passes from a motor axon collateral
into the nerve terminal, all boutons appear to be activated in a simultaneous,
synchronous fashion. Evidence for this comes from studies where neuromuscular
junctions have their synaptic vesicular membranes loaded with the styryl dye FM1-43.
Upon the induction of nerve stimulation in these preparation, all boutons are depleted of
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the dye at a similar rate (Betz et al., 1992; Betz and Bewick, 1992; Ribchester et al.,
1994).
1.3.4 Structure of the Postsynaptic Specialisation
The motor endplate of a skeletal muscle fibre is easily recognised in the EM due to the
folding of the postsynaptic membrane (junctional folds). These folds occur where
regions of electron dense postsynaptic membrane become convoluted into peaks and
troughs, extending down into the endplate for This arrangement is thought to
increase the safety factor for neuromuscular transmission (Martin, 1979; Wood and
Slater, 1997). The opening of a junctional fold is also positioned directly opposite an
active zone on the opposing motor nerve terminal (Patton et al., 2001).
The postsynaptic membrane is densely populated with nicotinic AChRs (>10 000 / /xm2;
Salpeter and Loring, 1985). The majority of these are located at the peaks, and a short
way down the sides, of junctional folds. In the troughs of the junctional folds are
voltage-gated sodium channels (Flucher and Daniels, 1989). These are responsible for
responding to the local endplate potential (EPP) produced by activation of the AChRs,
thereby triggering a muscle action potential.
The postsynaptic apparatus has a complex molecular network of cytoskeletal elements
associated with it. These are thought to play a role in generating and maintaining the
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postsynaptic folds as well as the different domains within them (Sanes and Lichtman,
1999). Cytoskeletal elements such as rapsyn (Wang et ah, 1999), utrophin (Gramolini
et al., 2000), and a-dystrobrevin-1, a member of the dystrophin family of proteins
(Peters et ah, 1998), are found to be associated with the AChRs at the top of junctional
folds. In the depths of the folds other cytoskeletal proteins such as ankyrin (Zhou et al.,
1998), (3-spectrin (Wood and Slater, 1998) and a-dystrobrevin-2 (a COOH-terminal
truncated version of a-dystrobrevin-1; Peters et al., 1998) are present.
Immediately beneath the foldings of the postsynaptic membrane are numerous
postsynaptic mitochondria as well as clusters of synaptic nuclei (Couteaux, 1973). A
recent study by Apel and colleagues (2000) has provided evidence for a novel protein
which may be involved in the formation and maintenance of nuclear clusters at the
NMJ: synaptic nuclear envelope-1 (Syne-1). Synaptic nuclei are larger and rounder than
those found extrasynaptically (Brosamle and Kuffler, 1996) and have been shown to be
transcriptionally specialised to exclusively express genes coding for synapse-specific
proteins such as the AchR subunits 8 and 8, utrophin and acetylcholinesterase
(Schaeffer et al., 2001).
1.3.5 Terminal Schwann Cells
Most Schwann cells in the PNS form myelin sheathes around axons (Waxman, 1997).
Myelin increases the conduction velocity of action potentials along the axon. Myelin-
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forming Schwann cells are also thought to provide the axon with trophic sustenance
(Oorschot and McLennan, 1998). The Schwann cells associated with the nerve terminal
itself, however, are a different, non-myelinating population. The extended processes of
these terminal Schwann cells cover the terminal arborisations, insulating them from the
surrounding environment. Whilst both myelinating and terminal Schwann cells arise
from the same progenitors, they express different genes during development; for
example, terminal Schwann cells strongly express S-100 and N-CAM whilst
myelinating Schwann cells have much higher expression levels of myelin basic protein,
P0 and myelin-associated glycoprotein (Mirsky and lessen, 1996).
Terminal Schwann cells, though not necessary, have been shown to play an important
role in the development, repair and maintenance of NMJs (Meier and Wallace, 1998). It
has been demonstrated, for example, that synpatogenesis can be induced by the release
of soluble glia-derived signals (Nagler et ah, 2001). Furthermore, following
denervation, terminal Schwann cells sprout processes (Reynolds and Woolf, 1992)
which guide regenerating axons back to the original sites of innervation (Son and
Thompson, 1995a). Following a partial denervation, similar sprouts are produced by
terminal Schwann cells, but these are directed to nearby innervated endplates. These
processes are capable of inducing intact nerve terminals to sprout along 'bridges' back
to reinnervate the denervated sites (Son and Thompson, 1995b). Sprouting of a
Schwann cell from a denervated site to a nearby innervated site also induces mitosis of
the resident Schwann cells at the innervated, but not at the denervated, endplate (Love
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and Thompson, 1998). These findings suggest that whilst terminal Schwann cells
become mitotic during reinnervation, previous studies have been correct in concluding
that denervation itself does not cause terminal Schwann cell mitosis (Connor et al.,
1987). These 'reactive' Schwann cells (i.e. those responding to the loss of nerve
terminal contact) are identifiable by an increase in the extent of cellular processes
(Torigoe et al., 1999), and are also capable of producing structural alterations in the
apposition of the pre- and post-synaptic apparatus (Trachtenberg and Thompson, 1997).
Under normal conditions terminal Schwann cells express muscarinic and purinergic
receptors, which respond to the release of acetylcholine and ATP respectively, from the
motor nerve terminal (Robitaille, 1995; Robitaille et al., 1997; Rochon et al., 2001).
These studies suggest that terminal Schwann cells can detect activity levels at the NMJ,
supported by findings that synaptic activity leads to an elevation of intracellular calcium
(Jahromi et al., 1992). The end result of such an increase in intracellular calcium
appears to be alterations in gene expression. For example, a blockade of activity
stimulates the expression of the gene for glial fibrillary acidic protein, which has been
shown to play a role in the formation of terminal Schwann cell sprouts (Love and
Thompson, 1998; Georgiou et al., 1994). There is also increasing evidence that glial
cells can actively modulate synaptic transmission, for example via the production of a
glia-derived soluble acetylcholine-binding protein (AchBP) in response to presynaptic
release of acetylcholine (Smit et al., 2001), or via the release of neurotransmitters
(Bezzi et al., 1998; Araque et al., 2000). A recent study suggests that withdrawal of
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terminal Schwann cells from innervated endplates induces abnormal nerve branching,
accumulation of neurofilaments, and intermittent failure of synaptic transmission
(Court, Brophy and Ribchester, 2001, in press).
1.3.6 Basal Lamina
A basal lamina ensheathes each individual skeletal muscle fibre. It passes through the
synaptic cleft and extends into the postsynaptic folds. Whilst the major components of
the muscle fibre's basal lamina are similar to the majority of other basal laminae found
throughout the body (collagen IV, laminin, entactin and heparan sulfate proteoglycans),
the synaptic portion differs in its isoform composition (Sanes and Lichtman, 1999).
The synaptic basal lamina also contains molecules which are crucial for the
establishment, maintenance and function of the NMJ, for example: acetylcholinesterase
(Krejci et al., 1997) and agrin. Agrin is a signalling molecule which is present
throughout the basal lamina of developing myotubes (Bowe and Fallon, 1995) as well
as being synthesised by motor neurones, which transport it to and release it from motor
nerve terminals before being incorporated into the synaptic basal lamina (McMahan,
1990; Reist et al., 1992; Cohen and Godfrey, 1992). The presence of certain isoforms
of nerve-derived agrin in the synaptic basal lamina has been shown to be crucial for
postsynaptic differentiation (McMahan, 1990; Gesemann et al., 1995; Gautam et al.,
1996; Jones et al., 1997; Cohen et al., 1997) and may have a role in the maintenance of
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the NMJ as it can still be found at synaptic sites (but not throughout the whole basal
lamina) in adult muscle fibres (Sanes and Lichtman, 1999).
Another signalling molecule found incorporated into the synaptic basal lamina is
neureglin, previously known as acetylcholine receptor-inducing activity (ARIA). This
molecule is produced, much the same as agrin, in motor neurones before being released
from the motor nerve terminals and incorporated into the basal lamina (Goodearl et al.,
1995). It has been suggested that neureglin may have a role in inducing AchR
clustering at differentiating postsynaptic sites (Sanes and Lichtman, 1999).
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1.4 Wallerian Degeneration
A peripheral nerve is a relatively well protected structure, surrounded and cosseted by
supporting glial cells, basal lamina and the perineurium. Minor pressure injuries applied
to such a nerve rarely result in more than a rapidly reversible compression of its
cytoskeletal elements. A major injury to the axonal process of a neurone, such as a
prolonged crush or lesion, results in a rapid disintegration of the portion of axon distal
to the lesion site however, including its motor nerve terminal. This occurs via a process
known as Wallerian degeneration (Figure 1.2). Nerve fibres located proximal to the site
of injury, which remain in contact with their soma, not only survive the insult but are
also primed for regeneration.
As well as being the major degenerative machinery instigated in an axotomised distal
nerve stump following lesion of a nerve, Wallerian degeneration is thought to play a
role in axonal death ('dying back' neuropathies) in many diseases of the central and
peripheral nervous systems; such as multiple sclerosis, amyotrophic lateral sclerosis,
peripheral neuropathies, human transmissible spongiform encephalopathies and
Guillain-Barre syndrome (Perry and Anthony, 1999; Narayanan et al., 1997; Dalcanto
and Gurney, 1995; Fujimura et al., 1991; El Hachimi et al., 1998; Trojaborg, 1998).
Whilst the morphological characteristics of Wallerian degeneration have been well
documented, the underlying mechanisms remain unclear.
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Fig. 1.2 Schematic Representation of Wallerian Degeneration.
A. The cellular organisation of a motor neurone, skeletal muscle fibre and Schwann
cells.
B. Following an axonal lesion, the distal stump of the axon and its motor nerve
terminal degenerate. The resident Schwann cells dedifferentiate and proliferate. The
axonal, nerve terminal and myelin debris are removed by phagocytosing Schwann cells
as well as invading macrophages. The cell body undergoes chromatolysis and the
nucleus translocates.
C. After the removal of all debris and the formation of Bands of Biingner by Schwann
cells, the proximal nerve stump regenerates back to the denervated muscle fibre.
Adapted from Nicholls, J.G., Martin, A.R. & Wallace, B.G. (1992) 'From neuron to
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1.4.1 Historical Perspectives
Wallerian degeneration was first described by Augustus Waller in 1850. He examined
the effects of lesioning the hypoglossal and glossopharyngeal nerves upon the
innervation of the tongue in the frog. After 3 days, he found a loss of both muscular
contraction and sensation in the muscle. Upon examination of the distal nerve stump,
he described the axons as appearing discontinuous, fragmented and granulated. He
suggested that these events were due to a degenerative process caused by the separation
of an axon from its cell body, and hence due to a loss of trophic support.
Whilst Waller's findings were not universally accepted due to constraints imposed by
the staining techniques available during that period, his conclusions were supported by
subsequent findings from Ranvier in the late 19th century (1878) who gave a more
detailed description of the process of Wallerian degeneration. He observed the
fragmentation and granulation of the axon following nerve lesion as well as the
formation of ovoid bodies following the contraction of myelin and the subsequent
invasion of phagocytotic leucocytes. Ranvier's description of Schwann cell division
during this process was supported by the findings of Bungner (1891), who observed the
mitosis of Schwann cells following axotomy and their joining together to form
longitudinal bands, subsequently named 'bands of Bungner'. These early studies finally
gained acceptance following the corroborative findings produced by Ramon y Cajal
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(1928) who utilised silver staining techniques to conclusively demonstrate that axotomy
produces a specific degeneration of the distal nerve stump.
1.4.2 Wallerian Degeneration of the Axon
The primary event in Wallerian degeneration is axonal fragmentation and degradation,
accompanied by a failure of the nerve to conduct action potentials (Vial., 1958;
McDonald, 1972; Mastalgia et ah, 1976; Allt, 1976; Hallpike, 1976; Nicholls et al.,
1992). The length of lag period following axotomy before changes can be detected in
the axon varies between species. In mice; for example, the sciatic nerve becomes
incapable of conducting compound action potentials 1 to 2 days following axotomy. A
similar time course prevails in the guinea pig, in contrast to axotomised frog sciatic
nerve where compound action potentials can be recorded for up to 7 days post lesion
(Levenson and Rosenbluth, 1990; Chaudry, Glass and Griffin, 1992). In the giant
squid, crayfish and fish however, isolated axons are preserved for months rather than
days (Sheller and Bittner, 1992; Tanner et al., 1995; Raabe et al., 1996). Electron
microscopy has demonstrated that major early axonal changes include fragmentation of
endoplasmic reticulum and disintegration of neurofilaments and microtubules within
24-72 hours following nerve transection (Vial, 1958; Honjin et al., 1959; Ballin and
Thomas, 1969; Donat and Wisniewski, 1973; Schlaepfer and Hasler, 1979a). Soon
after the onset of these events it is also possible to detect a more distinctive degenerative
marker, the swelling and lysis of axonal mitochondria. These changes are thought to be
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mediated by a rise in the intracellular calcium concentration: when a threshold
concentration of 0.2mM is reached, neurofilament degradation occurs (Glass et al.,
1994). Possible mechanisms for this intracellular rise include; i) the reverse operation
of the Na+-Ca2+ exchanger (LoPachin and Lehning, 1997), ii) release from intracellular
calcium stores, and iii) entry of extracellular calcium through Ca2+ channels (George et
ah, 1995). Further evidence to support the hypothesis that a rise in intracellular calcium
levels initiates axonal degeneration comes from experiments which show that
neurofilaments do not degenerate when in a calcium-free environment (Schlaepfer and
Hasler, 1979b). The ability of calcium to produce axonal degeneration is thought to be
mediated by calcium dependent proteases known as calpains (for review see; Croall
and DeMartino, 1991; Chan and Mattson, 1999).
Following axonal fragmentation and degradation, the subsequent breakdown and
removal of the myelin sheath occurs by phagocytosis involving the invasion of
myelomonocytic cells (Beuche and Friede, 1984). Once the lesioned axon has begun to
fragment, the myelin sheath retracts from the nodes of Ranvier creating enlarged nodal
spaces. These then segregate the nerve into 'digestive chambers' or 'ellipsoids' (Allt,
1976). Within each of these compartments, the axon fragments proceed to a state of
complete degradation.
As degradation of the distal stump continues, 'ellipsoids' are removed by phagocytosing
Schwann cells and invading macrophages. At the same time, Schwann cells proliferate:
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in rabbit sciatic nerve, 25 days post-lesion, there are up to 13 times the number present
before injury (Abercrombie and Johnson, 1946). The Schwann cells join together, tip to
tip, forming the longitudinal 'bands of Btingner'. These bands play a major role in
inducing and guiding the regenerating proximal nerve stump axons back to denervated
sites, aided by the secretion of many different growth and adhesive factors such as NGF
(Heumann et al., 1987), N-CAM (Nieke and Schachner, 1985) and cytokines (including
members of the interleukin (IL-x) family (Rutkowski et al., 1999; for review see Fu and
Gordon, 1997)) from the Schwann cells.
The rate at which Wallerian degeneration proceeds is dependent upon temperature, the
age of the animal and the calibre and myelination of the nerve. Cold temperatures have
been shown to slow the rate of progression of Wallerian degeneration in mammalian,
lower vertebrate and invertebrate axons (Usherwood et al., 1968; Wang, 1985; Bittner,
1988; Sea et al., 1995; Tsao et al., 1999). The optic nerve of cats has also been shown
to degenerate slower in older animals than in their younger counterparts (Cook et al.,
1974). Unmyelinated axons degenerate first, followed by the smallest myelinated
fibres with the largest myelinated fibres degenerating last (Weddel and Glees, 1941;
Friede and Martinez, 1970; Lubinska, 1977). Recent experiments indicate that levels
of inducible nitric oxide synthase (iNOS) may also control the rate of Wallerian
degeneration, evidenced by findings that mice which lack iNOS have slowed Wallerian
degeneration in myelinated axons (Levy et al., 2001).
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In adults the proximal portion of an axotomised motor neurone does not normally
degenerate alongside the distal stump following axotomy, at least in the short term
(Romanes, 1941; Johnson and Duberley, 1998). However, marked changes occur to
both the cell body and its nucleus (Nicholls et al., 1992). The cell body swells, the
nucleus translocates, and the Nissl substance (endoplasmic reticulum) becomes
dispersed.
In contrast, survival of neonatal motoneurones is strongly dependent upon their
maintaining synaptic contact with their target muscles. Thus neonatal motoneurones
normally die by apoptosis within a few days of nerve section. In this case, motoneurone
death is mitigated by neurotrophic factors originating in the target muscles signalling
through transmembrane receptors to the Bax/Bcl-2/Bcl-X system, activating calcium-
dependent proteases (Arce et al., 1998; Knudson et al., 1995; Martinou et al., 1994;
Villa et al., 1998; reviewed by Pettmann and Henderson, 1998).
Immediate early genes (IEGs; see Morgan and Curran, 1991), which control the cell
body response following axotomy of adult motoneurones, are activated by transcription
factors including c-Jun and JunD, which are selectively expressed in axotomised
peripheral and central neurones within 10-15 hours of nerve lesion (for review see
Herdegen and Leah, 1998). By contrast, c-Fos, FosB, JunB and Fras expression do not
occur at all (Leah et al., 1991; Jenkins and Hunt, 1991; Herdegen and Zimmermann,
1994). Induction of c-Jun precedes the activation of several regeneration associated
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genes such as GAP-43, tubulins and other cytoskeletal proteins required for axon
regeneration (Herdegen and Zimmermann, 1994; Mikucki and Oblinger, 1991;
Tetzlaff et al„ 1991).
1.4.3 Wallerian Degeneration of the Motor Nerve Terminal
The progress of Wallerian degeneration at the mammalian NMJ has been well
documented by - amongst others - Reger (1959), Birks, Katz and Miledi (1960), Miledi
and Slater (1968 and 1970), Manolov (1974) and Winlow and Usherwood (1975).
Axotomy induces degeneration of nerve terminals before the degeneration of their
motor axons. The abrupt failure of neuromuscular transmission is one of the first
detectable events following nerve damage (Birks, Katz and Miledi, 1960; Miledi and
Slater, 1970): occurring within 24-26 hours after axotomy in rodents. Initial
degenerative changes in the nerve terminal include (after a lag period of 3-8 hours;
Manolov, 1974; Miledi and Slater, 1970): i) the swelling, partial disruption of cristae
and destruction of mitochondrial membranes; ii) reduction in the number of, and
clustering of the remaining, 50nm clear synaptic vesicles; and iii) the active invasion of
terminal Schwann cell processes into the synaptic cleft. More advanced degenerative
changes include: i) intensification of intra-terminal disintegration; ii) gross
fragmentation of nerve terminal membranes; and iii) phagocytosis of the engulfed nerve
terminal by the terminal Schwann cell. After phagocytosis of the nerve terminal is
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complete, terminal Schwann cells sometimes remain apposed to the post-synaptic folds
for up to 3 weeks (see above).
Mitochondria are often used as a definitive marker of nerve terminal degeneration.
Miledi and Slater (1970) quantified the changes in mitochondria at axotomised NMJs,
showing that degenerating mitochondria acquire an enlarged, spherical profile, swelling
from a diameter of 0.1-0.2/tm in control preparations up to as much as 0.7/tm. The
cristae in these mitochondria often appeared 'disorganized and broken up into small
vesicular fragments' (Miledi and Slater, 1970). The same was described by Manolov
(1974), who also reported the occasional occurrence of 'dense bodies' substituted for
mitochondria. Manolov's (1974) investigations also identified the sporadic occurrence
of membrane whorl structures, often associated with degenerating mitochondria or
vesicular aggregations (see below).
Reger (1959), Manolov (1974) and Winlow and Usherwood (1975) have described
changes in the numbers and localisation of the synaptic vesicle population in
degenerating motor nerve terminals. The numbers of synaptic vesicles dramatically
decrease with increasing time following axotomy. For example, in the experiments of
Manolov and Winlow and Usherwood, nerve terminal profiles from 3 hours post-
axotomy onwards showed a small reduction in vesicle numbers. This is in marked
contrast to the many nerve terminal profiles (from >6 hours post-axotomy) which
contained no vesicles. Reger (1959) found that there was no incidence of degeneration
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at neuromuscular synapses until more than 24 hours post-axotomy, and as a result he
quantified synaptic vesicle densities in degenerating nerve terminals for up to 120 hours
following nerve lesion. By 48 hours, there had been a 79.2% decrease in the number of
synaptic vesicles, falling from 28-114 SVs//xm2 in control preparations to 0-24
SVs//tm2. Interestingly, Manolov (1974) found that in many nerve terminals which
survive for more than 20 hours post-axotomy, the reduction in synaptic vesicle number
and the occurrence of degenerating mitochondria occurred in conjunction with a large
increase in the levels of intra-terminal neurofilaments.
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1.5 The Wlds Mutant Mouse
During their investigations into the role of recruited myelomonocytic cells in Wallerian
degeneration of mouse peripheral nerve, M.C.Brown, V.H.Perry and their colleagues in
Oxford discovered, quite serendipitously, a spontaneous mutation in the C57B1/6 line of
mice supplied originally from Olac laboratories (Lunn et al., 1989). Superficially, these
mice showed no readily discernible phenotype and were easy to breed. What
distinguished these mice was the findings that Wallerian degeneration is significantly
delayed and protracted after axotomy. Thus, the distal portion of cut axons and their
motor nerve terminals remain morphologically intact for as long as 2 weeks. A similar
breeding colony, from the same original source, was found to be established in
Edinburgh. In both colonies, the remarkable finding was made that isolated distal axons
were still capable of conducting action potentials, and neuromuscular synapses
continued to release neurotransmitter and recycle synaptic vesicles, despite being
disconnected from their cell bodies (Tsao et al., 1994; Ribchester et al., 1995). Both
sensory and motor axons are delayed in their degeneration in these "Ola" mice, and the
mutation also delays Wallerian degeneration in the central nervous system, for example
following section of the optic nerve (Perry et al., 1990a; Ludwin and Bisby, 1992).
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1.5.1 Molecular Genetics of the Wlds Mouse
Genomic analysis of the mutant subsequently led to it's redesignation as Wlds (Lyon et
al., 1993). The nature of the Wlds mutation has now also been almost unequivocally
demonstrated (Figure 1.3).
Perry et al (1990b) produced genetic outcrosses and backcrosses with the Wlds mouse
and as a result showed that the mutation is controlled by a single autosomal dominant
gene. Further studies mapped the Wld locus to the distal end of chromosome 4, the
region homologous with the human chromosomal region Ip34-lp36 (Lyon et al., 1993).
The Wld locus was subsequently identified to be an 85-kb tandem triplication within the
candidate region, although in some mice there is a duplication allele indicating that
there may be some instability in the repeat copy number (Coleman et al., 1998).
Recent studies have identified exons of three genes located within the 85-kb repeat
sequence which could account for the Wlds phenotype (Conforti et al., 2000). Two
genes, ubiquitin fusion degradation protein 2 (Ufd2) and a novel gene, D4Colele, were
reported to span the proximal and distal boundaries of the repeat unit, forming a
chimeric gene with an open reading frame coding for a 43kDa fusion protein. The Wlds
gene and its protein product are strongly expressed in the nervous system of Wlds mice.
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Fig 1.3 Genetics of the WIds Mouse.
(A) Location of exons within the 85-Kb triplication repeat unit in the Wlds mutant
mouse, showing the formation of the Ube4b/Nmnat chimeric gene and the triplication of
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It has since been shown that the novel sequence D4Colele incorporates the complete
sequence encoding Nicotinamide mononucleotide adenylyl transferase (Nmnat), the
enzyme responsible for synthesising NAD (Emanuelli et ah, 2001), but incorporating an
N-terminal sequence of 18 amino acids that is not normally translated in Nmnat.
Similarly, ubiquitin fusion degradation protein 2 (Ufd2) has been shown to be
homologous to the human ubiquitination factor E4b (Ube4b; Mack et al., 2001
submitted).
1.5.2 Evidence that Slow Wallerian Degeneration in the
Wlds Mouse is an Intrinsic Property of the Nerve
Despite the recent demonstration of the genetic characteristics of the Wlds mutant, the
exact function of the gene and the mechanisms by which it confers protection from the
effects of axonal injury are not known. In their initial paper describing the Wlds mouse,
Lunn et al (1989) postulated that the reason for the slow progression of Wallerian
degeneration was a problem with the recruitment of myelomonocytic cells to the distal
portion of the axon. However, they subsequently refuted this hypothesis, by showing in
transplant experiments that the phenotype was not due to a defect in the circulating
monocyte population (Perry et al., 1990c). They concluded that the mutation therefore
alters intrinsic properties of axons. These findings were supported by Glass et al (1993)
who showed that Wlds axons still degenerate slowly within grafted peripheral nerve
sheaths containing wild-type Schwann cells, while axotomised wild-type axons
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degenerate normally within an environment containing Wlds Schwann cells. Likewise,
axotomy of Wlds axons demyelinated by intraneural injection of lysophosphatidyl
choline resulted in slow degeneration of the distal stump (Hall, 1993).
Axotomised Wlds neurites also persist in tissue culture. For example, Deckwerth and
Johnson (1994) studied Wlds sympathetic neurones from the superior cervical ganglion.
In wild type neurones the cell body and axons degenerate concurrently following the
removal of NGF (Edwards and Tolkovsky, 1994). However, in cultures of Wlds
neurones where NGF was absent, the axons survived whilst cell bodies underwent
apoptosis. Distal neurites also persist following physical axotomy in culture (Glass et
ah, 1993), although the survival of axons depends on how long the neurones are
cultured before cutting their axons (Buckmaster et ah, 1995).
1.5.3 Effect of the Wlds Mutation on Axotomised
Neuromuscular Junctions
As well as axons, axotomised motor nerve terminals are preserved as a result of the
Wlds mutation. As mentioned above, Ribchester et al (1995) showed that Wlds NMJs
are retained alongside their axons and sustain their ability to release neurotransmitter
and recycle synaptic vesicle membrane for at least 3 days, and in some cases as long as
2 weeks, following nerve lesion. This study also provided some preliminary data
concerning the ultrastructure of persistent motor nerve terminals in axotomised Wlds
32
mice. The authors showed that the general architecture of a nerve terminal is preserved
5 days after axotomy with no signs of degeneration.
Furthermore, preliminary evidence of a piecemeal withdrawal process at axotomised
Wlds nerve terminals has since been presented based on studies using vital dye
labelling, immunocytochemistry, electrophysiology and nerve / muscle cultures
(Mattison et al., 1996; Parson et al., 1998). These studies suggest that nerve terminals
may retract from the endplate, bouton by bouton, until they form a characteristic
bulbous swelling at the distal end of the axon and become detached from the endplate
(R. Mattison, PhD Thesis, University of Edinburgh). Physiological changes at these
synapses include a reduced quantal content and the occasional appearance of 'giant'
MEPPs. Taken together, these findings suggest that the events taking place at
axotomised Wlds NMJs are distinct from the synchronous degeneration of terminals
observed at wild-type denervated NMJs. No systematic study of the morphology of
axotomised synaptic boutons at an ultrastructural level had been carried out prior to
those described in the present thesis.
1.5.4 Secondary Characteristics of the Wlds Mutation
Although the Wlds mouse appears indistinguishable in appearance and behaviour from
the C57B1/6J mouse, both operated and unoperated Wlds mice show some subtle, as yet
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unexplained, phenotypic features, suggesting that slow nerve degeneration is not the
only effect of the Wlds mutation.
Brown et al (1991) found that normal, unoperated Wlds soleus muscles express greater
intrinsic tension, fewer macrophages per muscle fibre and lower basal levels of
acetylcholine sensitivity than their wild type counterparts. Using high resolution 'H
magnetic resonance spectroscopy (MRS), Tsao et al (1999a) detected altered cerebral
metabolism (indicated by decreased levels of glutamate and phosphocholine relative to
total N-acetyl aspartate content) in Wlds mice compared to wild type controls.
Other studies describe specific axotomy-related secondary characteristics associated
with the Wlds phenotype. For example, axotomy-induced motoneurone death in
neonates (Lapper et al., 1994) and retrograde degeneration of cell bodies in axotomised
adult retinal ganglion cells (Perry et al., 1990a) are also significantly delayed. In
denervated Wlds muscles, the initiation of muscle atrophy and development of
acetylcholine sensitivity have a slower onset, and the rise in serum creatine kinase
levels is also delayed (Brown et al., 1991). Interestingly, the degenerative axonal
response following exposure to the neurotoxin vincristine is delayed in the Wlds mouse,
suggesting common pathophysiological mechanisms between Wallerian degeneration
and toxic neuropathy (Wang et al., 2001).
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Axon-glia signalling plays an important role in the maintenance and control of both cell
types in vivo. Sprouting responses of non-myelinating terminal Schwann cells are
delayed by several days (both in vivo and in vitro) following denervation in the Wlds
(Barry et al., 1997; Parson et ah, 1998a). The resident Schwann cells in peripheral
nerve produce potential maintenance factors which are taken up by the axon: for
example, ciliary neurotrophic factor (CNTF). Following axotomy in the Wlds mouse,
both mRNA and protein levels of CNTF remain normal for up to 4 days, whereas in
wild type animals they both decline rapidly and synchronously (Subang et al., 1997).
However, by ten days after axotomy, CNTF mRNA levels in the Wlds mice have
decreased to wild type levels, but levels of CNTF protein remain unchanged. This
suggests that the CNTF protein is relatively stable in axotomised Wlds axons. Its
retention could contribute some protection against degeneration.
The failure of macrophage recruitment after axotomy (see above) may be due to a
failure of the nerve to produce a chemotactic signal, or there may be some form of
blockade which prevents the myelomonocytic cells entering the nerve (Perry et al.,
1990c). Some candidates for this chemotactic signal are the monocyte chemoattractant
protein-1 (JE) which fails to be induced in Wlds mice following axotomy (Carroll and
Frohnert, 1998) and granulocyte macrophage colony stimulating factor (GM-CSF)
whose levels are also deficient following axotomy in Wlds Mice. It is also possible that
persisting distal axons produce a factor that inhibits macrophage recruitment, whereas
production of this normally ceases in axotomised wild-type axons (Ludwin and Bisby,
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1992). Whether any or all of these features are related to Ube4b/Nmnat over expression
in Wlds mice remains to be tested.
1.5.5 Effects of the Wlds Mutation on Nerve Regeneration
Following axotomy in the PNS, immediate-early gene expression is initiated within a
few hours, and after an initial "dying back", the proximal axon stump is primed for
regeneration, which begins 5-48hrs after the lesion (Ramon y Cajal 1928; Brecknell and
Fawcett, 1996). In mice, this process gains momentum and proceeds over a number of
days before achieving a reinnervation of skeletal muscle after about 2-3 weeks.
Previously Wallerian degeneration was thought to play a functional role in generating
an environment conducive to nerve regeneration (Ramon y Cajal., 1928). It was
therefore hypothesised that in the Wlds mouse, intact distal nerve stumps would be
equivalent in their obstructive effect to intact nerves. Brown et al (1991a) showed that
severed axons would not grow into a completely undegenerated portion of nerve.
Remarkably however, regeneration of motor axons after a nerve crush injury in the Wlds
is not prevented by the presence of axons in the remaining distal nerve stump (Lunn et
al., 1989). This suggests that even though Wlds axons persist after axotomy and remain
capable of functioning normally, they may undergo some conformational changes that
allow regenerating nerves to progress along the distal stump.
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Other studies suggest that whilst motor axons appear able to regenerate almost as well
as in wild type mice, sensory nerve regeneration in Wlds mice is significantly impaired
(Bisby and Chen, 1990; Brown et ah, 1992). Sommer and Schafers (1998) showed that
the delay in sensory nerve regeneration leads to prolonged mechanical allodynia (a
condition in which ordinarily non-painful stimuli evoke pain). One possible
explanation for the disparity between the regeneration of motor and sensory nerves is
that axotomised sensory nerve axons degenerate and regenerate more slowly because
they are responsive to NGF levels (Bisby and Chen, 1990) and NGF levels do not
increase as rapidly after nerve section in Wlds mice compared to wild-type (Brown et
al., 1991). Motor axons do not respond to NGF. They also appear to be more
opportunistic, using myelinating and non-myelinating Schwann cells to guide
regeneration (Brown et al., 1992; Brown et al., 1993). Tenascin-C is upregulated
selectively in Schwann cells of axotomised muscle nerves of Wlds mice, and axons
regenerate more rapidly in these nerves than in cutaneous nerves where there is delayed
expression of Tenascin-C (Fruttiger et al., 1995). Conversely, Myelin-associated
glycoprotein (MAG) normally inhibits axon regeneration, but the rate of axon
regeneration in Wlds mice was partially restored when these mice were cross-bred with
MAG knockout mice (Schafer et al., 1996).
Shi and Stanfield (1996) also reported differences in sprouting and regeneration patterns
in the CNS of the Wlds mouse. In wild type mice, sprouting responses are detected in
the septohippocampal and hippocampal commissural projections within 3 days of a
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lesion to the perforant path to the dentate gyrus. However, in Wld5 mice
septohippocampal axonal sprouting was only observed 5-7 days after a perforant
pathway lesion and changes in the distribution of commissural axons in the dentate
gyrus were not observed before 12 days. It would clearly be of interest to establish the
fate of axotomised synapses, and their associations with astrocytic neuroglia following
axonal lesions in the brains of Wlds mice.
Alterations in the rate and extent of both motor and sensory reinnervation occurring as a
result of the Wlds mutation are not due to problems with the cell body reaction to
axotomy. The time-course of expression of transcription factors such as c-Jun is very
similar in Wlds mice to those in BALB/c controls (Brown et al., 1993).
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1.6 Mechanisms of Neurodegeneration
The distinctive nature of neuronal cell death by apoptosis (for reviews see Nijhawan et
al., 2000; Yuan and Yanker, 2000), and the Wallerian degeneration of distal axons
suggests that more than one mechanism is embedded in neurones for executing
neurodegenerative processes.
1.6.1 Neuronal Apoptosis
The term 'apoptosis' was coined by Kerr et al (1972), to describe a process involved in
the normal turnover of hepatocytes: intrinsic cell suicide. It was subsequently shown to
be a widespread mechanism found in almost all tissues of the body. There are three
main regulators of apoptosis in neurones: the Bcl-2 family of proteins, an adaptor
protein known as apoptotic protease-activating factor 1 (Apaf-1) and the cysteine
protease caspase family (Yuan and Yanker, 2000). Recent evidence has complicated the
matter however, by showing that the "involvement of specific caspases and the
occurrence of caspase-independent programmed cell death may be dependent on brain
region, cell type, age, and species" (Oppenheim et al., 2001). In the majority of
instances, neuronal apoptosis is also inhibited by growth factors and by over-expression
of genes such as Bcl-2. By contrast, Wallerian degeneration appears to be independent
of the same growth factors from the cell bodies, and is unaffected by the overexpression
of Bcl-2 (Dubois-Dauphon et al., 1994; Sagot et al., 1995; Burne et al., 1996).
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1.6.2 'Cytoplastic' Apoptosis of Axons
Whilst some of the cellular processes which occur during Wallerian degeneration (for
example; ellipsoid body formation) are remarkably similar to those seen during
apoptosis, Wallerian degeneration obviously cannot involve all apoptotic cellular
processes (eg. DNA degradation) because axotomised distal stumps do not include
motoneurone cell bodies. However, it has previously been shown that apoptosis can
occur in the absence of RNA or protein synthesis (Martin, 1993) and in cells lacking
nuclei (Ellerby et al., 1997; Jacobson et ah, 1994). Thus, a number of authors have
suggested that axonal degeneration might be viewed as a form of 'cytoplastic apoptosis'
(Ribchester et al., 1995; Buckmaster et al., 1995; Alvarez et al., 2000). Studies in
which the role of Bcl-2 in axonal degeneration was examined also concluded that the
molecular mechanisms involved are distinct from those activated during apoptosis of
neuronal cell bodies. Burne et al (1996) showed that over-expression of the human Bcl-
2 protein in retinal ganglion cells protects the cell body as expected. However, the
axons were not protected from Wallerian degeneration. Similar findings were reported
in a study by Sagot et al (1995) who examined the fate of cell bodies and axons in a
mouse model of motor neurone disease with Bcl-2 over-expression. The increased level
of Bcl-2 rescued facial motoneurones and restored their soma size and choline
acetyltransferase expression. However, there was no effect on the rate of axonal
degeneration in facial and phrenic motoneurones. Thus it seems unlikely that Bcl-2
itself plays a significant role in axon degeneration.
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Finn et al (2000) recently examined whether the molecular machinery of Wallerian
degeneration depends upon the caspase family of cysteine proteases. They found that
caspase-3 (which is thought to be important for apoptosis in neurones) was not activated
in the axon during Wallerian degeneration. Thus, they argued that Wallerian
degeneration is molecularly distinct from the classical caspase-dependent apoptotic
process implicated in axonal degeneration.
1.6.3 'Synaptic Apoptosis'
Evidence in support of the hypothesis that the degeneration of synapses is regulated
independently from that of cell bodies or axons is currently lacking in comparison to the
data available concerning somatic and axonal degeneration. Some data has been
obtained in recent studies of CNS neurones however. For example, Ivins et al (1998)
have shown that exposure to an apoptotic stimulus (amyloid (3-peptide) plays a crucial
role in inducing the activation of caspases and hence apoptosis in cultured hippocampal
neurones. Using the same cell-death stimulus, Mattson et al (1998b) found no caspase
activation in axons, but instead reported that caspases were activated in cortical
synaptosomes. Their data also provide evidence that apoptotic biochemical cascades
(such as caspase activation) are selectively triggered at synaptic sites following
exposure to staurosporine and Fe2+. The term 'synaptic apoptosis' was proposed
(Mattson et al., 1998a; Mattson et al., 1998b; Mattson, 2000; Guo and Mattson, 2000).
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1.7 Synapse Elimination
The withdrawal of nerve terminals during synapse elimination is currently the best
understood incidence of synapse specific rearrangement and plasticity in the
mammalian nervous system. As it has been suggested that the withdrawal of
axotomised synaptic terminals in Wlds mice may resemble certain aspects of synapse
elimination (Mattison et al., 1996; Parson et al., 1998; R. Mattison, PhD Thesis,
University of Edinburgh), it would hardly be surprising if common mechanisms were
involved.
Early studies by Tello (1917) and Boeke (1921) described how neonatal mammalian
skeletal muscle fibres are innervated at a single site by multiple motor nerve terminals
arising from several motoneurones ('polyneuronal innervation'; Redfern, 1970; Brown
et al., 1976). A similar innervation pattern is re-established following nerve injury and
subsequent regeneration in adult muscle (McArdle, 1975; Ribchester, 1988; Costanzo
et al., 1999; Costanzo et al., 2000). A refinement of these synaptic connections occurs
with time via a process known as synapse elimination, resulting in the vast majority of
endplates being innervated by a single motor axon (see Ribchester, 2001 for recent
review).
Whilst the majority of research into synapse elimination has been undertaken using
NMJ preparations, there are numerous other studies which describe developmental
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synapse elimination occurring in regions of the CNS: in the visual system (Hubel et al.,
1977), in autonomic ganglia (Lichtman, 1977) and in the cerebellum (Lohof et al.,
1996). These can involve multiple inputs being withdrawn, leading to single
innervation, as at climbing fibre/Purkinje cell synapses in the cerebellum, or can involve
a 'rearrangement' of many inputs whilst maintaining multiple innervation such as
occurs during the development of thalamocortical / cortical layer 4 synapses in the
visual system. As this study concentrates on plastic mechanisms at the NMJ, the
following introduction will refer to the transition from multiple to single innervation.
1.7.1 The Nature of Synapse Elimination at the NMJ
Neuromuscular synaptogenesis begins shortly after myoblast fusion occurs during
development (Bennett and Pettigrew, 1974). It appears to occur in a random manner,
with each motor neurone establishing synapses on many different muscle fibres
(Jennings, 1994). The end result of this synaptogenic period is that each skeletal muscle
fibre receives convergent inputs from more than one motor axon. In rodents it is not
until the first few postnatal weeks however that synapse elimination refines these
connections (Redfern, 1970; Brown et al., 1976; Betz et al., 1979). Other studies
extended these findings to show that synapse elimination occurs in the nervous systems
of other species such as kittens (Bagust et al., 1973) and humans (Huttenlocher et al.,
1982; Ijkema-Paassen and Gramsbergen, 1998).
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Brown and colleagues showed, in their now-classic (1976) study on innervation of the
neonatal soleus muscle, that the elimination of polyneuronal innervation does not occur
by axonal death or degeneration (Brown et ah, 1976). Evidence for this was provided
by demonstrating that during the transition from poly- to mono-innervation there was no
reduction in the number of motor neurones innervating the muscle. They therefore
concluded that the removal of supernumerary inputs reflects a reduction in the number
of synaptic connections made by each individual motor neurone. Furthermore, these
authors demonstrated that the process of synapse elimination occurs without transient
denervation of endplates. Moreover, such a retention of synaptic interactions has
subsequently been shown to be crucial for the normal postnatal development of other
extra-synaptic portions of the neurone, such as the soma and dendrites (Dekkers and
Navarrete, 1998).
When the ultrastructure of nerve terminals on neonatal muscle fibres was examined
using the electron microscope, convincing evidence was provided that synapses are
indeed retracted from endplates during synapse elimination rather than undergoing a
degenerative process similar to Wallerian degeneration. Both Korneliussen and Jansen
(1976) and Bixby (1981) found no signs of degenerative processes occurring in any
nerve terminal profiles during the period of synapse elimination in rats and rabbits
respectively. These findings were extended in studies by Riley who observed axonal
retraction during synapse elimination using both the light and electron microscope
(Riley, 1977; Riley, 1981). He described how axons and their nerve terminals which
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are withdrawing from an endplate forming 'retraction bulbs', characterised by a
terminal oval enlargement. Ultrastructural observation of such bulbs showed them to be
laden with vesicles, strongly suggesting that they are the morphological manifestations
of a packaged up nerve terminal.
There has been one study however which proposes that supernumerary terminals are
removed by degenerative mechanisms. Rosenthal and Taraskevich (1977) described
ultrastructural profiles of neonatal endplates showing signs of "abnormal structure"
during the period of synapse elimination. Some of the terminals they examined showed
a clustering of synaptic vesicles as well as terminal Schwann cell encroachment into the
synaptic cleft. They also described the presence of large areas of postsynaptic
membrane with only a Schwann cell present. All of these are characteristics associated
with Wallerian degeneration of motor nerve terminals. Despite this study, for which an
adequate explanation has yet to be provided, the vast majority of evidence supports the
hypothesis that supernumerary inputs are removed by a process of withdrawal rather
than degeneration.
1.7.2 Mechanisms Underlying Synapse Elimination at the
NMJ
Although the current study is not specifically directed towards the study of synapse
elimination, an understanding of the mechanisms which underlie this phenomenon,
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whilst demonstrating the fine cellular control present at synaptic connections in general,
may also provide insights into the machinery which is responsible for regulating the
synaptic events occurring at axotomised Wlds NMJs.
The occurrence of synapse elimination is neither spontaneous nor random (Costanzo et
al., 2000). It is usually considered to be a competitive process whereby neurones and
their synapses compete within spatial and / or consumptive constraints (Betz et al.,
1980; Ribchester and Barry, 1994). However, other studies (Thompson and Jansen,
1977; Fladby and Jansen, 1987) have shown that nerve terminals can be withdrawn
from the endplate, even in the absence of competitors, thereby suggesting that such
terminals are capable of responding to an intrinsic programme of the motor neurone to
reduce its number of synapses. Smallheiser and Crain (1984) proposed a similar
intrinsic mechanism of nerve terminal loss, whereby the process of synapse elimination
is driven by 'sibling neurite bias'. Whilst the reasons underlying the conflicting results
from these studies have yet to adequately addressed, it remains possible that both
mechanisms may occur during synapse elimination, acting either in conjunction with
one another or independently.
One hypothesis which explains synapse elimination as a competitive phenomenon
utilises the 'neurotrophic theory'. It proposes that neurones depend upon their target
organs (in the case of the NMJ, skeletal muscle fibres) for trophic sustenance (Purves,
1988). This leads to a situation whereby neurones compete for a limited amount of a
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trophic substance (neurotrophic factor) provided by the muscle fibre (Grinnell et al.,
1979; Purves and Lichtman, 1985; Ribchester and Barry, 1994). Those terminals best
capable of securing and utilising such a factor may therefore gain a competitive
advantage over neighbouring terminals competing for the same resource.
It is also thought that orthograde patterns of activity in a neurone may have a role in
controlling the level of production, availability and / or accessibility of trophic factors
from the target organ (Ribchester and Barry, 1994). For example: upon the initial,
polyneuronal, innervation of a muscle fibre, general activity levels are relatively low,
leading to large amounts of neurotrophic factor release. As receptors on the motor
nerve terminals are therefore binding high levels of such a factor, they gradually
increase their ability to release neurotransmitter (Ribchester et al., 1998) thereby
upregulating their level of activity. An increased level of motor neurone activity then
suppresses the production of neurotrophic factors by the muscle fibres. If one of the
competing inputs manages to take up more of the trophic substance than others, it gains
a major competitive advantage as it can strengthen it's own connection whilst reducing
the levels of trophic factor being produced. With a lower level of trophic factor present,
other competing inputs can no longer gain enough to sustain themselves nor strengthen
their connections. This situation could quite feasibly lead to a domination by a single
input, and a subsequent withdrawal of all others.
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The neurotrophic theory of synapse elimination is probably an oversimplification
however. A more intricate mechanism for synapse elimination has since been proposed
in an elegant series of experiments by Balice-Gordon and Lichtman (1994). These
authors focally applied a-bungarotoxin to a small region of a NMJ. This block in
neurotransmission led to long-lasting synapse elimination at that portion of the endplate.
In contrast they showed that an application of a-bungarotoxin to the whole of a NMJ
did not lead to any synapse elimination. From these experiments they concluded that
active synapses produce both an elimination and a protective signal, whilst inactive
synapses produce neither. This, they argued, can lead to the elimination of an inactive
synapse and the retention of it's active 'competitor'. Whilst it is unlikely that any of the
converging inputs at an endplate would be completely inactive, this model can easily be
applied to a more subtle situation, where slightly stronger inputs (possibly due to the
effect of a simple 'neurotrophic' style competition) are able to both protect themselves
better, at the same time as producing a stronger elimination signal, than weaker inputs.
Many studies have shown that the pattern of neural activity is a major driving force
behind synapse elimination (Hubel at el, 1977; LeVay et ah, 1980; Wiesel, 1982;
Jennings, 1994; Lohof et ah, 1996; Sanes and Lichtman, 1999). Experiments utilising
the NMJ have addressed the hypothesis that an asynchronous activation of postsynaptic
receptors is responsible for the initiation of synapse elimination (Balice-Gordon and
Lichtman, 1994). Over the course of several days following the application of a
saturising dose of bungarotoxin, receptors were lost from the post synaptic apparatus.
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Following this, nerve terminals which were previously overlying the now vacated
receptor sites were seen to retract from the endplate. These events reflect both the time
course and pattern of events witnessed during naturally occurring synapse elimination
(Lichtman and Colman, 2000). In a recent study by Bussetto and colleagues (Bussetto
et ah, 2000), these findings were further extended by showing that synchronous axonal
activation indeed prevents synapse elimination. The conclusions to be drawn from
these studies imply that it is not activity per se, but rather the relative size, strengths and
firing patterns of different portions of the NMJ which are responsible for determining
the likelihood of withdrawal of small, inactive inputs. Furthermore, recent evidence
suggests that these processes may be mediated by the differing roles played by
presynaptic calcium channel types at separate inputs converging on a polyneuronally
innervated NMJ (Santafe et ah, 2001).
Whilst it is almost universally accepted that activity is influential on synapse
elimination, the hypothesis which states that the level and synchronisation of activity is
the main underlying force responsible for driving synapse elimination is slowly being
refuted. Studies have shown that if a portion of axons supplying a muscle are blocked
during development, the inactive axon collaterals are less susceptible to synapse
elimination than their active counterparts (Callaway et ah, 1987). Studies of NMJs in
control and reinnervated muscle preparations have provided evidence for the persistence
of polyneuronal innervation in a few junctions, many months after the synapse
elimination period is completed (Werle and Herrera, 1987; Jordan et ah, 1988; Werle
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and Herrera, 1991; Barry and Ribchester, 1995). The only possible way in which these
results can support the activity hypothesis is if the activity patterns of converging inputs
at these persistent junctions are synchronous. Whilst this is not impossible, it has to be
considered highly unlikely.
Further evidence has recently been provided to show that activity, whilst being
influential, is neither sufficient nor necessary for synapse elimination (Costanzo et al.,
1999 and 2000), which appears to refute the activity hypothesis of Balice-Gordon and
Lichtman (1994). These studies demonstrated that activation (either evoked or
spontaneous) of postsynaptic receptor sites is not required for the competitive
elimination of an existing terminals by a regenerating axon, and that the remodelling of
synapses in general can continue in the absence of activity.
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1.8 Aims of the Present Study
This thesis has three main aims;
1) To extend knowledge and understanding of the fate of NMJs in normal and Wlds
mice following axotomy. Qualitative and quantitative vital staining,
immunocytochemical and ultrastructural experiments were carried out on control and
axotomised Wlds nerve/muscle preparations. One purpose of these experiments was to
seek evidence in support of previous studies which have shown that axotomised Wlds
motor nerve terminals are lost by a process of piecemeal withdrawal. The main purpose
however, was to extend these findings to include a systematic study of the morphology
of axotomised synaptic boutons at an ultrastructural level. The latter was aimed at
providing unequivocal evidence that the loss of axotomised nerve terminals from young
(<2 month old) Wlds mice occurs via a process separate and distinct from that of
Wallerian degeneration. In order to achieve this, both qualitative and quantitative data
from control NMJ profiles were compared to those from axotomised Wlds NMJ profiles
at 3, 4, 5 and 7 days post axotomy.
2) To address the controversy in the literature over a possible age-dependent
expression of the Wlds phenotype. This was achieved by a qualitative and quantitative
comparison of the morphological and ultrastructural events occurring at axotomised
NMJs from Wlds of 2, 4 and 7 months of age. These experiments were designed not
only to assess variations in the rate, but also the mechanisms, of nerve terminal loss in
Wlds of different ages. By comparing these findings to those produced from wild-type
preparations as well as previous descriptions of the morphological events underlying
Wallerian degeneration, it was possible to assess the incidence of the latter at
axotomised nerve terminals from all Wlds age groups. An examination of cross sections
from the tibial nerve, from both above and below the site of nerve lesion, allowed for a
comparison of alterations in the rate of axonal and nerve terminal degeneration from
young and old Wlds mice.
3) To test the hypothesis that the Wlds phenotype is produced as a result of the
expression of a Ube4b/Nmnat chimeric gene. This hypothesis was tested by examining
the effect of axotomy on NMJs from transgenic mice engineered to strongly express the
Ube4b/Nmnat chimeric gene and its protein under a (3-actin promoter. Morphological
and ultrastructural analysis of these preparations, alongside comparisons made against
the findings from Wlds and wild-type studies described above, allowed an assessment of





The protocols detailed in this section are common to all chapters. Procedures specific
to an individual chapter are detailed in subsequent sections.
2.1.1 Animals and Animal Care
Male and Female C57B1/Wlds mice, female C57B1/6J, C3H and Swiss mice were used
for experiments. Animals were housed in cages of 5 or less with free access to food and
water. Environmental conditions were those of a standard animal house.
2.1.2 Aseptic Procedures
All surgical procedures were undertaken in aseptic conditions and were fully licensed
by the UK Flome Office. All instruments, cloths and gowns used were sterilised on site.
Other equipment such as gloves and suture threads were sterilised by the manufacturer
before delivery. The operative areas of the animal were shaved and swabbed with




Anaesthesia was induced via inhalation, by placing the animal in a sealed perspex
chamber into which Halothane (Rhone-Poulenc Rorer, Ltd.) at 5% in N20 / 02(1:1) was
delivered, using a Fluovac System (International Market Supply). Upon the induction
of anaesthesia, the animal was transferred to the operating table where anaesthetic was
continued to be delivered via a face mask. Following a toe-pinch reflex test to assess
the level of anaesthesia, the level of halothane was reduced to 1% in N20 / 02 (1:1).
The animal was monitored throughout the procedures to maintain the correct level of
anaesthesia.
Nerve Cut
Once a suitable depth of anaesthesia had been achieved, the skin and fascia covering
either the sciatic nerve in the thigh, or the tibial nerve in the calf, were opened and
reflected. When the nerve was sufficiently exposed a l-2mm section was cut out using




All animals were killed either by cervical dislocation or by exposure to ever increasing
levels of C02, in accordance with schedule 1 of the licensing regulations provided by
the UK Home Office.
2.1.5 Nerve-Muscle Preparations
Flexor Digitorum Brevis (FDB)
Immediately following sacrifice, hind limbs were removed and FDB muscles were
dissected, with or without their intact nerve supply, in mammalian physiological saline
(mM concentrations: NaCl 120; KC1 5; CaCl2 2; MgCl2 1; NaHC03 23.8; D-
glucose 5.6), bubbled with O, / C02 (95% / 5%). Dissected FDB preparations were
pinned out in Sylgard (Dow Corning) coated petri dishes, containing the oxygenated
physiological saline, using 0.2mm diameter minutien pins (Interfocus Ltd).
Transversus Abdominus (TA)
Immediately following sacrifice, the rib cage and its attached inferior musculature were
removed. The gross dissections were pinned out in Sylgard coated petri dishes,
containing oxygenated physiological saline, using 0.2mm diameter minutien pins. The




Immediately following sacrifice, hind limbs were removed and IDLs and/or 4DLs were
dissected, with or without their intact (dual in the case of 4DL) nerve supply, in
oxygenated mammalian physiological saline. Dissected preparations were pinned out in
Sylgard coated petri dishes, containing the oxygenated physiological saline, using
0.2mm diameter minutien pins.
2.2 Fluorescent Labelling of the Postsynaptic Apparatus
Muscle preparations pinned out in a Sylgard-lined dish were fixed in a 4%
paraformaldehyde (Sigma) solution for 45mins before incubation in a 5/xg/ml TRITC-
a-BTX solution to label AchRs. The solution was kept in permanent motion by placing
the dish on a rotating platform for 30mins. The a-BTX solution was discarded and the
preparation washed in 0.1M PB. See end of chapter for detailed protocol.
2.3 Labelling of Axons and Motor Nerve Terminals using
Immunocytochemistry
Following labelling of postsynaptic sites with a-BTX, muscles were permeabilised and
tagged with 1° monoclonal antibodies (Developmental Studies Hybridoma Bank)
57
directed against synaptic vesicle (SV) proteins (SV2) and 165kDa neurofilament (NF)
proteins (2H3). The 1° antibodies were then labelled with FITC-conjugated sheep anti-
mouse 2° antibodies (Diagnostics Scotland, Law Hospital, Carluke, Lanarkshire, UK).
See end of chapter for detailed protocol.
2.4.1 Visualisation of Fluorescent 2° Antibodies / Dyes
(Standard Fluorescence Microscope)
Immunocytochemically labelled nerve/muscle preparations were viewed in a
fluorescence microscope (CF Fluorescent, Nikon) using a Zeiss 40x water immersion
objective and a mercury lamp (Nikon HBO-lOOW/2). An FITC excitation/emission
filter block (450-490nm excitation filter, 510nm dichroic mirror and 510-520 emission
filter; Nikon) was used for visualising FITC labelled antibodies, a TRITC
excitation/emission filter block (510-560nm excitation filter, 580nm dichroic mirror and
590 emission filter; Nikon) was used for visualising TRITC labelled aBTX, and a triple
band pass filter (with excitation and emission filters containing selective filters for both
FITC and TRITC and the dichroic mirror containing complementary reflection and
transmission bands specific to the excitation and emission filters; Chroma) was used for
visualising both FITC and TRITC simultaneously.
The fluorescence microscope was mounted on a stage support (Microinstruments M2B)
attached to an anti-vibration table (Newport). Images were captured using a colour
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chilled 3CCD camera (Hamamatsu C5810) connected to an Apple G4 computer running
Openlab (Improvision) and Adobe Photoshop software. Images were enhanced and
analysed using Adobe Photoshop before being printed on an Epson Stylus Colour 900
printer.
2.4.2 Quantification of Immunocytochemically Labelled
Neuromuscular Junctions
All NMJs on every slide were counted and assessed. Each NMJ was scored with regard
to the proportion of the endplate which was contacted by an overlying nerve terminal,
and placed into one of the following categories: 100% occupied, 99-75% occupied, 74-
50% occupied, 49-25% occupied, 24-1% occupied or vacant. All data were inserted
into a Microsoft Excel 2001 spreadsheet for further analysis, and graphs were produced
in SigmaPlot (SPSS Science).
2.4.3 Visualisation of Fluorescent 2° Antibodies / Dyes
(Confocal Microscope)
Some immunocytochemically labelled nerve/muscle preparations were viewed in a
Radiance 2000 confocal microscope (Biorad) attached to a Nikon Eclipse E600
microscope equipped with a 40x water immersion objective (Nikon). Images were
captured using Lasersharp 2000 software running on a Dell Poweredge 1400 computer.
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TIFF files were exported into Adobe Photoshop before being printed on an Epson
Stylus Colour 900 printer.
Some confocal images were created as stereo pairs. These images were produced using
the Lasersharp 2000 software which can rotate confocal views. An original confocal
image was rotated by +6 degrees and -6 degrees, thereby producing two separate
rotated images. When these images are placed adjacent to one another, and the two
profiles fused by the eyes of the viewer, a three-dimensional image is produced.
2.5 Visualisation of NMJ Ultrastructure using
Transmission Electron Microscopy
Preparations were pinned out on dental wax before being immersed in a 4%
paraformaldehyde / 2.5% glutaraldehyde (Sigma) solution for 4-6 hours at 4 °C. The
fixed preparation was then washed and post-fixed in a 1% osmium tetroxide (Sigma)
solution before dehydrating through a series of alcohols (incorporating a uranyl acetate
stain; Sigma) and embedding in Durcupan resin (Sigma). 70-90nm sections were cut
using a Diatome Ultra 45 diamond knife on a Reichert 'Ultracut' ultramicrotome
(Reichert). Sections were picked up on 2x1 mm Formvar slot grids (Agar Scientific)
and stained with Reynold's lead citrate before viewing in a Philips CM12 transmission
electron microscope. See end of chapter for detailed protocol.
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2.6 Ultrastructural Quantification of Withdrawing /
Degenerating Motor Nerve Terminals
To prevent counting any one nerve terminal more than once, thin sections were cut at
50/xm intervals. Stained grids (see above) were examined in the electron microscope
and all nerve terminal profiles were scored as either normal, partially occupied with no
signs of degeneration, partially occupied with signs of degeneration, degenerating or
vacant (with or without terminal Schwann cell remaining opposed to the postsynaptic
folds). Markers of degeneration included: more than 20% of mitochondria with
swelling and disruption of membranes (up to 19% is observed in control preparations
and is thought to represent the normal turnover of terminal mitochondria; Winlow and
Usherwood, 1975), nerve terminal membrane fragmentation and terminal Schwann cell
phagocytosis. Synaptic vesicle levels were also analysed (see below). All data was
entered into a Microsoft Excel 2001 spreadsheet for further analysis.
2.7 Ultrastructural Quantification of Sub-Cellular
Organelles at the NMJ
A new series of thin sections were cut as described above. The reason that the initial set
of electron micrographs, used for the analysis of partial occupancy, could not be used
for quantitative analysis was that they were taken over a large range of magnifications
(2500x up to 120000x). This is not suitable for accurate quantification, therefore TEM
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negatives of nerve terminal profiles from the new series of sections, all taken at 13000x
magnification, were scanned at 600dpi using a Linoscan 1200 transparency scanner
(Heidelberg) connected to an Apple iMac equipped with Linocolour Elite 6.0 software
(Heidelberg). TIFF files were created and exported into Adobe Photoshop for contrast
enhancement and printing on an Epson Stylus Colour 900 printer. These images were
then subjected to two forms of quantitative analysis.
2.7.1 Quantification of Organelles at the NMJ
A dot grid (25 x 27 dots at 4mm spacing) acetate sheet was superimposed on individual
electron micrographs (adapted from the method described by Hirji et al., 2000). The
area of an individual nerve terminal was calculated (using units of dots/terminal"1) by
counting the total number of dots landing within or contacting the outer membranes of
the terminal. The number of dots landing within or contacting the membranes of
synaptic vesicles, neurofilaments and mitochondria within the terminal were also
recorded.
2.7.2 Quantification of Overall Synaptic Vesicle Density at
the NMJ
Synaptic vesicles to be counted were identified using a slight modification of the
criterion established by Winlow and Usherwood (1975). To be included in the count,
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vesicles had to display: a) a clear lumen, b) an unbroken membrane, and c) a diameter
of no more than approximately 120nm. Coated vesicles, dense core vesicles and
cisternae were included in the count, although they were only occasionally observed.
Synaptic vesicle density within a nerve terminal profile was calculated using the
following formula (where 121 represents the number of dots on the counting grid
equivalent to 1/xm2):
Total Terminal Area
SV density (SV//mr) = Number of SV profiles
121
2.7.3 Quantification of Synaptic Vesicle Packing Density
at the NMJ
The proportion of the terminal filled by neurofilaments and mitochondria was calculated
and then subtracted from the total area of the terminal, thereby leaving the area in which
it is theoretically possible for synaptic vesicles to occur (this method is adapted from
that used in previous studies by Usherwood and Rees (1973) and Winlow and
Usherwood (1975)):
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Total Terminal Area - (NF Area + Mitochondria Area) = Area Available For SV
The percentage of the area available for synaptic vesicles which was actually occupied
by vesicles (synaptic vesicle packing density) could then be calculated:
SV Area
% of Available Terminal Occupied by SV = x 100
(NF Area + Mitochondria Area)
All raw data were entered into a Microsoft Excel 2001 spreadsheet where standard
statistics were calculated.
2.7.4 Localisation of the Synaptic Vesicle Population at
the NMJ
Whilst the quantitative analysis described above provides accurate data with regard to
the numbers of synaptic vesicles, it gives no indication as to their localisation within a
nerve terminal. To establish the numbers of vesicles located at, or near, active zones on
the presynaptic membrane (representing 'docked' vesicles from the functionally and
morphologically distinct 'ready releasable pool'; Sudhof, 2000; Schikorski and
Stevens,2001), a 4.5mm radius circle marked on an acetate sheet was superimposed
onto individual electron micrographs (producing a 125nm radius circle on the scale of
the electron micrograph). The centre of the measuring circle was placed directly on top
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of an active zone on the presynaptic membrane. Active zones were identified as the
area of presynaptic membrane (sometimes appearing more electron dense than the
membranous regions either side of the zone) directly opposing the opening of a
postsynaptic junctional fold. The number of vesicle profiles either within the circle or
contacting the boundaries of the circle were counted. The criteria used for the
identification of synaptic vesicles was the same as described previously. This procedure
was repeated at up to 4 active zones on each terminal. This method is similar to that
recently published by Schikorski and Stevens (2001).
The raw data were entered into a Microsoft Excel 2001 spreadsheet where standard
statistics were calculated.
2.8 Statistical Analysis
Unless otherwise stated, the following statistical tests were performed using Instat
(Graphpad Software) running on an Apple iMac computer:
i) Unpaired, nonparametric tests (e.g. Mann Whitney).
ii) Unpaired t tests (eg. Student t test or Welch's test).
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2.9 Neurofilament, Synaptic Vesicle and AchR
Immunocytochemistry Protocol
1. Preparations were fixed in 4% Paraformaldehyde for 40mins:
4g Paraformaldehyde
100ml 1 x Phosphate Buffered Saline (PBS; Sigma)
Heat to 60-70°C whilst stirring continuously
Add 4-5 drops of 0.1M NaOH
Wait until solution clears
Chill to 4°C in fridge
2. Wash 3 times for lOmins in fresh 1 x PBS
All steps now undertaken on a platform rotator at room temperature and in a sealed,
dark box to keep light out.
3. Incubate in a 0.1M glycine solution for lhour
4. Incubate in a fresh 5/xg/ml TRITC-a-BTX solution for 30mins









7. Incubate for 1 hour in fresh primary soln.
8. Wash 3 times for lOmins in blocker
9. Incubate in 2° antibody solution for 4 hours:
4ml lx PBS
20pl FITC sheep-anti-mouse antibody
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10. Wash 3 times for 30mins in lxPBS
11. Mount preparation in Vectashield (Vector Laboratories Inc.) on a slide and
coverslip.
12. Store in dark box at 4°C
67
2.10 Transmission Electron Microscopy Protocol
1. Preparations were fixed in a fresh 4% Paraformaldehyde / 2.5%
Glutaraldehyde solution for 4-6 hours at 4 °C:
4g Paraformaldehyde
35ml ddHUO
Heat to 60-70°C whilst stirring continuously
Add 4-5 drops of 0.1M NaOH
Wait until solution clears
Filter solution
Add 10ml of 25% Glutaraldehyde stock solution
Add 50ml 0.2M PB
Make up to lOOmls with ddH20
Chill to 4°C in fridge
2. Wash 3 times for lOmins in fresh 0.1M PB at 4 °C
3. Post-fix preparations in 1% Osmium tetroxide for 45mins on rotator:
5ml 4% Osmium Stock Solution
5ml ddH20
10ml 0.2M PB
4. Wash 2 times for lOmins in fresh 0.1M PB at 4 °C
5. Wash 2 times for lOmins in ddH20
6. Dehydrate through a descending series of alcohols;
50% for lOmins
70% (including 1% Uranyl Acetate (Sigma)) for 45mins
90% for 15mins
100% for 15mins
100% (with dry filters) for 15mins
7. Immerse in propylene oxide for 2 x 15mins
8. Leave specimens in Durcupan resin overnight at room temperature
9. Block out specimens in resin and leave in oven (65°C) for 48 hours
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10. Blocks were trimmed to a 1mm2 cutting face using a razor blade before thick
sections were taken using a glass knife. Light microscopic analysis of thick
sections identified when a suitable area of the muscle had been reached.
11. Thin (70-90nm) sections were cut on a Diatome Ultra Diamond knife and
collected on the surface of double distilled, boiled water contained within the
attached 'boat'.
12. Sections were exposed to chloroform to remove any excess folding before being
collected on Formvar slot grids and left to dry naturally.
13. Grids were stained with uranyl acetate and lead citrate in a LKB 'Ultrostainer'




3. Responses of Normal and Wlds Motor Nerve
Terminals to Axotomy
3.1 Background
Lesion of a vertebrate nerve normally results in the rapid degeneration and subsequent
phagocytosis of distal axon stumps and motor nerve terminals, via the process of
Wallerian degeneration. The specific characteristics of Wallerian degeneration at motor
nerve terminals have been well documented (see chapter 1; Reger, 1959; Miledi and
Slater, 1968; Miledi and Slater, 1970; Manolov, 1974; Winlow and Usherwood,
1975). In the naturally occurring Wlds mutant mouse, degeneration of the axon and
motor nerve terminals is significantly delayed following axotomy (Lunn et ah, 1989;
Tsao et ah, 1994; Ribchester et al., 1995). Furthermore, previous studies have
suggested that axotomised motor nerve terminals in these mice may undergo a separate
kind of degenerative process, morphologically and functionally distinct from that of
Wallerian degeneration. There is immunocytochemical evidence for an intermediate
stage of partial occupancy of endplates, whereby areas of postsynaptic receptors are
present but not contacted by an overlying terminal. This suggests that Wlds nerve
terminals may be retracted in a piecemeal fashion from the endplate following axotomy
(Ribchester et ah, 1995; Mattison et ah, 1996; Parson et ah, 1998; Ribchester et ah,
1999). Ribchester et ah (1995) also provided a limited account of the ultrastructural
preservation of Wlds motor nerve terminals, showing that terminal architecture is
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retained for up to 5 days post axotomy. Electrophysiological investigation of
axotomised Wlds NMJs suggested that nerve terminal withdrawal is accompanied by a
progressive weakening of synaptic transmission, as indicated by an increased variance
in EPP amplitude and a reduced quantal content (Ribchester et al., 1999; Derek
Thomson, personal communication).
This chapter confirms and extends the above findings, and includes evidence which
supports the hypothesis that axotomised Wlds nerve terminals are lost by a mechanism
that is distinct from the mechanism of degeneration at wild-type NMJs.
First, I present experimental data regarding the morphological and ultrastructural
characteristics of unoperated, axotomised and toxin-treated wild-type mouse NMJs
using immunocytochemistry, vital-dye staining, confocal microscopy and electron
microscopy. Although the events which occur at axotomised wild-type NMJs have
been well documented (see chapter 1), and a few comparisons within this thesis are
made using previously published findings, this 'control' data was generated for several
reasons. Firstly, it provided an accurate representation of wild-type characteristics
using the tissue processing techniques specific to this study. Other authors have used
experimental protocols which differ from those described in this thesis to assess the role
of axotomy at the NMJ. Some examples of these differences include: Miledi and Slater
(1970) and Manolov (1974), who both used rats rather than mice; Miledi and Slater
(1970), Manolov (1974) and Winlow and Usherwood (1975), who all used diaphragm
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muscle preparations rather than FDB muscle preparations; Manolov (1974), who relied
on a single osmium fixation step rather than inserting a paraformaldehyde /
glutaraldehyde fixation step before post-fixation in osmium; and Winlow and
Usherwood (1975), who used Araldite resin to embed their tissue rather than Durcupan
resin. Whilst these methods may only deviate slightly from my own, and variability of
results should theoretically be minimal between these different studies, by producing
wild-type data using the same techniques as those used for Wlds preparations described
later in this study, comparisons between different experimental groups should be more
accurate. Secondly, control preparations were treated with a-latrotoxin and Steatoda
toxin in order to assess the sensitivity of the ultrastructural quantification techniques
used in this study. Application of purified a-latrotoxin (2nM) produces very high,
sustained MEPP frequencies (several hundred sec"1; Ribchester et al., 1998) within five
minutes of application. Similarly, application of gland extract from the theridiid spider,
Steatoda paykulliana (often mistaken for the black widow spider; Cavalieri et ah, 1987)
increases the MEPP rate from less than one sec"1 to several hundred sec"1 (Gillingwater
et ah, 1999). Both of these toxins produce rises in intracellular calcium via the insertion
of Ca2+ channels in membranes (Usmanov et ah, 1985), and as a result a mass
exocytosis of synaptic vesicles. Following application of either toxin for more than 20
minutes, MEPP frequency declines until no further signs of spontaneous transmitter
release can be detected. Ultrastructural analysis confirmed a resultant depletion of
synaptic vesicles, yet a retention of the overall architecture at all nerve terminal profiles
(Gillingwater et ah, 1999). By analysing nerve terminal profiles which have undergone
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a confirmed qualitative ultrastructural alteration, it is possible to compare quantitative
data from control preparations with these data from the toxin treated preparations, the
result of which provides a good indicator as to the sensitivity of the synaptic vesicle
quantification methods used in the current study (see chapter 2).
The second part of this chapter provides a qualitative and quantitative
immunocytochemical and ultrastructural analysis of axotomised Wlds mouse NMJs. By
analysing immunocytochemically labelled NMJs from young Wlds mice at 3, 4, 5 and 7
days post axotomy, it has been possible to produce a more complete appraisal of the
temporal and morphological aspects of nerve terminal degeneration in the Wlds mouse.
This part of the study was carried out in parallel with a series of electrophysiological
and molecular experiments, performed by others: the contralateral FDB muscle to the
one prepared for immunocytochemistry was used for intracellular recording by Mr D.
Thomson in our laboratory, and several organs from the same mouse (including the
brain, spleen and portion of muscle) were frozen in liquid nitrogen and shipped to Dr
M.P. Coleman's lab in Cologne for molecular analysis (see discussion). My
ultrastructural analysis of nerve terminal profiles from Wlds mice at 3, 4, 5 and 7 days
post axotomy has also provided novel data on the nature of axotomy-induced
degeneration of motor nerve terminals.
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3.2 Methods
The majority of experiments contained within this chapter were carried out using
methods described in chapter 2. The following section describes methods which are
specific to this chapter.
3.2.1 Styryl Dye Staining of Motor Nerve Terminals
Recycling synaptic vesicles at motor nerve terminals on FDB and TA muscle
preparations from unoperated Wlds, Swiss, C57B1/6 and C3H mice were stained using
the vital aminostyryl dye FM1-43 (Molecular Probes; for mechanism of action see Betz
et ah, 1992). lmg/ml stock (in dFFO) FM1-43, stored in a -20°C freezer, was diluted
with oxygenated physiological saline to produce a final working concentration of 5/xM.
Nerve/muscle preparations were bathed in the FM1-43 solution for 5mins prior to
loading, whilst the nerve was taken up into a suction electrode connected to a pulse
stimulator (Harvard). Pulses were delivered to the nerve at 20Hz, 10V, 0.1ms
bandwidth for lOmins. Following nerve stimulation, the preparation was left in the
FMl-43/Ringers solution for a further 5 minutes before washing for 30-60mins in
oxygenated saline. After washing, postsynaptic receptor sites were labelled by
incubation in a 5jUg/ml solution of TRITC-a-BTX (Molecular Probes) in oxygenated
saline for lOmins. Preparations were washed for a further 20mins in oxygenated saline
before viewing and subsequent quantification in a in a fluorescence microscope (CF
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Fluorescent, Nikon) using a Zeiss 40x water immersion objective and a mercury lamp
(Nikon HBO-lOOW/2). A customised filter block (435nm excitation filter, 455nm
dichroic mirror and 515 IF emission filter; Nikon) was used for visualising FM1-43
fluorescence and a standard TRITC excitation/emission filter block (510-560nm
excitation filter, 580nm dichroic mirror and 590 emission filter; Nikon) was used for
visualising TRITC labelled aBTX. Individual NMJs were analysed as to their level of
occupancy using the same method applied to immunocytochemically stained
preparations.
3.2.2 Depletion of Synaptic Vesicles by Toxin Application
FDB and TA muscle preparations were dissected from C57B1/6 mice and bathed in
normal physiological saline (with 2mM Ca2+) containing either 2nM purified oc-
latrotoxin (kindly supplied by Dr Y. Ushkaryov) or 5/iM partially-purified Steatoda
toxin (kindly supplied by Dr D. Kalikulov) for 20 minutes. Muscle preparations were
then immediately immersed in a 4% paraformaldehyde / 2.5% glutaraldehyde (Sigma)
solution for 4-6 hours at 4 °C. The fixed preparation was washed and post-fixed in a 1%
osmium tetroxide (Sigma) solution before being processed for standard electron
microscopy (see chapter 2). Ultrastructural quantification was carried out using the
methods described in Chapter 2.
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3.3 Results
3.3.1 Morphology and infrastructure of the Mouse
Neuromuscular Junction
3.3.1.1 Morphological Correlation of the Pre- and Post¬
synaptic Apparatus
NMJs from unoperated Wlds (n=274, N=2), Swiss (n=724, N=2) and C3H (n=736,
N=2) mice FDB muscles were labelled immunocytochemically for NF, SV2 and a-
BTX. Each NMJ was individually assessed as to its level of occupancy, with the
majority of those studied showing exact matching of the pre and post-synaptic apparatus
(Figure 3.1). Evidence of partial occupancy (the occurrence of areas of AchRs with no
overlying nerve terminal) at a small number of control NMJs from unoperated Wlds
(N=3), C57B1/6 (N=2) and Swiss (N=2) mice FDB and TA muscles labelled with FM1-
43 and a-BTX, is provided in Figure 3.2. In the majority of these cases, only one or
two nerve terminal boutons were missing from the endplate. Evidence for partial
occupancy was detected in all immunocytochemically labelled control preparations:
3.07% ±0.24 (SEM) of wild-type unoperated endplates had areas of unoccupied AChRs
(Figure 3.3).
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3.3.1.2 Ultrastructural Correlation of the Pre- and Post¬
synaptic Apparatus
Electron microscopic analysis of NMJ profiles from unoperated Wlds mice FDB
muscles (n=34, N=4) confirmed the exact coordination of the pre- and post-synaptic
apparatus at the majority of endplates (Figure 3.4). A polarised distribution of 50nm
clear synaptic vesicles and nerve terminal mitochondria is easily detected in these
preparations. Quantitative analysis of SV density within control nerve terminals
revealed levels ranging from 35.18 SV//xm2 up to 184 SV//rm2 (n=34, N=4). The density
of packing of these vesicles ranged from 6.82% (of the total area available for SVs; see
chapter 2) up to 52.08% (n=34, N=4). The number of synaptic vesicles within a 125nm
radius of the active zone varied from 2 to 11 (n=75, N=4). The percentage of terminal
occupied by mitochondria and neurofilaments ranged from 0% to 44.09% and from 0%
to 7.09% respectively. Occasionally, a terminal Schwann cell process was identified in
the synaptic cleft. This invasion of the cleft did not appear to be phagocytotic in nature,
however.
As in the immunocytochemically labelled preparations described above, there was
evidence for partial occupancy at some ultrastructurally examined control NMJs from
unoperated Wlds FDB muscles. Out of 120 NMJ profiles located (N=4 muscles), three
were partially occupied, with areas of secondary postsynaptic folds not contacted by
overlying nerve terminal, and one was vacant. The overall degree of remodelling
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detected by ultrastructural analysis (3.33%) resembles the levels observed in
immunocytochemical experiments (3.07%).
3.3.2 Ultrastructural Analysis and Quantification of
Synaptic Vesicle Depletion in Wild-Type NMJs
Following Toxin Treatment
Following 20 minutes of either a-latrotoxin or steatoda toxin treatment, nerve terminal
profiles from C57B1/6 mice FDB and TA muscles (n=6, N=2) showed retained pre- and
post-synaptic architecture, except for a conspicuous decrease in the numbers of synaptic
vesicles (Figure 3.5). Some nerve terminal mitochondria had swollen profiles with
disrupted membranes and cristae. Qualitative analysis suggested that in the two nerve
terminal profiles with the least synaptic vesicles, the postsynaptic folds appeared
flattened and compressed into the endplate (Figure 3.5 panel B). Quantitative
comparisons between the SV densities in control and toxin treated terminals revealed a
significant decrease in the latter (PcO.OOl for both a-latrotoxin and steatoda toxin;
Figure 3.6a). Whereas control terminals had a mean SV density of 78.31 SV//T.m2
(±6.04 SEM), a-latrotoxin and steatoda toxin treated terminals had densities of 16.53
SV/jiim2 (±2.78) and 4.11 SV//rm2 (±0.88) respectively. The number of synaptic
vesicles located proximal to the presynaptic membrane (within a 125nm radius) also
declined significantly in toxin treated preparations (P<0.001 for both a-latrotoxin and
steatoda toxin; Figure 3.6b). a-latrotoxin treated terminals had a mean of 0.67 (±0.28
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SEM) SVs within a 125nm radius whilst Steatoda treated terminals had a mean of 0.60
(±0.24). This contrasts with control preparations which had a mean of 5.04 (±0.18) SVs
within a 125nm radius. Unsurprisingly, the packing density of synaptic vesicles in the
toxin treated terminals was also significantly reduced compared to controls (P<0.001 for
both a-latrotoxin and steatoda toxin).
3.3.3 Morphology and Ultrastructure of Axotomised Wild-
Type Mouse NMJs
3.3.3.1 Morphological Correlates of Wallerian Degeneration
at Axotomised Wild-Type NMJs
NMJs from 1 day (n=1137, N=2) and 2 day (n=842, N=2) axotomised C57B1/6J mice
FDB muscles were labelled immunocytochemically for NF, SV2 and a-BTX. Each
NMJ was individually assessed as to its state and level of occupancy. At both time
points following axotomy, the majority of NMJs were vacant, with most remaining
terminals being fully occupied (out of the 25 occupied terminals visualised, only 1 was
partially occupied) yet with punctuated and fragmented nerve terminal staining (Figures
3.7 and 3.8a). Intramuscular nerves also appeared very fragmented in these
preparations (Figure 3.8a). Figure 3.8b illustrates the levels of occupancy recorded at 1
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and 2 days post axotomy. Within 24 hours of axotomy, the level of occupied terminals
in wild-type FDB muscles was reduced to <1% of those found in control muscles.
3.3.3.2 Ultrastructural Correlates of Wallerian Degeneration
at Axotomised Wild-Type NMJs
Out of the 28 NMJ profiles from 1-day axotomised C57B1/6 mouse FDB muscles (N=3)
located in the electron microscope, only one was occupied (Figure 3.9a). This profile
displayed a fragmented nerve terminal being phagocytosed in-situ by a terminal
Schwann cell. A few SVs and dense bodies (remnants of mitochondria; Manolov,
1974) were still identifiable within the engulfed terminal. All of the remaining 27 NMJ
profiles which were examined were vacant, with Schwann cell processes located close
to the vacated postsynaptic folds (Figure 3.9b).
3.3.4 Morphological and Ultrastructural Preservation of
Motor Nerve Terminals at Axotomised Wlds NMJs
Immunocytochemically labelled NMJs (NF, SV2 and a-BTX) from 3 day (n=1795,
N=6), 5 day (n=1398, N=7) and 7 day (n=1136, N=6) axotomised 2 month old Wlds
mice FDB muscles were individually assessed as to their level of occupancy. At 3 days
post axotomy, in stark contrast to wild-types, the majority of Wlds endplates (95.31%
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±1.39 SEM) were still occupied. This prevalence decreased to 74.05% ±2.51 at 5 days
and 52.29% ±4.26 at 7 days (Figure 3.10). None of the nerve terminals observed had
the fragmented staining patterns associated with most axotomised wild-type NMJs.
Qualitative ultrastructural analysis of nerve terminal profiles from 3, 5 and 7 day
axotomised Wlds NMJs confirmed that nerve terminals were preserved without any
degenerative changes (Figure 3.11).
3.3.5 Partial Occupancy at Endplates of Axotomised Wlds
NMJs
3.3.5.1 Immunocytochemistry of Partial Occupancy at
Axotomised Wlds NMJs
A significant proportion of immunocytochemically labelled NMJs from 2 month Wlds
mice showed evidence of partial occupancy, at all time points following axotomy (3, 5
and 7 days). Examples of endplates across the whole spectrum of occupancy (1-100%)
were identified in all muscles that were analysed (Figure 3.12). As expected, the
boutons which were initially lost at partially occupied endplates were located at the
extremities of each branch of the motor nerve terminal, but not necessarily at the
extremities of the endplate (see Figure 3.12). Nerve terminals enduring at partially
occupied endplates appeared healthy, with no signs of fragmentation of terminal
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boutons or motor axon collaterals. The last boutons remaining at partially occupied
endplates took the form of 'retraction bulbs' (Figure 3.13). These are classified as
swellings at the distal end of a motor axon branch, often located over a small patch of
postsynaptic receptors, but occasionally appearing isolated from any endplate.
Data from the morphological quantification of the incidence of partial occupancy at
axotomised Wlds NMJs are summarised in Figure 3.14. Whilst there is a small
incidence of partial occupancy in control (unoperated) preparations (3.07% ±0.24
SEM), this figure increased to 25.10% ±4.98 in 3 day axotomised preparations, peaking
at 54.58% ±3.22 in 5 day preparations before falling to 47.24% ±4.58 7 days after
axotomy. The occurrence of differing states of occupancy between neighbouring
endplates (for example, a fully occupied endplate can often be found next to a partially
occupied endplate, with both neighbouring a vacant endplate) suggests that the
piecemeal removal of motor nerve terminals occurs in a asynchronous fashion, whereby
individual nerve terminals withdraw from their endplate at different times to terminals
at adjacent endplates (Figures 3.15 and 3.16).
Following axotomy, motor axon branches supplying NMJs in 2 month old Wlds mice
also have a distinctive morphology. Immunocytochemically labelled Wlds FDB muscle
preparations (NF, SV2 and a-BTX) from 3, 5 and 7 days post axotomy have axon
branches which appear very thin and wispy, occasionally interrupted by brightly
stained, large accumulations of neurofilament (Figure 3.17). This pattern of bright NF
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staining also occurs in Wlds nerve terminals, suggesting that NF accumulation may also
occur in nerve terminal boutons (see below).
3.3.5.2 Ultrastructural Features of Partial Occupancy at
Axotomised Wlds NMJs
Electron microscopical examination of NMJs from axotomised 2 month old Wlds mice
FDB muscle preparations provided ultrastructural evidence of partial occupancy. An
endplate was classified as partially occupied when there was an expanse of postsynaptic
foldings with no overlying nerve terminal, as well as an area of occupied postsynaptic
folds, on the same muscle fibre (Figure 3.18). Ultrastructural quantification of the
levels of occupancy and partial occupancy (Figure 3.19) provided similar data to that
gained from immunocytochemical experiments shown previously. In 3 day axotomised
FDB preparations (n=105, N=3) 89.84% ±3.64 (SEM) of endplates were occupied (1-
100%) and 32.76% ±3.16 of endplates were partially occupied (1-99%). Analysis of 4
day axotomised preparations (n=96, N=3) showed that 86.83% ±2.87 of endplates and
43.33% ±5.71 of endplates were fully and partially occupied respectively, whilst at 7
days after axotomy (n=95, N=3), those levels had dropped to 53.18% ±12.58 and
31.18% ±1.81 respectively.
Accumulation of neurofilaments was conspicuous in many of the nerve terminal profiles
examined at all time points post axotomy. This build-up of neurofilament proteins
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appeared to have displaced organelles from the centre of nerve terminal boutons, but did
not appear to disrupt the overall polarised distribution of SVs and mitochondria (Figure
3.20). Quantification of neurofilament levels within nerve terminal profiles revealed
that there was a increase at terminal profiles from 3 days post axotomy (n=26, N=4),
where 5.37% ±1.58 of the terminal was filled with NF, compared to controls where
1.42% ±0.33 of the terminal was filled with NF, although this did not reach statistical
significance (P=0.4273). Significantly higher levels of NF were found in nerve
terminals at 4, 5 and 7 days post axotomy however (P=<0.0001 for all time points
compared to controls). At 4 days post axotomy (n=7, N=2), 19.28% ±5.33 of the
terminal was occupied by neurofilaments, with similar values of 17.32% ±2.63 and
20.53% at 5 (n=26, N=4) and 7 (n=l, N=l) days respectively (Figure 3.21).
Furthermore, it is possible to estimate the rate of axonal neurofilament transport from
the current data. Assuming that the tibial nerve stump is between ten and fifteen
millimetres long, that bi-directional transport of neurofilament occurs equally in both
directions (whereby only 50% of the axonal NF is transported distally), and that NF
accumulation saturation point is reached by 4 days post axotomy (as evidenced by the
graph in Figure 3.21), the rate of 1.25-1.88mm/day can be calculated.
Despite the evidence for partial occupancy and accumulation of neurofilaments, the
incidence of degenerative markers within nerve terminal profiles from 3,4,5 and 7 day
axotomised 2 month old Wlds mice was minimal. Out of the 294 motor nerve terminals
examined (N=9) for their levels of occupancy (at all time points following axotomy),
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only 7 (3.1%) were classified as having signs of degeneration. In all of these cases, the
only reason that the terminal was classified as degenerating was because more than 20%
of mitochondria had disrupted profiles. No evidence for nerve terminal membrane
fragmentation and/or terminal Schwann cell phagocytosis of the nerve terminal was
found.
Qualitative analysis of the synaptic vesicle population within axotomised Wlds nerve
terminals suggested that there was no reduction in either their numbers or distribution,
although 'giant' vesicles of more than 50nm diameter (in some instances as large as
150nm), rarely observed in control preparations, were occasionally identified (Figure
3.22). Quantification of the synaptic vesicle density within axotomised 2 month old
Wlds nerve terminals confirmed these findings. There was no significant reduction in
the density of synaptic vesicles at any time point following axotomy (Figure 3.23a).
Levels of 78.31 SV/[xm2 ±6.04 in controls (n=34, N=4) were maintained at 3 (83.76
SV/jitm2 ±5.70 SEM; n=26, N=4), 4 (79.03 SV/^m2 ±11.33; n=7, N=2), 5 (78.75
SV/jU,m2 ±5.72, n=26, N=4) and 7 (80.44 SV/jUm2; n=l, N=l) days post axotomy.
Subsequent analysis showed that there was no significant difference in the SV density
between fully and partially occupied nerve terminals (Figure 3.23b). The density of
pasting of SVs within axotomised Wlds nerve terminals was significantly higher
(P=<0.0001 at all time points following axotomy) than in control preparations (Figure
3.24a). Whilst control preparations (n=34, N=4) had 28.25% ±1.95 of the area available
to SVs actually occupied by SVs, 3 day axotomised Wlds terminals (n=26, N=4) had
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40.64% ±1.71, 4 day axotomised Wlds terminals (n=7, N=2) 54.91% ±3.96, 5 day
axotomised Wlds terminals (n=26, N=4) 41.40% ±2.18 and 7 day axotomised Wlds
terminals (n=l, N=l) 48.55% occupied by SVs. There was a significantly higher
density of packing in partially occupied terminals compared to fully occupied terminals
at 3 days (P=0.0275) and 5 days (P=0.0303) post axotomy, but no significant difference
at 4 days (Figure 3.24b). There was no significant reduction (P=>0.12 in all analyses)
in the numbers of vesicles within a 125nm radius of an active zone at any time-point
following axotomy in Wlds nerve terminals compared to controls (Figure 3.25). Levels
of 5.04 ±0.18 vesicles in controls (n=75, N=4) were maintained at terminals from 3
(5.41 ±0.16; n=75, N=4), 4 (5.07 ±0.47; n=15, N=2), 5 (5.25 ±0.17; n=55, N=4) and 7
(4.67; 0.33; n=3, N=l) days post axotomy.
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Fig. 3.1 Morphology of control (unoperated) NMJs.
(A) Confocal image of four NMJs from a Wlds mouse FDB (NF, SV2 and a-BTX).
Note the alignment of pre- and post-synaptic structures. Scale bar = 20/rm.
(B & C) Standard fluorescence microscope image of a NMJ from a C57B1/6 mouse
FDB. Panel B shows the axonal and motor nerve terminal component stained for NF
and SV2 (green). The triple band pass image (panel C) demonstrates the almost perfect
alignment of presynaptic structures with the postsynaptic AchRs (labelled with a-BTX;
red). Scale bar = 20/xm.
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Fig. 3.2 Evidence for Remodelling of Neuromuscular Synapses Under
Normal Conditions (FM1-43)
(A) & (B) Two examples of FM1-43 labelled nerve terminals and a-BTX labelled
AchRs from an unoperated Wlds FDB muscle. Areas of unoccupied receptors with no
overlying terminal are indicated by arrows. Scale bars - 20/xm.
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FM1-43 (/-BTX
Fig. 3.3 Evidence for Remodelling of Neuromuscular Synapses Under
Normal Conditions (Immunocytochemistry)
(A, B & C) Immunocytochemically stained nerve terminals and AchRs (A = NF, SV2
and a-BTX; B = NF and SV2; C = only a-BTX channel shown from image A) from an
unoperated Swiss mouse FDB. Areas of vacant receptors with no overlying terminal are
indicated by arrows. Note how the brightness of a-BTX staining is reduced at
unoccupied compared to occupied boutons. Scale bar = 20/rm.
(D) Table summarising immunocytochemical data on the occurrence of fractional





Mouse Strain % of Partially Occupied Endplates % of Partially Occupied Endplates
Muscle t Muscle 2
V Ids 4 2.68
Swiss 3.27 2.23
C3H 3.24 3.02
Fig. 3.4 Ultrastructure of Control NMJs.
(A) Ultrastructural profile of a nerve terminal bouton from a control Wlds mouse FDB
muscle. The nerve terminal contains numerous mitochondria distal to the presynaptic
membrane (red arrows) and numerous clear ~50nm synaptic vesicles proximal to the
presynaptic membrane (red arrowhead). The nerve terminal is capped by a terminal
Schwann cell (blue arrow) and directly opposes the secondary postsynaptic folds on the
skeletal muscle fibre (blue arrowheads). Scale bar = 0.5/rm.
(B) Summary table of the levels and distribution of sub-cellular organelles within a
control nerve terminal, as calculated using the ultrastructural quantification methods
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(S3 of Area Available for SVs)
No. of SVs Within 125nm
Radius of Active Zone
Control Wlds
(n=34, N=4) 23.36±1.67 t ,42±0.33 78.31 ±6.04 28.25±1.95 5.04±0.18
Fig. 3.5 Ultrastructure of a-latrotoxin and Steatoda Toxin Treated NMJs.
(A) Ultrastructural profile of a nerve terminal bouton from a C57B1/6 mouse exposed
to 2nM purified a-latrotoxin for 20mins before immediate fixation. Note the paucity of
synaptic vesicles within the terminal. Scale bar = 0.5/rm
(B) Ultrastructural profile of a nerve terminal bouton from a C57B1/6 mouse exposed to
5/rM partially-purified Steatoda toxin for 20mins before immediate fixation. Synaptic
vesicles were even more scarce than in the a-latrotoxin terminal shown above, but the
rest of the nerve terminal architecture was preserved. In this example, the postsynaptic
foldings appear to be compressed and compacted into the endplate. Scale bar = 0.5jum
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Fig. 3.6 Quantification of Synaptic Vesicle Density and Localisation in Nerve
Terminals from a-Iatrotoxin and Steatoda Toxin Treated NMJs.
(A) Bar chart comparing synaptic vesicle densities at control (n=34, N=4), oc-latrotoxin
(n=4, N=l) and Steatoda Toxin (n=2, N=l) treated NMJs. Both LTX (p<0.001) and
STX (pcO.OOl) treated preparations had significantly reduced densities of synaptic
vesicles compared to control preparations (unpaired t-test). Error bars represent ±SEM,
(B) Bar chart showing comparative synaptic vesicle localisation towards active zones at
control (n=75, N=4), a-latrotoxin (n=12, N=l) and Steatoda Toxin (n=5, N=l) treated
NMJs. Both LTX (pcO.OOl) and STX (pcO.OOl) treated preparations had significantly
reduced numbers of synaptic vesicles clustered by active zones compared to control





Fig. 3.7 Morphology of Axotomised Wild-Type NMJs
(A & B) Standard fluorescence microscope image of two immunocytochemically
labelled (A = NF, SV2 and a-BTX; B = NF and SV2 only) NMJs from a 1 day
axotomised wild-type C57B1/6 FDB muscle. These are both examples of fully occupied
endplates with exact alignment of pre- and postsynaptic structures and no signs of
fragmentation or degeneration. Scale bar = 20/rm
(C & D) Immunocytochemically labelled (A = NF, SV2 and a-BTX; B = NF and SV2
only) NMJ from a 1 day post-axotomy wild-type C57B1/6 FDB muscle. Note the
grossly fragmented and degenerating nerve terminal and how the process appears to be
synchronous, with no single portion of terminal undergoing degeneration before
another. Scale bar = 20fim
94
 
Fig. 3.8 Morphology and Quantification of Axotomised Wild-Type NMJs
(A) Immunocytochemically labelled (NF, SV2 and cc-BTX) NMJs from a 1 day
axotomised C57B1/6 FDB muscle. This example includes two vacant endplates and a
nearby degenerating intramuscular nerve. Scale bar = 20jum
(B) Graph showing the rapid decline of endplate occupation at wild-type (C57B1/6)
FDB NMJs following tibial nerve section. Red triangles represent the mean value from

















Fig. 3.9 Ultrastructure of Axotomised Wild-Type NMJs
(A) Electron micrograph of a 1 day post axotomy C57B1/6 mouse NMJ, The grossly
fragmented nerve terminal (red star) is being phagocytosed in-situ by a another cell,
presumably the terminal Schwann cell (blue star). Scale bar = 1/xm
(B) Electron micrograph of a 1 day post axotomy C57B1/6 mouse NMJ. All nerve
terminal debris has been removed and a terminal Schwann cell profile is left opposing
the postsynaptic folds. Scale bar = 1/im
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Fig. 3.10 Preservation of Motor Nerve Terminals at Axotomised Wlds NMJs
(A & B) Confocal micrographs from a 3 day axotomised Wlds FDB (NF, SV2 and cc-
BTX). An example of a fully occupied endplate with no signs of nerve terminal
degeneration is shown in panel A. Two examples of partially occupied endplates (see
below) with no degenerative markers are shown in panel B. Scale bars = 20jitm
(C) Graph of the percentage of occupied endplates against days post axotomy in 2
month old Wlds mice. Black triangles represent data from individual muscles and red
triangles represent mean values.
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Fig. 3.11 Ultrastructural Preservation of Motor Nerve Terminals at
Axotomised Wlds NMJs
(A) Electron micrograph from a 3 day axotomised FDB muscle from a 2 month old
Wlds mouse. The ultrastructure of the nerve terminal is wholly intact, with a uniform
distribution of mitochondria and synaptic vesicles. Scale bar = 1/rm
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Fig. 3.12 Immunocytochemical Evidence of Partial Occupancy at Endplates of
Axotomised Wlds NMJs
(A & B) Fluorescence micrographs from a 2 month Wlds mouse, 3 days post axotomy
(A = MB, SV2 and a-BTX. B = NF and SV2 only). A partially occupied endplate with
approximately 10-15% of AchRs not contacted by overlying nerve terminal is shown.
Scale bar = 20/im
(C & D) Fluorescence micrographs from a 2 month Wlds mouse, 7 days post axotomy
(A = NF, SV2 and a-BTX. B = NF and SV2 only). A partially occupied endplate with
approximately 40-50% of AchRs not contacted by overlying nerve terminal is shown.
Scale bar - 20jum
(E) Confocal micrograph from a 2 month Wlds mouse, 3 days post axotomy (NF, SV2
and a-BTX). A partially occupied endplate with approximately 50-60% of AchRs not
contacted by overlying nerve terminal is shown. Scale bar - 20/xm
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Fig. 3.13 Immunocytochemical Evidence of Retraction Bulb Formation at
Axotomised Wlds NMJs
(A & B) Fluorescence micrographs from two, 2 month Wlds mice, 3 days post axotomy
(NF, SV2 and a-BTX). Retraction bulbs, indicated by the bulbous swelling at the
termination of the axon, have formed at both endplates. Panel B is a higher power
image of one NMJ shown previously in Figure 3.10b. Scale bars = 20/xm.
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Fig. 3.14 Incidence of Partial Occupancy at Axotomised Wlds NMJs
(Immunocytochemical Analysis) in 2 month Wlds mice FDB muscles
(A) Graph of the percentage of partially occupied (ranging from 1 to 99% occupied)
endplates against days post axotomy. Note that the data plotted for 0 days post axotomy
represents the level of remodelling seen in unoperated control preparations (see Fig
3.3). Black triangles represent data from individual muscles and red triangles represent




Fig. 3.15 Asynchronous Withdrawal of Axotomised Nerve Terminals in Wlds
Mice
(A) Confocal micrograph from a 2 month Wlds mouse FDB, 3 days post axotomy (NF,
SV2 and a-BTX). 3 neighbouring endplates are shown in varying states of occupancy.
The endplate on the left is fully occupied, the middle endplate is partially occupied and
the endplate on the right is vacant. Scale bar = 20/im
(B) Confocal micrograph from a 2 month Wlds mouse FDB, 3 days post axotomy (NF,
SV2 and a-BTX). 4 neighbouring endplates are shown in varying states of occupancy.
The endplate on the top right is fully occupied, the top left and bottom right endplates
are partially occupied (arrows indicate vacant portions of AChRs) and the endplate on
the bottom left is almost vacant, with only a small area of receptors contacted by a
retraction bulb. This panel contains two of the endplates previously shown in Figure
3.10b. Scale bar = 20/xm
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Fig. 3.16 Asynchronous Withdrawal of Axotomised Nerve Terminals in Wlds
Mice (Confocal Stereo Pair)
(A) Stereo pair of confocal micrographs from a 2 month Wlds mouse FDB, 3 days post
axotomy (NF, SV2 and a-BTX). 6 neighbouring endplates (and an incoming axon
bundle) are shown in varying states of occupancy. The endplates present are either fully
or partially occupied. To create a three-dimensional image, fuse the two images by eye
to produce a third, central view. Visual accommodation and focussing on the central
panel should yield a 3D image. Scale bar = 20jim
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Fig. 3.17 Distinct Morphology of Motor Axon Branches in Wlds Mice
Following Axotomy
(A) Confocal micrograph from a 2 month Wlds mouse FDB, 3 days post axotomy (NF,
SV2 and a-BTX). Two neighbouring endplates are shown, both with an incoming
motor axon branch showing characteristics observed in the majority of axotomised Wlds
preparations: axon branches are thin, with occasional swellings showing accumulations
of neurofilament (arrows). Scale bar = 20/rm
(B & C) Fluorescence micrographs from a 2 month Wlds mouse FDB, 7 days post
axotomy (B = NF, SV2 and a-BTX; C = NF and SV2 only). Another example of the
neurofilament accumulations (arrows) and thin axonal profiles often observed in
axotomised Wlds preparations is shown. Scale bar = 20jttm
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Fig. 3.18 Electron Microscopic Evidence for Partial Occupancy at
Axotomised Wlds NMJs.
(A) Electron micrograph from a 2 month Wlds mouse FDB, 3 days post axotomy. This
portion of an NMJ has postsynaptic receptor sites with no overlying nerve terminal
present. Schwann cell occupation at some of the vacated synaptic sites is indicated
(arrows). Scale bar = 2/i.m
(B) Electron micrograph from a 2 month Wlds mouse FDB, 3 days post axotomy. This
nerve terminal bouton is from the same NMJ as (A), thereby permitting classification as
a partially occupied endplate. The terminal architecture appears intact, with a uniform
distribution and normal numbers of SVs and mitochondria. Scale bar = 1/xm
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Fig. 3.19 Levels of Occupancy and Partial Occupancy at Axotomised Wlds
NMJs (Electron Microscopical Analysis)
(A) Graph of the percentage of occupied endplates (all from 1 to 100% occupied are
included) against time after axotomy in 2 month Wlds FDB muscle. Note that the data
plotted for 0 days post axotomy represents the level of remodelling observed in
unoperated control preparations. Black triangles represent data from individual muscles
and red triangles represent the mean value at each time point.
(B) Graph of the percentage of partially occupied endplates (all from 1 to 99%
occupied are included) against time after axotomy in 2 month Wlds FDB muscle. Note
that the data plotted for 0 days post axotomy represents the level of remodelling
observed in unoperated control preparations. Black triangles represent data from
individual muscles and red triangles represent the mean value at each time point.
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Fig. 3.20 Neurofilament Accumulation in Axotomised Wlds Motor Nerve
Terminals
(A) Electron micrograph from a 2 month Wlds mouse, 3 days post axotomy. Note the
conspicuous neurofilament accumulation in the centre of the nerve terminal (arrows).
Scale bar - 0.5fim
(B) Electron micrograph from a 2 month Wlds mouse, 3 days post axotomy.
Neurofilament accumulation in the centre of the nerve terminal is again present
(arrows). Scale bar = 0.5/tm
107
 
Fig. 3.21 Quantification of Neurofilament Accumulation in Axotomised WIds
Motor Nerve Terminals
(A) Graph of the percentage of nerve terminal occupied by neurofilaments against time
after axotomy in 2 month Wlds mice FDB muscles. There is no significant difference
between the levels of neurofilament in control (0 day) and 3 day post axotomy nerve
terminals (P = 0.4273), but there is a significant accumulation in 4, 5 and 7 day
axotomised terminals (all are P = <0.0001). Error bars = SEM (no error bar for 7 day

















Fig. 3.22 Synaptic Vesicle Preservation in Axotomised Wlds Motor Nerve
Terminals
(A) Electron micrograph of a NMJ from a 2 month Wlds mouse, 5 days post axotomy.
Despite the accumulation of NF, qualitatively the synaptic vesicles appear normal in
both number and distribution, located as they are proximal the presynaptic membrane.
Scale bar = 0.5jum
(A) Electron micrograph from a 2 month Wlds mouse, 5 days post axotomy. This nerve
terminal profile contains an example of a 'giant' vesicle (arrow). Scale bar = 0.5jUm
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Fig. 3.23 Quantification of Overall Synaptic Vesicle Density Within
Axotomised Wlds Motor Nerve Terminals
(A) Graph of the number of SVs per fxm2 against time after axotomy in 2 month Wlds
mice. There was no significant difference between the SV density in nerve terminals
from 3, 4, 5 or 7 days post axotomy compared to controls. Error bars = SEM. Statistical
tests = Unpaired t test.
(B) Bar chart of the number of SVs per /rnr against time after axotomy (in fully versus
partially occupied profiles) in 2 month Wlds mice. At all time points post axotomy,
there was no significant difference between partially and fully occupied terminals. Error
bars - SEM. Statistical tests = Unpaired t test.
110
Days Post Axotomy
Fig. 3.24 Quantification of Synaptic Vesicle Packing Density Within
Axotomised Wlds Motor Nerve Terminals
(A) Graph of the percentage of terminal area available for synaptic vesicles (total
terminal area minus area occupied by mitochondria and NF; see chapter 2 for details)
occupied by synaptic vesicles against days post axotomy in 2 month Wlds mice. At all
time points following axotomy, the density of SV packing was significantly higher (P =
<0.0001) than in controls. Error bars = SEM. Statistical tests = Mann Whitney.
(B) Bar chart of the percentage of terminal area available for SVs occupied by synaptic
vesicles against days post axotomy (in fully versus partially occupied profiles) in 2
month Wlds mice. In mice 3 days post-axotomy, there was a higher density of SVs in
partially occupied terminals compared to fully occupied terminals (P = 0.0275). In 4
day axotomised preparations there was no significant difference between fully and
partially occupied terminals (P - 0.4) whilst, as in the 3 day axotomised terminals, 5
day axotomised partially occupied terminals had a higher SV density than fully
occupied terminals (P = 0.0303). Error bars = SEM. Statistical tests = Mann Whitney.
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Fig. 3.25 Quantification of Synaptic Vesicle Population Localisation Within
Axotomised Wlds Motor Nerve Terminals
(A) Graph of the number of synaptic vesicles within a 125nm radius of an active zone
('docked' vesicles) against time after axotomy in 2 month Wlds mice. At all time points
post-axotomy, there was no significant reduction (in all cases P = >0.12) in the numbers
of SVs clustered toward active zones on the presynaptic membrane Error bars = SEM.






In this chapter I compared the effects of axotomy on Wlds mouse neuromuscular
junctions with wild-type mouse NMJs. The morphological and ultrastructural
techniques I used strongly suggest that the mechanisms of nerve terminal loss occurring
at axotomised Wlds NMJs are fundamentally different from those which occur during
wild-type degeneration. The interpretations of my observations alongside potential
sources of error are considered in this discussion, and the emerging hypothesis, that
presynaptic nerve terminal degeneration is regulated by mechanisms distinct from axon
degeneration, is pursued in following chapters.
3.4.1 Accuracy of the Quantification Methods Used in the
Present Study
The immunocytochemical and electron microscopical data reported in this study have
been generated using techniques adapted from previous studies alongside novel
methods of analysis. Comparison of data from this study with those provided in the
literature suggests that the techniques used have produced accurate and reliable results.
For example, the ultrastructural preservation of healthy looking mitochondria in control
preparations, as was achieved with the current tissue processing protocol (Figure 3.4), is
a key factor if subsequent use of degenerating mitochondrial profiles as a marker of
degeneration is to be used. The majority of mitochondrial profiles from control
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micrographs had a well preserved ultrastructure (fulfilling the same criteria as those
defined by Miledi and Slater (1970), Manolov (1974) and Winlow and Usherwood
(1975)), and those that did not were very similar in appearance to mitochondria
identified by Winlow and Usherwood (1975) to be undergoing a process of natural
turnover. Similarly, when calculating the density of synaptic vesicles within motor
nerve terminals using the current method, a range of values from 35 SV//rm2 to 184
SV//xm2 was generated. These figures resemble the control levels as reported by Reger
(28-114 SV//xm2; 1959) and Winlow and Usherwood (36-209 SV//rm2; 1975). The
slight variation between the three sets of data most probably represents differences in
the calculation methods used as well as a small diversification in nerve terminal
morphology between individual muscles and animals.
Closer scrutiny of the methods used for the quantification of SV density and localisation
within nerve terminals, by comparing control with toxin treated preparations, confirmed
that they are sensitive enough to detect changes in all parameters of the SV population
(Figures 3.5 and 3.6). Interestingly, some of the NMJ profiles from toxin-treated
muscles appeared to indicate a compression and flattening of the secondary postsynaptic
folds. One plausible hypothesis to explain this phenomenon is that a compression
occurs as a result of a significant increase in the total membrane area of the nerve
terminal due to the large amount of SV exocytosis that is caused by toxin application.
A mass exocytosis of synaptic vesicles has previously been shown to cause a large
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expansion in the size of the nerve terminal, and hence a compression of the postsynaptic
apparatus (O'Hanlon et ah, 2001).
3.4.2 Remodelling of Neuromuscular Connections
The immunocytochemical and ultrastructural evidence for partial occupancy in control
preparations (Figures 3.2 and 3.3) suggests that in vivo remodelling at synaptic
connections of NMJs on FDB and TA muscles in adult mice is relatively common. One
possible criticism of the FM1-43 experimental data however, is that even though some
terminal boutons are not labelled with FM1-43, it does not mean that they are not
present. This explanation is plausible if the unstained boutons are present but 'silent',
thereby not recycling any synaptic vesicles and as a result blocking the uptake of FM1-
43. This proposal seems unlikely however, as it has been shown that all boutons of a
motor nerve terminal operate as a single functional unit (Betz et ah, 1992; Ribchester et
ah, 1994). Immunocytochemical and ultrastructural experiments, which do not require
boutons to be active to allow identification, support the FM1-43 findings however,
thereby unequivocally demonstrating the occurrence of partial occupancy at control
NMJs from a number of different strains of mice (Wlds, Swiss, C3H and C57B1/6).
Remodelling of neuromuscular synapses has been previously reported in a variety of
other muscle preparations, including: mouse sternomastoid (Lichtman et ah, 1987), frog
sartorius (Herrera et al., 1990), mouse soleus (Wigston, 1989), rat soleus (Cardasis and
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Padykula, 1981) and mouse pectineus (Hill et al., 1991). The level of remodelling
apparent in these muscles appears to differ however. For example, this study of mouse
FDB muscle suggests that approximately 3% of NMJs are undergoing remodelling at
any one time, whereas Lichtman and colleagues report a level of <1% in mouse
sternomastoid muscle (Lichtman et al., 1987). One possible reason for this difference
may be the staining techniques used. Lichtman and colleagues (1987) used 4-Di-2-ASP
to label motor nerve terminals, a technique which sometimes produces an incomplete
stain (Wigston, 1989). This could feasibly lead to slight differences in the counting
criteria used in the different studies. A more plausible hypothesis is that differences in
the composition and activity levels of the muscles studied require higher or lower levels
of remodelling to maintain suitable synaptic connections. For example, fast-twitch
muscle NMJs are known to have a more complex morphology than those found on
slow-twitch muscle fibres (Lpmo and Waerhaug, 1985), therefore any slight change in
the properties of the muscle fibre (as has been shown to occur in rat soleus; Kugelberg,
1976) would require a more rigorous remodelling process of the motor nerve terminals
than would be required on stable muscle fibres. Alternatively, differences in the patterns
or amounts of neural activity occurring at different muscle groups may produce
different rates of remodelling (Wigston, 1989).
The ultrastructural evidence for partial occupancy at control nerve terminal profiles
presented in this chapter closely resembles the findings of Cardasis and Padykula
(1981), who described the ultrastructural characteristics of remodelling NMJs in rat
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soleus muscle preparations. These authors described the occurrence of vacant
junctional folds, not associated with nerve terminals, residing next to regions of intact
synaptic associations. They also noted the occasional intervention of terminal Schwann
cell processes into the synaptic cleft. Both of these situations were observed at a
minority of control nerve terminal profiles assessed in the current study. Indeed, it
raises the possibility that a Schwann cell invasion of an otherwise 'normal' appearing
NMJ synaptic cleft may represent the initiation of remodelling processes at the specific
bouton(s) involved.
3.4.3 Retention and Withdrawal of Motor Nerve Terminals
Following Axotomy in the Wlds Mouse
The data presented in this chapter confirm previous findings that motor nerve terminals
are preserved, alongside their axons, for several days following axotomy in Wlds mice
of 2 months or younger (Ribchester et al., 1995; Mattison et al., 1996; Parson et al.,
1998). Immunocytochemical data report that at 7 days post axotomy, 52.29% of
endplates were occupied in Wlds FDB muscle preparations (Figure 3.10). This level of
retention is significantly higher than the levels observed using FM1-43 staining in
axotomised Wlds TA muscle (approximately 19%; Mattison, R.J. 1999, PhD Thesis,
University of Edinburgh). This difference could derive from many sources; firstly, that
the length of the distal axonal stump was shorter in axotomised TA preparations;
secondly, that FM1-43 staining was reduced as a result of a loss of function at
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remaining nerve terminals; and thirdly, that nerve terminals on TA muscle fibres are
more susceptible to axotomy in the Wlds mouse than terminals on FDB muscle fibres.
With regard to the nerve stump dependence hypothesis, it has been shown that the
length of the distal axonal stump alters the rate of degeneration at both wild-type (Luco
and Eyzaguirre, 1955; Birks, Katz and Miledi, 1960; Miledi and Slater, 1970) and
Wlds (Ribchester et al., 1995) nerve terminals. In Wlds mice, an increase of 1cm in the
length of the distal stump delayed degeneration by -1-2 days (Ribchester et ah, 1995).
Therefore, if the distal nerve stumps in the TA preparations used in Mattison's TA
experiments were 1cm shorter than those left in my FDB preparations, a comparable
level of occupancy nearing 50% would be expected (5 day data from Mattison, R.J.
1999, PhD Thesis, University of Edinburgh), the same level observed at 7 days in the
present study. The distal stump in my FDB muscle preparations was -10-15mm in
length, similar to the nerve stump length left in TA preparations (Dr R Ribchester,
personal communication). Because there was no specific data on the length of distal
nerve stumps given in Mattison's experiments, it is not possible to accurately assess
whether or not a difference in stump length underlies the differences between the two
studies. It remains possible therefore, that differences in staining patterns between FM1-
43 and NF/SV2 labelled preparations may be the cause of the discrepancy. As it has
been suggested that axotomised Wlds nerve terminals undergo a progressive weakening
of synaptic transmission (Ribchester et al., 1999; D.Thomson, personal
communication), it is possible to speculate that some persistent terminals may not be
recycling synaptic vesicles. Such terminals would be detected using NF/SV2 staining,
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but not FM1-43, possibly explaining the higher levels of occupancy in my
immunocytochemical experiments. Finally, it is plausible that the properties of
individual motor units, and differences in the muscle fibre type(s) they innervate, may
provide the overriding factor in controlling the susceptibility to axotomy of nerve
terminals. This hypothesis could be addressed by utilising a muscle preparation in
which all nerve terminals from a single motor unit are identified (see Lichtman and
Wilkinson, 1987). If the loss of a nerve terminal is controlled by the properties of its
motor unit, it would be expected that all other nerve terminals from the same unit
should be lost synchronously and at the same rate.
As the immunocytochemical analysis of nerve terminal loss at axotomised Wlds FDB
muscle preparations was carried out in conjunction with electrophysiological studies
(contralateral axotomised FDB muscles were used for intracellular recording by Mr D.
Thomson), a comparison of the findings has proved important (Figure 3.26). The
percentage of occupied fibres as calculated from the electrophysiological data (an
occupied endplate being identified if an individual muscle fibre showed evoked
responses following nerve stimulation) was significantly lower (P=0.0426; Mann
Whitney test) than those detected using the morphological data, with levels of 31.00%
±5.86 (SEM) and 52.29% ±4.26 respectively at 7 days post axotomy.
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Fig. 3.26 Comparison of Morphological and Electrophysiological Analyses of
Nerve Terminal Loss at Axotomised Wlds FDB Muscle Preparations.
(A) Graph of number of occupied endplates versus days post axotomy from 2 month
old Wlds mouse FDB muscle preparations analysed using immunocytochemical
techniques (NF, SV2 and cc-BTX). Black triangles represent data from individual
muscles and red triangles represent the mean value (reproduced from Figure 3.10).
(B) Graph of number of occupied endplates versus days post axotomy from 2 month
old Wlds mouse FDB muscle preparations analysed using electrophysiological
techniques. Black triangles represent data from individual muscles and red triangles









Similar differences were observed when comparing the 3 day and 5 day post axotomy
data. The most likely explanation for the discrepancy between these two sets of data is
that the electrophysiological data was gained from the analysis of endplates showing
evoked responses only, rather than evoked and spontaneous responses. This raises the
possibility that any terminals which were present but did not have either enough surface
area to produce a postsynaptic endplate potential upon evoked release, or had severely
impaired evoked release mechanisms, were not detected using the electrophysiological
method of analysis. Further scope for discrepancy is introduced when the fact that the
functional data was gathered using a very small sample size (only 30 fibres were
impaled per muscle) compared to the whole muscle analysis undertaken using
morphological techniques. When comparing the current morphological data with
previously published intracellular recording measurements from axotomised Wlds
soleus muscles however, similar levels of approximately 50% occupancy were detected
at 7 days post axotomy using either method (Ribchester et ah, 1995).
Ultrastructural analysis of the preservation of motor nerve terminals in Wlds mice
following axotomy lends further support to the immunocytochemical findings (Figures
3.11 and 3.19). Quantification of electron micrographs from 7 day axotomised Wlds
mouse FDB muscles showed that 53.18% ±12.58(SEM) of endplates were occupied in
comparison to 52.29% ±4.26 of endplates from the morphological analysis. A
qualitative comparison between electron micrographs at 5 days post axotomy from the
current study and those shown in Ribchester and colleagues (1995) study shows a
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similar retention of terminal architecture, although the degree of mitochondrial damage
depicted in the previous study's unquantified micrographs are never observed in my
preparations. The most obvious explanation for these findings is that different tissue
processing techniques were used, whereby the current study's protocol was much more
suitable for fast and strong fixation than that used previously. The use of a strong
paraformaldehyde / glutaraldehyde fixation solution followed by an immediate osmium
post-fixation step was employed after initial experiments using fixation protocols, such
as that used by Ribchester et al. (1995), proved to be unreliable (unpublished
observations).
In Wlds mice NMJs at 4 days post axotomy and beyond, ultrastructural profiles from
many of the remaining terminals showed signs of neurofilament accumulation within
the centre of synaptic boutons (Figure 3.20 and 3.21). This phenomenon has been
observed in a previous study of axotomised Wlds NMJs (Ribchester et al., 1995) as well
as in the last few remaining nerve terminals undergoing Wallerian degeneration in wild-
type preparations (Manolov, 1974). The most likely explanation for these events is
provided from a study by Watson et al. (1993) who showed that within a few days of
axotomy, there was a marked accumulation of alpha- and beta-tubulin, actin, and
nonphosphorylated neurofilament epitopes at the proximal and distal ends of transected
axons, suggesting that bi-directional transport continues in the distal nerve stump.
Furthermore, these authors showed that there was a loss of these proteins from the
centre of the isolated nerve segment. This study was limited in its resolution by the use
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of biochemical techniques however. The results from the current study, which provided
a high enough resolution to study axonal events at the distal extremities of the nerve,
suggest that the accumulation of NF is not continuous. Thus, axonal branches
supplying motor nerve terminals often appeared thin and wispy, only occasionally
interrupted by large accumulations of neurofilament proteins (Figure 3.17). One
possible explanation for this is that the axons observed in the current study are still
undergoing the translocation of NFs from the middle of the axon to the extremes of the
axon segment (hence the thin axonal appearance), and that the neurofilament
accumulations may represent an aggregation of NFs which are in the process being
transported the final few microns to the extremities of the axon segment. To address
this hypothesis, real-time visualisation of these neurofilament bundles is required, to
assess whether or not they are still being transported towards the nerve terminals.
Alternatively, it is possible that the retraction of nerve terminals into the axon reverses
this process, resulting in the compression and subsequent movement of NF
accumulations back towards the centre of the nerve. As a further point of interest, the
current study estimates that the rate of slow axonal transport (by which neurofilaments
are transported bi-directionally in the axon; Vallee and Bloom, 1991; Glass and
Griffin, 1991) is ~1.25-1.88mm/day in Wlds mouse tibial nerve. This value falls well
within the accepted range of rates for slow axonal transport as reported by Glass and
Griffin (0.1-4mm/day; 1994).
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If these axonal aggregations of NF observed at axotomised Wlds motor axon collaterals
are not simply 'in transit', a different explanation may be required. Pathological
aggregations of NF proteins in axons have been described as a hallmark of amyotrophic
lateral sclerosis (ALS; Hirano et ah, 1984; de Aguilar et al., 1999), a condition in
which motoneurone degeneration has been observed (Lim et ah, 2000). Furthermore, in
a pathological study of superoxide dismutase (SOD-1) transgenic mice which develop
strong ALS symptomatology and pathology, Morrison and colleagues (2000) have
described sporadic accumulations of NF within sciatic nerve axons which qualitatively
resemble those seen in axotomised Wlds motor axon collaterals. These authors
proposed that deficits in axon transport may underlie their observed pathology, a
mechanism which has previously been ruled out in the Wlds mouse however (Glass and
Griffin, 1991; Glass and Griffin, 1994). Nevertheless, any developments from studies
on the SOD-1 transgenic mouse with regard to NF accumulations may be applicable to
the Wlds phenotype. Indeed it may be of interest to ALS researchers to learn that the
Wlds mouse, whilst containing similar NF aggregations, shows no readily discernable
ALS-like symptomology. As a further point of interest, the similar time-course of NF
accumulation in Wlds and wild-type NMJs provides further evidence that neither the
rate of axonal transport of NFs, nor NF stability, is affected by the Wlds mutation (Glass
and Griffin, 1991; Tsao et al., 1994; Glass and Griffin, 1994).
Previous reports suggesting that nerve terminals withdraw from their endplates in young
Wlds mice following axotomy are supported by findings from the present study.
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Lesioned axons from Wlds mice, whilst being preserved for several weeks, do
eventually degenerate (Lunn et al., 1989; Tsao et al., 1994). Whether this process
occurs via the same mechanisms as classical Wallerian degeneration or not has yet to be
definitively addressed however (Brown et al., 1992). This would suggest that motor
nerve terminals should undergo a similar, delayed but eventual, process of Wallerian or
Wallerian-like degeneration. In contrast, evidence that nerve terminals appear to be lost
via a gradual piecemeal retraction from the endplate has been presented, using vital dye
staining as well as NF/SV2 immunocytochemical staining (Parson et al., 1998;
Ribchester et al., 1999; Mattison, R.J. 1999, PhD Thesis, University of Edinburgh).
Morphological evidence of endplates at all states of partial occupancy (1-99% occupied)
is presented in the current study from 2 month old Wlds mice at 3, 5 and 7 days post
axotomy (Figures 3.12, 3.13 and 3.14). Immunocytochemically labelled partially
occupied NMJs visualised in the present study have the same type of appearance as
those described in previous studies which have used FM1-43 labelling alongside
immunocytochemistry (Parson et al., 1998; Ribchester et ah, 1999; Mattison, R.J. 1999,
PhD Thesis, University of Edinburgh). Areas of vacated AchRs appear as brightly
labelled as neighbouring occupied regions, whilst nerve terminals at these endplates
have healthy appearing boutons connected by thin, wispy axon strands. The
identification of endplates at all levels of partial occupancy, from a single bouton
unoccupied through to the formation of 'retraction bulbs' suggests that the process of
withdrawal gradually proceeds, bouton by bouton, until all nerve terminal boutons have
been retracted back into the parent axon. The observation that terminal boutons at the
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extremities of nerve terminal branches (but not necessarily at the extremes of the
endplate) are lost first, rather than in a non-sequential manner, provides further evidence
that boutons are 'retracted' back into their parent axon (Figure 3.12). This temporal
hypothesis can not be wholly accepted however until real-time visualisation of
axotomised Wlds nerve terminals has been accomplished. Real-time techniques have
been used to visualise the withdrawal of nerve terminals from polyneuronally
innervated NMJs during development (for example; Balice-Gordon and Lichtman,
1993) and their application to observing synaptic events at axotomised NMJs of Wlds
mice either in vitro or in vivo will hopefully be achieved in the near future (S.H.Parson
and R.R.Ribchester, personal communication).
Whilst similar immunocytochemical experiments to those described in this chapter
have previously been undertaken, no study to date has analysed the process of nerve
terminal withdrawal in conjunction with providing data on in vivo synaptic remodelling.
Data concerning the level of synaptic remodelling (see above) that occurs naturally at
mammalian NMJs suggests that previous analyses of partial occupancy at axotomised
Wlds NMJs may be slightly inaccurate. If 3% or more of nerve terminals are
undergoing remodelling at any one point in time, as the data presented in this study
suggest, then a simple identification of a partially occupied endplate in a Wlds muscle
preparation may not be enough to assume that it is undergoing axotomy induced
withdrawal. The current study takes background levels of remodelling into account
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(see Figures 3.3, 3.14 and 3.19) by plotting accurate control data on those graphs which
assess the trends of partial occupancy levels at various time points following axotomy.
Similarly, no other study to date has provided combined morphological and
electrophysiological data from the same animals (Figure 3.26). Whilst the current
findings suggest that isolated electrophysiological experiments may underestimate the
true level of occupancy at axotomised Wlds FDB muscle preparations, the coordination
of morphological and functional experiments has produced many interesting findings.
Firstly, the increasing incidence of partially occupied endplates and NMJs exhibiting
weak synaptic transmission, with progressive days following axotomy, matched each
other closely (D.Thomson, personal communication). Thus, it is possible to conclude
that a decline in the occupancy of the endplate may occur concurrently with a decline in
synaptic function. This hypothesis is supported by a few intracellular recordings made
from identified junctions by Ribchester et al. (1999), who showed that as the occupancy
of an endplate declined, the incidence of failures increased. To adequately address the
hypothesis however, many more of these identified recordings need to be made.
Secondly, the occurrence of both an increased MEPP rate and increased incidence of
'giant' MEPPs (>lmV) in intracellular recordings from axotomised 2 month Wlds FDB
muscle preparations could be explained by morphological and ultrastructural
characteristics. At many of the immunocytochemically labelled partially occupied NMJ
preparations from Wlds FDB muscles following axotomy, the intensity of FITC
labelling over the endplate appeared more intense than in control preparations (Figure
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3.12). This suggested either an accumulation of NF or SV2 proteins within the
terminal, both of which were eventually identified at ultrastructural nerve terminal
profiles (Figures 3.20, 3.21 and 3.24; for evaluation of increased NF levels see below).
The increased packing density of SVs in regions close to the presynaptic membrane at
many axotomised Wlds nerve terminal profiles provides a plausible reason for an
increased MEPP rate. When there are more vesicles clustered towards the presynaptic
membrane, the probability of spontaneous release will almost certainly be higher.
Interestingly however, there was no increase in the number of 'docked' vesicles
between control and axotomised Wlds nerve terminals (Figure 3.25) as may be expected
if more vesicles are packed towards the presynaptic membrane. This finding suggests
that maximal levels of docked vesicles may already be reached in control preparations.
Finally, the increasing occurrence of 'giant' MEPPS in electrophysiological recordings
from axotomised Wlds FDB muscles correlates with the increased incidence of giant
vesicles, some of which were almost three times the diameter of normal vesicles, from
ultrastructural profiles of axotomised Wlds nerve terminals, and which were rarely seen
in control profiles (Figure 3.22). It seems quite plausible that the fusion of a 'giant'
vesicle with the presynaptic membrane would release much more neurotransmitter than
a regular vesicle, hence the increase in MEPP amplitude. The presence of giant vesicles
suggests that there may be some impairment in the fine control of the synaptic vesicle
recycling pathway, or subsequent fusion of pre-existing vesicles, within axotomised
Wlds nerve terminals.
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As has previously been noted (Ribchester et al., 1999; Mattison, R.J. 1999, PhD Thesis,
University of Edinburgh), the asynchronous nature of nerve terminal loss and partial
occupancy at axotomised Wlds NMJs (Figures 3.15 and 3.16) bear comparison with
similar features of NMJs undergoing developmental synapse elimination. The current
study supports these findings and suggests that the withdrawal of Wlds nerve terminals
may represent a recapitulation of this process. On a basic level, both involve an
apparent piecemeal withdrawal from the endplate alongside a lack of degenerative
markers (O'Brien et al., 1978; see below). More specifically however, some of the
most compelling evidence for this statement comes from observing the incidence and
appearance of retraction bulbs at axotomised Wlds endplates (Figure 3.13). The
distinguishing features of these terminal axon swellings closely resemble the retraction
bulbs which have been observed during synapse elimination (Riley, 1977; Riley, 1981;
Balice-Gordon et al., 1993). A more detailed discussion with regards to the
implications of these associations can be found in the final discussion (Chapter 6).
Some aspects of nerve terminal withdrawal at axotomised Wlds NMJs do not have
parallels in synapse elimination, however. For example, whilst NF accumulation is a
prominent feature in axotomised Wlds NMJs, Roden et al. (1991) have shown that loss
of NF proteins from nerve terminals is a common feature during synapse elimination.
Whilst morphological evidence of partial occupancy has been reported previously, the
presence of electron microscopical data in the current study provides the first
ultrastructural description of this phenomenon at axotomised Wlds NMJs (Figures 3.18
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and 3.10). It should be noted, however, that ultrastructural identification of partially
occupied NMJs is not a particularly accurate measure (for example, compare figures
3.14 and 3.19b). The main reason for this is that: when observing a 70-90nm thick
section through a NMJ down the electron microscope, it is only possible to visualise
those synaptic boutons which are contained within that plane of section. Whilst this can
provide enough information for an acceptable analysis of an NMJs level of occupancy
in a number of cases (e.g. when there are areas of occupied and unoccupied
postsynaptic folds in the same plane of section, thereby allowing identification as being
partially occupied), when all boutons are occupied/unoccupied, it is not possible to say
with conviction that the whole terminal is occupied or unoccupied as there may be
boutons out of the plane of section which are in an opposing state. On some occasions
it has been possible to look at sequential sections from the same NMJ, to include more
boutons in the analysis of occupancy, but even this is not 100% accurate unless a NMJ
is serially sectioned and every bouton is included. I considered doing this, but decided
that it would have been largely confirmatory and ultimately too time-consuming for the
likely added value in the context of the present research project.
Even though ultrastructural analyses appear to slightly underestimate the overall levels
of partial occupancy occurring at axotomised Wlds NMJs, the current data strongly
supports the morphological findings that boutons are removed in a piecemeal fashion
from the endplate. Whilst, as in the immunocytochemical experiments, it has not been
possible to isolate remodelling processes from withdrawing processes using
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ultrastructural analyses, base levels of synaptic remodelling have been taken into
account (Figure 3.19b). Interestingly, the ultrastructural correlates of partially occupied
terminals from axotomised Wlds NMJs closely resemble the appearance of partially
occupied terminals undergoing remodelling (see above; Cardasis and Padykula, 1981).
The areas of unoccupied endplate appear normal under both conditions, with no
disruption of the postsynaptic architecture or basal lamina, and are often clear of all
cellular material except for the presence of terminal Schwann cell processes at a few
profiles. This raises the possibility that the two processes may share some common
mechanisms.
3.4.4 Wallerian Degeneration is Absent At Axotomised
Nerve Terminals in the Wlds Mouse
Many previous functional and morphological studies of the piecemeal withdrawal of
nerve terminals from axotomised Wlds endplates have hypothesised that Wallerian
degeneration is not occurring at these synapses (Parson et al., 1998; Ribchester et al.,
1999; Mattison, R.J. 1999, PhD Thesis, University of Edinburgh). The morphological
data from the current study supports this hypothesis by demonstrating the lack of
morphological markers of degeneration (a fragmented and vacuolated appearance;
Figure 3.7; Kawabuchi et al., 1991) at all axotomised Wlds nerve terminals. The fact
that partial occupancy occurs at all is also major evidence to support the hypothesis that
Wlds nerve terminals are lost by a process distinct from that of Wallerian degeneration.
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The classical description of Wallerian degeneration, corroborated by
immunocytochemical and ultrastructural evidence from the present study (Figures 3.7,
3.8 and 3.9), involves a fragmentation and destruction of the endplate in situ (Reger,
1959; Miledi and Slater, 1970; Manolov, 1974; Winlow and Usherwood, 1975).
Therefore, if the withdrawal of nerve terminals at Wlds NMJs is simply a protracted
version of Wallerian degeneration, it would not be expected to observe partial
occupancy, except at the small number of terminals undergoing remodelling.
Most knowledge of the cellular processes and identification of Wallerian degeneration
at the NMJ has been derived from ultrastructural studies, and yet, to date there has not
been a systematic morphological study of the ultrastructure of axotomised Wlds
synaptic boutons. In the present study however, nerve terminals from axotomised 2
month old Wlds mice at 3, 4, 5 and 7 days post axotomy, at all states of occupancy, have
been subjected to qualitative and quantitative examination. The results of these
experiments unequivocally demonstrate that the process of nerve terminal withdrawal
from axotomised Wlds endplates occurs by a mechanism separate and distinct to that of
Wallerian degeneration.
Out of the 296 motor nerve terminals from two month old Wlds muscles analysed, only
7 (3.1%) were identified as showing possible signs of degeneration, a similar level to
that which has been shown to occur during synapse elimination (Reier and Hughes,
1972). These data were derived from nerve terminal profiles at all levels of occupancy,
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and at 3, 4, 5 and 7 days following axotomy. There is a strong likelihood however, that
in this instance, levels of 3.1% may turn out to be an overestimate. The only reason that
each of these terminals was categorised as degenerating was because they contained
more than 20% of mitochondrial profiles showing signs of swelling and cristae
fragmentation. Whilst disrupted mitochondrial profiles were rarely seen in my control
preparations, the figure of 20% was used as a threshold level because of the findings of
Winlow and Usherwood (1975) who showed that up to 19% of mitochondria in normal
axon terminals were damaged, representing a natural turnover. As a result, it is possible
to suggest that the slightly higher levels of disrupted mitochondrial profiles identified in
my preparations represent an increased level of turnover rather than the onset of
Wallerian degeneration. Further evidence to support the hypothesis that these terminals
have been misidentified comes from the lack of other degenerative markers present.
None of the 'degenerating' terminals had any signs of terminal membrane disruption,
SV depletion and clustering or terminal Schwann cell phagocytosis. It remains a strong
possibility therefore, that the identification of degenerating mitochondrial profiles is not
occurring as a result of Wallerian degeneration at these nerve terminals.
Even if it transpires that the 3.1% of 'questionable' terminals are undergoing Wallerian
degeneration, the reality remains that 96.9% of axotomised Wlds nerve terminals are
removed from the endplate by a process which shows no signs of classical degeneration
whatsoever (Figures 3.11 and 3.18-3.25. The data demonstrate that the overwhelming
majority of nerve terminal loss at axotomised Wlds NMJs occurs without any reduction
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in synaptic vesicle number, with no terminal membrane fragmentation and with no
phagocytosis by a terminal Schwann cell. Thus, it appears that nerve terminal
ultrastructure is retained throughout the withdrawal process. Indeed, it would be
interesting to discover what the eventual fate of the retained subcellular organelles is
following their retraction back into the parent axon.
Finally, the hypothesis that the withdrawal of nerve terminals following axotomy in
young Wlds mice and during synapse elimination share some common mechanisms is
further supported by the present ultrastructural findings. The retention of nerve terminal
ultrastructure throughout the withdrawal process in young Wlds mice is unequivocally
demonstrated in the present study. Similar demonstrations of the lack of degenerative
processes occurring during synapse elimination have been provided from studies by
Korneliussen and Jansen (1976), Riley (1981) and Bixby (1981; but see Rosenthal and
Taraskevich, 1977). One major technical hurdle concerning the ultrastructural analysis
of nerve terminal loss during synapse elimination, which has yet to be overcome, is the
problem of identifying which synaptic bouton comes from which axonal branch at a
polyinnervated endplate. This has limited previous studies to just being able to look for
signs of degeneration across the whole nerve terminal rather than being able to look for
subtle differences between competing synaptic boutons, one of which will end up being
withdrawn. During the course of the present study, I made sustained and numerous
attempts to use axotomised Wlds NMJs in order to overcome this problem, with the aim
of allowing a more accurate comparison of the processes of nerve terminal withdrawal
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occurring at axotomised Wlds NMJs and during synapse elimination. Unfortunately,
standard and modified protocols of FM1-43 photoconversion (whereby identified
fluorescently labelled frog motor nerve terminals illuminated under the standard
fluorescence microscope are exposed to a diaminobenzidine solution, thereby
converting fluorescence into an electron dense reaction product contained solely within
FM1-43 loaded SVs, which is visible down the EM; see Henkel et ah, 1996) could not
be made to work in my preparations of lumbrical muscle, TA muscle or even levator
auris longus muscle. It has subsequently been found that the concentration of FM1-43
contained within SVs is of paramount importance for producing photoconversion
reaction product (Schikorski and Stevens, 2001). Thus, it appears that the
concentrations of FM1-43 used in my unsuccessful experiments (5/xM), which work
adequately in the frog (Henkel et al., 1996; Richards et ah, 2000; Prof. W.J. Betz,
personal communication), may have been too dilute to produce photoconversion
reaction product. If FM1-43 photoconversion could be made to work in the future, it
should become possible to load nerve terminals supplied by one nerve whilst leaving
others supplied by another nerve unstained (for example see; Costanzo et al., 1999;
Costanzo et al., 2000). As a result, ultrastructural profiles of competing nerve terminals
could be identified at polyinnervated NMJs undergoing synapse elimination.
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3.4.5 Summary
The data presented in Chapter 3 of the current study unequivocally demonstrate that
young Wlds motor nerve terminals are lost from the endplate, following axotomy, via a
process separate and distinct from that of Wallerian degeneration. Furthermore,
additional evidence is provided to support the hypothesis that this terminal loss occurs
by a process of piecemeal withdrawal, whereby boutons are retracted, one at a time,
back into the parent axon. The similarities between this withdrawal process and the
retraction of supernumerary terminals during developmental synapse elimination are
also apparent. Taken together, these findings support the hypothesis that independent
mechanisms may underlie degenerative processes in separate compartments of the
neurone, whereby synaptic degeneration is separate and distinct from that of somatic
and axonal degeneration (see Chapter 6). Many unanswered questions remain however.
For example, there is a long running debate as to what effect age has on the Wlds
phenotype. Similarly, it is still unclear as to what in the Wlds genotype is responsible
for producing the distinctive axotomy-induced phenotype described above. It is these




4. Effect of Age on the Phenotypic Expression of the
Wlds Mutation
4.1 Background
Whilst the preservation of distal axons and motor nerve terminals following axotomy
has been unequivocally demonstrated in Wlds mice of 2 months and under (Chapter 3;
Lunn et al., 1989; Ribchester et al., 1995), there remains controversy over whether the
effectiveness of this 'protection' declines with age. Perry and colleagues (1992)
showed that the rate of axonal loss in axotomised sciatic nerve (as measured by the size
of the compound action potential) increased with age in Wlds mice. For example, in 1
month old Wlds sciatic nerve, compound action potentials declined to -70-80% of their
normal amplitude at 5 days post-axotomy. In contrast, no compound action potentials
could be excited from 1 year old Wlds preparations. The age-related decline in axonal
preservation appeared to occur gradually however: intermediate levels of retention were
detected in 3 to 6 month old mice preparations, whereby compound action potentials of
-20-30% of those seen in control preparations were recorded. A subsequent molecular
study from the same lab supported these findings by showing that neurofilament levels
in Wlds sciatic nerve following axotomy, as well as compound action potentials,
declined faster with increasing age (Tsao et al., 1994).
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Further evidence to support the hypothesis that increasing age reduces the effectiveness
of the Wlds phenotype was provided in a study of motor nerve terminal loss following
axotomy in Wlds mice by Ribchester and colleagues (1995). These authors
demonstrated that the level of preservation of functional motor nerve terminals also
declines with age. Thus, in FDB muscles from 4 month old Wlds mice, 2-3 days after
axotomy, <1% of muscle fibres responded to nerve stimulation. This is in contrast to
data from 1 month old Wlds mice at the same time post-axotomy, where -90-100% of
muscle fibres responded to nerve stimulation.
Despite the strong evidence for a decline in the effectiveness of the Wlds gene with age
provided by Perry et al. (1992), Tsao et al. (1994) and Ribchester et al. (1995), a
morphological study by Crawford et al. (1995) and a very recent biochemical study by
M.P. Coleman (personal communication) appear to repudiate these findings. In the
latter, it has been demonstrated that age has no effect on the retention of NF levels
following axotomy in Wlds mice from the colony maintained in Cologne. In the earlier
study, Crawford et al. showed that, in their Wlds breeding colony in Baltimore, the
period of both axonal and motor nerve terminal survival after nerve lesion was the same
in mice ranging from 1 to 16 months old. Thus, at 5 days after axotomy, -80% of
endplates were still innervated in both 1 and 7 month old Wlds mice (Figure 4.1). They
tried to explain the differences in their findings by suggesting that the use of
electrophysiological methods by previous investigators (Perry et al., 1992, Tsao et al.,
1994) may have yielded false conclusions, owing to the possibility that old Wlds axons
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Fig. 4.1 Data from the Study by Crawford et al. (1995) on the Innervation of
NMJs following Axotomy in Wlds mice of Different Ages.
(A) Comparison of innervated NMJs at 0 and 5 days post axotomy in 1 month old and
7 month old Wlds mice (mean ± SD). There is a small loss of innervation after 5 days,
but there is no significant difference between 1 month old and 7 month old animals.
Figure and legend adapted from Figure 7 in: Crawford, T.O., Hsieh, S-T., Schryer,
B.L. & Glass, J.D. (1995) Prolonged axonal survival in transected nerves of C57Bl/01a
mice is independent of age. Journal ofNeurocytology 24: 333-340
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might survive axotomy, but age may have an effect on their conduction properties. This
does not explain the findings of Tsao et al. (1994) however, that NF levels following
axotomy also decline faster with age. Crawford and colleagues (1995) also left open an
alternative possibility, that the disparity involving their findings and those described
above may be due to differences between the separate breeding colonies used.
This chapter provides morphological data on axon numbers in lesioned distal nerve
stumps and immunocytochemical and ultrastructural data on axotomised NMJs from
Wlds mice of different ages, the latter of which was undertaken in parallel with a
concurrent electrophysiological study (by Mr D. Thomson in our laboratory). Data from
experiments regarding axon preservation following nerve lesion were not conclusive,
neither supporting nor dismissing the age-related phenotypic loss hypothesis. However,
unequivocal evidence is provided in support of the hypothesis that the effectiveness of
the Wlds phenotype declines with age at axotomised motor nerve terminals. Thus, in our
colony at least, mice older than 4 months do not express the Wlds phenotype at NMJs, at
levels anywhere near those found in young (2 month old) mice. Furthermore, the data
presented in this chapter provide evidence that it is not only the rate of nerve terminal
loss that is modified with age. Immunocytochemical and electron microscopic findings
suggest that the nature of nerve terminal loss too, appears to undergo a conversion with
age in Wlds mice.
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4.2 Methods
The majority of experiments contained within this chapter were carried out using
methods described in chapter 2. The following section describes methods which are
specific to this chapter.
4.2.1 Morphological Quantification of Axonal Preservation
Tibial nerve cuts were performed in 2 and 7 month old Wlds mice (see chapter 2). Four
days later, the animal was killed and proximal and distal nerve stumps were dissected
out and fixed in 4% paraformaldehyde / 2.5% glutaraldehyde for 4 hours. The first
2mm of the proximal and distal nerve stumps were discarded. The remaining stumps
were prepared for electron microscopy using the same protocol as for muscle
preparations (see chapter 2). Cross-sections (1/xm) taken using a glass knife on a
Reichert 'Ultracut' ultramicrotome were collected on glass slides before staining with
toludine blue (1% in dH20; Sigma). Sections were examined using a Zeiss 40x water
immersion objective attached to a standard light microscope. Images were captured and
enhanced using the protocol described in Chapter 2.
The total number of myelinated axon profiles (non-myelinated axons were not readily
detectable using the current protocol; cf. Crawford et ah, 1995) were counted in cross-
sections from both proximal and distal nerve stumps. To be included in the count,
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axons had to exhibit normal myelin sheaths and a uniform axoplasm. Each cross-
section was analysed on three separate occasions, to allow for human error in counting.




4.3.1 Qualitative and Quantitative Morphological
Comparison of the Preservation of Distal Axons in 2
and 7 Month Wlds Mice Tibial Nerve Following
Axotomy
Semi-thin (ljum) sections of tibial nerve, taken from regions both proximal and distal to
the site of a 4 days previous nerve lesion are shown in Figure 4.2. There were no
qualitative differences apparent between the proximal and distal portions of the 2 month
Wlds tibial nerve, with numerous myelinated axon profiles present in both (Figure 4.2a
and 4.2b). The proximal portion of the 7 month Wlds tibial nerve appeared very similar
to those obtained from 2 month old animals (Figure 4.2c), although there was a slight
reduction in the number of myelinated axon profiles in the distal nerve stump (Figure
4.2d).
Quantitative analysis of axon counts from 2 month old Wlds tibial nerve indicated that
there was no significant difference (P=0.0696, Unpaired t test) between the number of
axon profiles proximal (597.33 ±1.15 SD; n=3, N=l) and distal (611.33 ±6.66; n=3,
N=l) to the lesion (Figure 4.3). This was in contrast to the 7 month old data which
showed that there were significantly fewer axon profiles (P=<0.001; unpaired t test) in
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sections of tibial nerve distal to the lesion site (537.67 ±2.52; n=3, N=l) compared to
regions of the nerve proximal to the lesion (578.67 ±2.08; n=3, N=l). The loss of 7%
of axons in the distal stump of 7 month old Wlds mouse 4 days after axotomy, whilst
statistically significant, does not begin to approach the level of axonal loss in 1 year old
Wlds mice preparations as observed in the studies by Perry et al. (total loss of the
compound action potential at 5 days post axotomy; 1992), and thus is not conclusive
with regards to addressing the age-related expression of the Wlds phenotype in axons
(see discussion). Similarly, the rate of axonal loss in lesioned 7 month old Wlds nerve
did not approach the rate observed in wild-type preparations (Figure 4.3c). However,
the effect of age on the degeneration of motor nerve terminals contrasted strongly with
that of axons.
4.3.2 Rate of Axotomy-lnduced Nerve Terminal Loss in
Wlds Mice of Different Ages
Immunocytochemically labelled NMJs (NF, SV2 and a-BTX), at 3, 4, 5 and 7 days post
axotomy, from 2 month (n=4329, N=19), 4 month (n=3871, N=17), 7 month (n=5319,
N=14) and 12 month (n=4573, N=14) old Wlds mice FDB muscles were individually
assessed as to their level of occupancy (Figure 4.4 and 4.5). The rate of decline in
endplate occupancy increased in Wlds mice of 4 months compared to 2 months (Figure
4.4). For example, at 3 days post axotomy in 2 month Wlds FDB muscles there were
substantially more occupied endplates than at the same time point in 4 month Wlds
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mice, with levels of 95.31% ±1.39 (SEM) and 33.75% ±7.96 respectively (P=0.0043,
Mann-Whitney test). Similarly, at 7 days post axotomy there were significantly more
occupied endplates remaining (P=0.0022) in 2 month Wlds preparations (52.29% ±4.26)
compared to 4 month preparations (4.39% ±1.92). The increase in the rate of decline in
endplate occupancy was even more marked in 7 month Wlds muscles than in the 4
month preparations. Thus, in the 7 month Wlds preparations at 3 days axotomy only
1.3% ±0.27 of endplates were occupied, significantly less than in both 2 month old
preparations (P=0.0022; 95.31% ±1.39) and 4 month old preparations (P=0.0043;
33.75% ±7.96). There was no further significant increase in the rate of decline in
endplate occupancy at both 3 (P=0.6991) and 5 (P=0.8889) days post axotomy when
comparing 7 month and 12 month data.
4.3.3 Immunocytochemistry of Axotomised Nerve
Terminals in Wlds Mice of Different Ages
Immunocytochemically labelled NMJs (NF, SV2 and a-BTX), at 3, 4, 5 and 7 days post
axotomy, from 2 month (n=4329, N=19), 4 month (n=3871, N=17), 7 month (n=5319,
N=14) and 12 month (n=4573, N=14) old Wlds mice FDB muscles were individually
assessed as to the state of their nerve terminals. In 2 month old preparations, at 3, 5 and
7 days post axotomy and in all states of full or partial occupancy (1-100%), persistent
nerve terminals appeared to be healthy, with no signs of terminal fragmentation (Figure
4.6a; also see Chapter 3). Whilst the rate of nerve terminal loss increased in 4 month
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old preparations, remaining nerve terminals also retained their architecture and showed
no evidence of terminal fragmentation (Figure 4.6b).
Of the few remaining nerve terminals in 7 month Wlds preparations at 3 and 5 days post
axotomy, most showed no signs of terminal fragmentation (Figure 4.7a). Residual nerve
branches often appeared disrupted or fragmented however, indicative of classical
degenerative pathways (Figure 4.7b). Furthermore, intramuscular nerve branches
identified in Wlds FDB muscles of 7 months or older were grossly fragmented,
providing further evidence of classical degeneration mechanisms (Figure 4.7c).
4.3.4 Effect of Age on the Incidence of Partial Occupancy
at Axotomised NMJs in Wlds Mice
A quantitative analysis of the immunocytochemically labelled preparations described
above showed a decrease in the incidence of partial occupancy with increasing age
(Figure 4.8). Thus, out of the total number of occupied endplates assessed in 2 month
Wlds preparations (n=4834, N=6), 64.87% were partially occupied. This level gradually
declined with increasing age, producing figures of 47.04%, 30% and 15.87% in 4
(n=523, N=17), 7 (n=120, N=14) and 12 (n=208, N=14) month preparations
respectively.
147
It should be noted that these data (Figure 4.8 as well as Figure 4.14, see below) are
presented as a percentage of the total number of occupied endplates, rather than simply
the total number of endplates. This method leaves unoccupied endplates out of any
analysis. The reason for using this method of analysis is that it is not possible to
distinguish what mechanism was responsible for the loss of a nerve terminal from a
vacated endplate. For example, in a 7 month Wlds mouse FDB muscle, 3 days post
axotomy, only -1% of nerve terminals remain. Whilst this rate of terminal loss appears
to approach that of wild-types, it is not possible to say that as a result, all or some of
those terminals were lost by a classical, in situ degenerative process found in wild-
types, rather than a speeded up piecemeal withdrawal process. As a result, only
occupied terminals were included, allowing accurate assessment of the mechanism by
which they were being lost.
4.3.5 Ultrastructural Characteristics of Axotomised Nerve
Terminal Morphology in Wlds Mice of Different Ages
Retention of nerve terminal architecture and a paucity of classical degenerative markers
were features of the overwhelming majority of NMJ profiles from 2 month Wlds FDB
muscle preparations at all time points following axotomy (Figure 4.9a; Chapter 3).
Similar examples of fully and partially occupied endplates, with retention of nerve
terminal architecture were common at NMJ profiles from 4 month Wlds FDB muscle
preparations at all time points following axotomy (Figure 4.9b). Thus, at many NMJ
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profiles from 4 month Wlds preparations, ultrastructural characteristics similar to those
observed in 2 month old preparations were evident (e.g. NF invasion, 'giant' vesicles,
retention and compression of SVs towards the presynaptic membrane; Figure 4.10).
However, there was one major difference between 2 month and 4 month preparations;
an increase in the incidence of a major classical degenerative marker, namely the
disruption and fragmentation of nerve terminal mitochondria (Figure 4.10). An
increased incidence of degenerating mitochondrial profiles (identified by swollen
membranes and disrupted cristae) was observed at both fully and partially occupied
endplates (Figure 4.10 and 4.11). In some instances boutons with healthy mitochondrial
profiles had neighbouring boutons containing degenerative mitochondria at the same
NMJ (Figure 4.11b).
The incidence of disrupted mitochondrial profiles was also high in NMJ profiles from 7
month Wlds FDB muscle preparations at all time points following axotomy (Figure
4.12). This degenerative marker was often accompanied by sparse synaptic vesicles
(Figure 4.12b) and terminal membrane disruption (Figure 4.12a). In a few NMJ profiles
observed, terminal Schwann cells were seen to be phagocytosing grossly fragmented
nerve terminals (Figure 4.13a) in a process which bears all the hallmarks of classical
degeneration. Furthermore, at the majority of vacant endplates examined in 7 month
Wlds preparations (96.30% ±3.70 SEM; n=73 NMJs, N=3 muscles), terminal Schwann
cell profiles were located on top of the postsynaptic folds (Figure 4.13b). This is in
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contrast to 2 month preparations where only 30.04% ±7.34 (n=66, N=9) of vacant
endplates had opposing terminal Schwann cell profiles.
An age-related increase in the incidence of ultrastructural markers of degeneration
occurring at axotomised Wlds NMJs is shown in Figure 4.14. Thus, out of the total
number of occupied endplates assessed in 2 month Wlds preparations (n=228, N=9),
3.1% showed signs of degeneration. This level gradually increased with age, whereby
39.8% (n=103, N=3) of occupied endplate profiles in 4 month Wlds preparations and
91.3% (n=23, N=4) of occupied endplate profiles in 7 month Wlds preparations
contained degenerative markers. It should be noted that, as for the graph of partial
occupancy (Figure 4.8), the data in Figure 4.14 is presented as a percentage of the total
number of occupied endplates, rather than simply the total number of endplates (see
above for explanation).
As in 2 month Wlds preparations (see Figures 3.20 and 3.21), nerve terminals from 4
and 7 month Wlds FDB muscle preparations often showed an intra-terminal
accumulation of NF following axotomy (Figure 4.15). Similarly, the NF accumulation
in these terminals did not appear to disrupt the polarised distribution of synaptic
vesicles and mitochondria. Quantification of this phenomenon (Figure 4.16) showed
that the level of NF in nerve terminals from 4 month (11.9% ±3.39SEM; n=30, N=4)
Wlds axotomised FDB preparations was significantly higher than in controls (n=34,
N=4; P=0.0006, Mann Whitney test). The levels of NF accumulation in 7 month
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preparations (8.31% ±3.61; n=14, N=4), whilst noticeably higher, did not quite reach
statistical significance compared to controls (P=0.0863).
In the majority of nerve terminal profiles from 4 month old Wlds FDB preparations, 3
days after axotomy, the numbers and distribution of synaptic vesicles appeared very
similar to those seen in control and axotomised 2 month old Wlds FDB preparations
(Figure 4.17a). This is in contrast to many of the terminal profiles observed from 7
month Wlds preparations, 3 days after axotomy, where synaptic vesicles were scarce
(Figure 4.17b). Quantitative analysis of these nerve terminal profiles supported the
qualitative observations (Figure 4.18). Thus, in 4 month old Wlds nerve terminals 3
days after axotomy (93.32SV//zm2 ±6.32SEM; n=30, N=4), the density of synaptic
vesicles was almost significantly higher than in control preparations (78.31SV/jttm2
±6.04; P=0.0884, unpaired t test; n=34, N=4) and slightly higher than in 2 month Wlds
(83.76SV//i.m2 ±5.70; n=26, N=3) preparations. Furthermore, in 7 month old Wlds
nerve terminals 3 days after axotomy (42.56SV//rm2 ±4.59; n=14, N=4), the density of
synaptic vesicles was significantly less than in control, 2 month Wlds and 4 month Wlds
preparations (P=<0.0001 for all; Figure 4.18a).
Unsurprisingly, the packing density of SVs was reduced in 7 month, but retained in 4
month, Wlds preparations, compared to controls (Figure 4.18b). 7 month Wlds nerve
terminals, 3 days after axotomy, had a SV packing density of 12.31% ±1.34 (n=14,
N=4). This was significantly lower (P=<0.0001, Mann Whitney test) than in control
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(28.25% ±1.95; n=34, N=4) and 2 month, 3 day axotomised Wlds (40.64% ±1.71; n=26,
N=3) nerve terminals. Nerve terminal profiles from 4 month Wlds FDB muscles at 3
days post axotomy (47.16% ±1.78; n=30, N=4) had a significantly higher SV packing
density than control (P=<0.0001) and 2 month Wlds, 3 day axotomised (P=0.0123)
preparations. Quantitative analysis of the numbers of vesicles within 125nm of an
active zone ('docked' vesicles) showed that there was no significant difference
(P=0.8319 and P=0.2503; unpaired t test) between 4 month Wlds nerve terminals at 3
days post axotomy (5.10 ±0.22) and control (5.04 ±0.18) and 2 month, 3 day
axotomised, Wlds (5.41 ±0.16) nerve terminals (Figure 4.19). This is in contrast to the
numbers of docked vesicles in 7 month old Wlds preparations, 3 days after axotomy
(2.52 ±0.27), which were significantly less than the numbers detected in control nerve
terminals (P=<0.0001) and 3 day axotomised terminals from 2 and 4 month old Wlds
mice (P=<0.0001 for both).
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Fig. 4.2 Preservation of Distal Axons Following Nerve Lesion in Young and
Old Wlds Mice
(A) Light micrograph of a transverse section through tibial nerve, 2mm proximal to the
site of lesion, from a 2 month old Wlds mouse, 4 days after axotomy. The nerve appears
healthy, with a good distribution of myelinated axon profiles.
(B) Light micrograph of a transverse section through tibial nerve, 2mm distal to the site
of lesion, from a 2 month old Wlds mouse, 4 days after axotomy. As in the proximal
stump, the distal nerve stump appears healthy, with a good distribution of myelinated
axon profiles.
(C) Light micrograph of a transverse section through tibial nerve, 2mm proximal to the
site of lesion, from a 7 month old Wlds mouse, 4 days after axotomy. Once again, the
nerve appears healthy, with a good distribution of myelinated axon profiles.
(D) Light micrograph of a transverse section through tibial nerve, 2mm distal to the site
of lesion, from a 7 month old Wlds mouse, 4 days after axotomy. Qualitatively, the
nerve appears relatively healthy, with no evidence of a major reduction in axon
numbers.
Scale bar - 20/rm.
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Fig. 4.3 Quantification of the Preservation of Distal Axons Following Nerve
Transection in Young and Old Wlds Mice
(A) Bar chart representing the number of axon profiles counted in transverse sections
of tibial nerve from 2mm proximal and distal to a nerve lesion in a 2 month old Wlds
preparation, 4 days after axotomy. There was no significant difference between the two
regions of nerve (P=0.0696, unpaired t test).
(B) Bar chart showing the number of axon profiles counted in transverse sections of
tibial nerve from 2mm proximal and distal to a nerve lesion in a 7 month old Wlds
preparation, 4 days after axotomy. Statistically there were significantly fewer axon
profiles in the distal stump compared to the proximal nerve stump (P=<0.001, unpaired
t test), but this reduction did not begin to approach the level of axon loss observed in
wild-type preparations (see C).
(C) Bar chart produced from data provided in Perry et al. (1992) showing the size of
the compound action potential in the distal stump of sciatic nerves from wild-type
(C57B1/6J) mice of 1 and 2 months old, 2 days post axotomy. This data shows the rapid
loss of axonal function in wild-type preparations following axotomy, and is supported
by earlier experiments which showed a similar loss of action potentials (Luttges et al.,
1976) alongside a concomitant reduction in the levels of neurofilaments (Schlaepfer and















Fig. 4.4 Morphological Quantification of the Effect of Increasing Age on
Endplate Occupancy (1-100%) Following Axotomy in Wlds Mice (1)
(A) Graph of days post axotomy versus percentage of occupied endplates in 2 month
old Wlds mice as calculated by counts of immunocytochemically stained (NF, SV2, a-
BTX) FDB muscle preparations. Black triangles represent data from individual muscles
and red triangles represent mean values.
(B) Graph of days post axotomy versus percentage of occupied endplates in 4 month
old Wlds mice as calculated by counts of immunocytochemically stained (NF, SV2, a-
BTX) FDB muscle preparations. Black triangles represent data from individual muscles
and red triangles represent mean values.
Curves were fitted using Sigmaplot as the best sigmoidal/exponential fit to the data.
Note that at this stage these curve fits should not be taken to imply any specific model











Fig. 4.5 Morphological Quantification of the Effect of Increasing Age on
Endplate Occupancy (1-100%) Following Axotomy in Wlds Mice (2)
(A) Graph of days post axotomy versus percentage of occupied endplates in 7 month
old Wlds mice as calculated by counts of immunocytochemically stained (NF, SV2, a-
BTX) FDB muscle preparations. Black triangles represent data from individual muscles
and red triangles represent mean values.
(B) Graph of days post axotomy versus percentage of occupied endplates in 12 month
old Wlds mice as calculated by counts of immunocytochemically stained (NF, SV2, a-
BTX) FDB muscle preparations. Black triangles represent data from individual muscles
and red triangles represent mean values.
Curves were fitted using Sigmaplot as the best sigmoidal/exponential fit to the data.
Note that at this stage these curve fits should not be taken to imply any specific model
or kinetic scheme underlying the degenerative processes in Wlds mice of different ages.
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Fig. 4.6 Morphology of Axotomised NMJs from Wlds Mice of Different Ages
(1).
(A) Confocal image of three NMJs from a 2 month old Wlds mouse FDB muscle (NF,
SV2 and a-BTX) 3 days post axotomy. Examples of neighbouring endplates which are
fully occupied (left), partially occupied (centre) and vacant (right) are shown. The
motor nerve terminals present all appear healthy. Scale bar = 20/xm.
(B) Confocal image of two NMJs from a 4 month old Wlds mouse FDB muscle (NF,
SV2 and a-BTX) 3 days post axotomy. This micrograph shows a vacant endplate (on
the right) next to a remaining, fully occupied endplate (on the left) which appears
healthy. Scale bar = 20/xm.
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Fig. 4.7 Morphology of Axotomised NMJs from Wlds Mice of Different Ages
(2).
(A & B) Confocal images of NMJs from a 7 month old Wlds mouse FDB muscle (NF,
SV2 and a-BTX) 3 days post axotomy. Whilst the vast majority of endplates were
vacant, examples of some persistent nerve terminals are shown (arrows). Scale bar =
20/im.
(C) Confocal image of NMJs from a 7 month old Wlds mouse FDB muscle (NF, SV2
and a-BTX) 3 days post axotomy. This image shows all vacant endplates alongside a
fragmented, degenerating intramuscular nerve branch. Scale bar = 20/rm.
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Fig. 4.8 Morphological Quantification of the Effect of Age on the Occurrence
of Partial Occupancy (1-99%) at Endplates Following Axotomy in
Wlds Mice
(A) Graph of the percentage of total occupied endplates which were partially occupied
(1-99%) at all time points (3, 4, 5 and 7 days) following axotomy against the age of the
animal, in immunocytochemically stained (NF, SV2, a-BTX) Wlds mice FDB muscle
preparations.
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Fig. 4.9 Qualitative Analysis of the Effect of Increasing Age on the
Ultrastructure of NMJs Following Axotomy in WIds Mice (1)
(A) Electron micrograph of a nerve terminal bouton from a fully occupied NMJ in 2
month old Wlds mouse FDB muscle, 4 days after axotomy. Note the retention of the
terminal architecture and membranes as well as a healthy distribution of SVs and
mitochondria alongside an accumulation of neurofilament in the centre of the bouton.
Scale bar = 2/rm.
(B) Electron micrograph of two nerve terminal boutons from a fully occupied NMJ in 4
month old Wlds mouse FDB muscle, 3 days after axotomy. In this example, the
terminal architecture and membranes are preserved, along with a healthy distribution of
SVs and mitochondria. Scale bar = 2/xrn,
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Fig. 4.10 Qualitative Analysis of the Effect of Increasing Age on the
Ultrastructure of NMJs Following Axotomy in Wlds Mice (2)
(A) Electron micrograph of a nerve terminal bouton from a partially occupied NMJ in 4
month old Wlds mouse FDB muscle 3 days after axotomy. The bouton shown in this
example shows a retention of pre- and postsynaptic architecture, NF accumulation
(green star), a healthy distribution of SVs clustered towards active zones (red
arrowhead) and the occasional 'giant' vesicle' (red arrow). However, the majority of
mitochondria appear to be degenerating, evidenced by disrupted cristae (blue arrows).
Scale bar = Ijim.
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Fig. 4.11 Qualitative Analysis of the Effect of Increasing Age on the
Ultrastructure of NMJs Following Axotomy in Wlds Mice (3)
(A) Electron micrograph of a nerve terminal bouton from a fully occupied NMJ in 4
month old Wlds mouse FDB muscle 3 days after axotomy. The mitochondria in the
bouton shown are showing the classical signs of degeneration. When compared to
healthy postsynaptic mitochondria (red arrow) it can be observed that they have become
swollen and their cristae are disrupted and fragmented. Scale bar = Ijim.
(B) Electron micrograph of two nerve terminal boutons from a partially occupied NMJ
in 4 month old Wlds mouse FDB muscle 3 days after axotomy. The bouton on the right
has a normal appearance, whilst the bouton on the left contains degenerating
mitochondrial profiles; although both contain intact synaptic vesicles. Scale bar = 1/xm.
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Fig. 4.12 Qualitative Analysis of the Effect of Increasing Age on the
Ultrastructure of NMJs Following Axotomy in Wlds Mice (4)
(A) Electron micrograph of a nerve terminal bouton from a fully occupied NMJ in 7
month old Wlds mouse FDB muscle 2 days after axotomy. In this example, one of the
few remaining nerve terminals is shown. Qualitative degenerative characteristics are
present in all mitochondria, reduced synaptic vesicle levels and membrane disruption.
Neurofilament invasion of the nerve terminal can also be observed. Scale bar = 1/rm.
(B) Electron micrograph of a nerve terminal bouton from a fully occupied NMJ in 7
month old Wlds mouse FDB muscle 2 days after axotomy. Another example one of the
few remaining nerve terminals is shown. Degenerative characteristics are present in the
mitochondria and the bouton is severely depleted of synaptic vesicles. Scale bar = Ifim,
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Fig. 4.13 Qualitative Analysis of the Effect of Increasing Age on the
Ultrastructure of NMJs Following Axotomy in Wlds Mice (5)
(A) Electron micrograph of a nerve terminal bouton from a fully occupied NMJ in 7
month old Wlds mouse FDB muscle 2 days after axotomy. In this example, the
fragmented remnants of a nerve terminal (red star) are being phagocytosed by a terminal
Schwann cell (green star). Scale bar = ljum.
(B) Electron micrograph of a vacant endplate from a fully occupied NMJ in 7 month
old Wlds mouse FDB muscle 2 days after axotomy. A terminal Schwann cell can be
seen on top of the vacated postsynaptic folds. Scale bar = ljum.
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Fig. 4.14 Ultrastructural Quantification of the Effect of Increasing Age on the
Incidence of Degenerative Markers at Axotomised NMJs in Wlds
Mice
(A) Graph of the percentage of total occupied endplates which contained degenerative
markers, at all time points (3, 4, 5 and 7 days) following axotomy against the age of the
animal, in Wlds mice FDB muscle preparations.
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Fig. 4.15 Ultrastructural Evidence for Neurofilament Accumulation at
Axotomised NMJs in 4 and 7 Month Old Wlds Mice
(A) Electron micrograph of two nerve terminal boutons from a 4 month Wlds FDB
muscle, 3 days following axotomy. Both boutons have significant accumulations of
NF. Scale bar = 1/tm.
(B) Electron micrograph of a nerve terminal bouton from a 7 month Wlds FDB muscle,
2 days following axotomy. The bouton pictured contains a very large accumulation of
NF . Scale bar = l[xm.
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Fig. 4.16 Ultrastructural Quantification of Neurofilament Accumulation at
Axotomised NMJs in 4 and 7 Month Old Wlds Mice
(A) Box chart showing the percentage of nerve terminal occupied by neurofilaments in
Wlds mice FDB muscle preparations of different ages, 3 days post axotomy. 4 month
Wlds nerve terminals have significantly increased levels of intra-terminal NF
(P=<0.001), whilst 7 month Wlds nerve terminals have higher, but not quite reaching
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Fig. 4.17 Qualitative Analysis of Synaptic Vesicle Density and Localisation at
Axotomised NMJs in 4 and 7 Month Old Wlds Mice
(A) Electron micrograph of a nerve terminal bouton, 3 days post axotomy, in a 4 month
old Wlds mouse FDB preparation. Note the large numbers of synaptic vesicles
distributed evenly within the terminal and close to active zones on the presynaptic
membrane. Scale bar = O.Sjum.
(A) Electron micrograph of a nerve terminal bouton, 2 days post axotomy, in a 7 month
old Wlds mouse FDB preparation. Note the scarcity of synaptic vesicles both within the
terminal and at active zones. Scale bar = 0.5nm.
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Fig. 4.18 Ultrastructural Quantification and Comparison of Synaptic Vesicle
Densities and Packing Densities at Axotomised NMJs in Control, 2,4
and 7 Month Old Wlds Preparations
(A) Box chart showing the density of synaptic vesicles within nerve terminals in
control and 3 day axotomised FDB muscle preparations from 2, 4 and 7 month old Wlds
mice. There was no significant difference between control, 2 month and 4 month
preparations, whereas 7 month nerve terminals had significantly fewer SVs than the rest
(P=<0.0001 for all, Mann Whitney test). Error bars = SEM.
(B) Box chart showing the packing density of synaptic vesicles within nerve terminals
in control and 3 day axotomised FDB muscle preparations from 2, 4 and 7 month old
Wlds mice. 4 month Wlds nerve terminals had a significantly higher packing density
than both control and 2 month Wlds terminals (P=<0.0001 and P=0.0123 respectively;
Mann Whitney test). 7 month Wlds nerve terminals had significantly reduced packing
densities compared to all other experimental groups (P=<0.0001 for all; Mann Whitney
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Fig. 4.19 Ultrastructural Quantification and Comparison of Synaptic Vesicle
Localisation at Active Zones in Axotomised NMJs from Control, 2, 4
and 7 Month Old Wlds Preparations
(A) Bar chart representing the number of synaptic vesicles within a 125nm radius of an
active zone ('docked' vesicles) in nerve terminals from control and 3 day axotomised
FDB muscle preparations from 2, 4 and 7 month old Wlds mice. There was no
significant difference between control, 2 month and 4 month Wlds preparations
(P=>0.253; unpaired t test), but intact nerve terminals in 7 month Wlds muscles had
significantly fewer docked vesicles than in 2 and 4 month Wlds and control mice
(P=<0.0001 for all; unpaired t test). Error bars = SEM.
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4.4 Discussion
Whilst the morphological techniques I used tentatively suggested that the level of
preservation of axons does not decline excessively with age in Wlds mice, as has
previously been reported (Perry et al., 1992), I have shown, using morphological and
ultrastructural analysis, that the preservation of motor nerve terminals in Wlds mice
following axotomy is unequivocally reduced with age. Furthermore, the current data
demonstrates that the nature of nerve terminal loss is also fundamentally altered with
age. The interpretations of my observations alongside potential sources of error are
considered in this discussion, and the hypothesis proposed in chapter 3, that presynaptic
nerve terminal degeneration is distinct from axon degeneration, is advanced.
4.4.1 The Retention of Distal Axons Following Axotomy in
Wlds Mouse Tibial Nerve Declines With Age
Changes in the rate of axonal Wallerian degeneration occurring as a result of age have
been demonstrated in wild-type preparations. For example, Cook et al. (1974) showed
that the rate of optic nerve degeneration was considerably slower in adult cats than in
kittens. Similarly, Perry et al. (1992) showed that the rate of Wallerian degeneration in
sciatic nerves from C57B1/6J mice was significantly slower in 8 month old mice than in
1 month old mice. Previous studies (with the exception of Crawford et al., 1995) have
suggested that the age related decline in the rate of axonal and nerve terminal
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degeneration is reversed in Wlds mice, whereby degeneration occurs faster in older
animals (Perry et al., 1992; Tsao et al., 1994; Ribchester et al.,1995). However, the
morphological assessment of distal axon preservation in 2 and 7 month old axotomised
Wlds tibial nerve included in the present study (Figures 4.2 and 4.3) does not support
these previous findings. Whilst there was no axonal loss in 2 month preparations
compared to a statistically significant axonal loss in 7 month preparations, the levels of
axonal loss in the latter were small (7% at 4 days) compared to the findings of, for
example, Perry et al. (100% loss at 5 days in 1 year old Wlds mice, a rate approaching
that seen in wild-type preparations; Figure 4.3c). Moreover, the use of morphological
methods in the current study appears to correlate more closely with the results from the
study by Crawford et al. (1995), who showed that there was no age-related effect in
their Wlds colony. My findings were not conclusive however, and further experiments
would be required to accurately readdress the issue of the effect of age on axon
preservation in Wlds mice. This was considered outside the scope of the present study,
however. Thus, the reason for undertaking an assessment of the level of axonal loss in
Wlds mice of different ages after axotomy was so that this data could be compared to
the level of motor nerve terminal loss in Wlds mice of similar ages following axotomy
(see below). However, now that the molecular genetics underlying the Wlds mutation
have been discovered (Conforti et al., 2000; Mack et al., 2001; see Chapter 5), it
should become possible to assess how differences in age-related phenotype of lesioned
axons may be explained by alterations in the genotype.
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4.4.2 The Rate of Motor Nerve Terminal Loss Following
Axotomy in Wlds Mice Increases With Age
Whilst my studies of distal axon preservation following axotomy have added little
weight to the argument that age reduces the phenotypic expression of the Wlds
mutation, the findings from the study of the fate of motor nerve terminals in axotomised
young and old Wlds FDB muscles have proved to be much more noteworthy.
My experiments show that the level of nerve terminal preservation following axotomy
declines with age in Wlds mice (Figures 4.4 and 4.5). Whilst these results concur with
previous findings from Ribchester et al. (1995), they are in disagreement with the
findings of Crawford et al. (1995), who showed that there was no decline in the level of
nerve terminal retention with age (Figure 4.1). This discrepancy may be due to
differences in the techniques used by the two studies however; the current experiments
were undertaken using immunocytochemical methods to label NF and SVs, whereas
Crawford and colleagues employed a modified silver/cholinesterase method. The
current study also suggests that loss of the Wlds phenotype occurs gradually; nerve
terminals are lost more rapidly in 4 month old Wlds preparations compared to 2 month
old Wlds preparations, but not as fast as nerve terminals in 7 and 12 month old Wlds
mice. The lack of difference between the 7 and 12 month old Wlds data (Figure 4.5)
suggests that the maximal rate of nerve terminal loss may be reached by 7 months of
age.
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As in the study of nerve terminal preservation in 2 month old Wlds mice described in
Chapter 3, the immunocytochemical assessment of nerve terminal loss in Wlds mice of
different ages was carried out in conjunction with electrophysiological experiments
undertaken by Mr D Thomson. Once again, levels of nerve terminal retention were
recorded in mice of 2, 4, 7 and 12 months using both methods (Figures 4.20 and 4.21)
and, as in the previous comparison, electrophysiological recordings consistently gave a
lower estimate of the levels of occupancy than morphological analysis (see Chapter 3
discussion for possible reasons underlying this difference). However, both
methodologies revealed that the time-course of nerve terminal degeneration in 7 month
and older Wlds mice approached that observed in wild-type preparations (cf. Figure
3.8).
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Fig. 4.20 Comparison of Morphological and Electrophysiological Analyses of
Nerve Terminal Loss at Axotomised Wlds FDB Muscle Preparations
in 2 and 4 Month old Mice.
(A & B) Graphs of the number of occupied endplates against days post axotomy in 2
month old Wlds mouse FDB muscle preparations analysed using immunocytochemical
techniques (A; NF, SV2 and a-BTX) and electrophysiological techniques (B). Black
triangles represent data from individual muscles and red triangles represent the mean
value (A is reproduced from Figure 3.10). Unpublished electrophysiological data
courtesy of Mr D. Thomson and Dr R. Ribchester.
(C & D) Graphs of the number of occupied endplates against days post axotomy in 4
month old Wlds mouse FDB muscle preparations analysed using immunocytochemical
techniques (C; NF, SV2 and a-BTX) and electrophysiological techniques (D). Black
triangles represent data from individual muscles and red triangles represent the mean
value (C is reproduced from Figure 4.3). Unpublished electrophysiological data
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Fig. 4.21 Comparison of Morphological and Electrophysiological Analyses of
Nerve Terminal Loss at Axotomised Wlds FDB Muscle Preparations
in 7 and 12 Month old Mice.
(A & B) Graphs of the number of occupied endplates against days post axotomy in 7
month old Wlds mouse FDB muscle preparations analysed using immunocytochemical
techniques (A; NF, SV2 and a-BTX) and electrophysiological techniques (B). Black
triangles represent data from individual muscles and red triangles represent the mean
value (A is reproduced from Figure 4.4). Unpublished electrophysiological data
courtesy of Mr D. Thomson and Dr R. Ribchester.
(C & D) Graphs of the number of occupied endplates against days post axotomy in 12
month old Wlds mouse FDB muscle preparations analysed using immunocytochemical
techniques (C; NF, SV2 and a-BTX) and electrophysiological techniques (D). Black
triangles represent data from individual muscles and red triangles represent the mean
value (C is reproduced from Figure 4.4). Unpublished electrophysiological data
courtesy of Mr D. Thomson and Dr R. Ribchester.
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Interestingly, even though the vast majority of nerve terminals assessed at endplates in 7
and 12 month old Wlds mice were lost within 3 days of axotomy (the same as in wild-
type preparations), a few NMJs had nerve terminals which persisted for up to 5 days
post axotomy (Figure 4.5). One possible explanation for the preservation of a minority
of nerve terminals is that they somehow retain the protection of the Wlds phenotype.
This hypothesis becomes more plausible when it is noted that some of these persistent
terminals showed signs of partial occupancy, associated with axotomised young Wlds
nerve terminals (see below). It would therefore be of interest to ascertain whether or
not all of the persistent terminals belonged to the same motor unit. If it does turn out
that certain motor units are protected whilst others lose the Wlds phenotype, elucidation
of any differences in the molecular characteristics of the two sub-types could provide
the key to understanding what is controlling the expression of the Wlds phenotype.
When the rate of distal axonal loss was compared to the rate of nerve terminal loss in 7
month old Wlds mice following axotomy, it became apparent that motor nerve terminals
are lost prior to their axons. Thus, at 4 days post axotomy, when -98% of motor nerve
terminals had been lost (Figure 4.5), -93% of axon profile levels detected in the
proximal nerve stump remained in the distal nerve stump. Even if the reduction in axon
profiles was occurring as a result of selective motor neurone loss (motor neurones
comprise 40-60% of a muscle nerve such as those supplying soleus and FDB; Boyd and
Davey, 1968), this would still only equate to a 17.5-11.7% loss of axons. The notion
that motor nerve terminals are lost before axons is not new however (Birks, Katz and
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Miledi, 1960; Miledi and Slater, 1970). One possible explanation for the differences in
the rate of loss between axons and nerve terminals is that the process of degeneration
operates in a distal-proximal manner. This assumes that the process of nerve terminal
degeneration is inextricably linked to the process of axonal degeneration. Hence, it
would be interesting to establish whether or not the axons in these mice are
degenerating in a distal-proximal manner. A second, more plausible explanation
however, is that nerve terminals are being lost by a mechanism separate and distinct
from that which underlies axonal degeneration, as well as the withdrawal of nerve
terminals in young Wlds mice following axotomy. Moreover, these findings provide
further evidence to support the hypothesis that synaptic compartments contain their own
mechanisms of degeneration, separate from those present in axons and cell bodies.
4.4.3 Variation in the Morphological Characteristics of
Motor Nerve Terminal Loss Following Axotomy in
Wlds Mice of Different Ages
Morphological analysis of NMJs from Wlds mice of different ages suggested that not
only was the time course of nerve terminal loss altered in older animals, but also the
nature of nerve terminal loss was transformed. The initial evidence for this suggestion
came from immunocytochemical analyses of the incidence of partial occupancy in Wlds
mice of different ages (Figure 4.8). These data showed a progressive decrease in the
incidence of partial occupancy with increasing age in Wlds mice. This suggests that
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nerve terminals in older Wlds mice are reverting to an in situ process of degeneration,
more reminiscent of classical Wallerian degeneration than the apparent withdrawal from
the endplate of nerve terminals associated with young Wlds mice after axotomy.
Interestingly, of the few remaining nerve terminals in both 7 and 12 month old Wlds
preparations after nerve lesion -15-30% still showed signs of partial occupancy. These
findings support the hypothesis that some of the 'persistent' nerve terminals in older
Wlds preparations are retained due to a continued local action of the Wlds phenotype.
One other possible explanation for these findings however, is that the evidence of
partial occupancy indicates that these nerve terminals are undergoing remodelling, or
were undergoing remodelling when the nerve lesion occurred. This may suggest that
nerve terminals which are undergoing remodelling could also gain some sort of
protection against rapid degeneration.
Electron microscopic investigation of nerve terminal profiles in Wlds mice of different
ages added significant weight to the hypothesis that nerve terminals are lost by a
different mechanism in old (7 months plus) Wlds mice compared to young (2 month and
under) Wlds mice. These experiments have unequivocally demonstrated that the nature
of nerve terminal loss reverts from a piecemeal withdrawal of terminal boutons, with a
retention of subcellular organelles and terminal architecture, to a classical in situ
degenerative process involving a gross destruction of nerve terminal architecture and
organelles (Figure 4.9a and Figure 4.12). The 8.7% of terminals which persisted in 7
month Wlds preparations, without any signs of degeneration, provide further evidence
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that some nerve terminals, or motor units, retain the protection of the Wlds phenotype,
even when the majority of others show no signs of resistance to degeneration.
Quantification of qualitative degenerative markers in Wlds mice revealed a progressive
increase in their incidence with increasing age (Figure 4.14). When the graph in Figure
4.14 is compared with the partial occupancy graph in Figure 4.8, it is clear that as the
incidence of partial occupancy falls, the incidence of degeneration increases.
Interestingly, both graphs show that the loss/gain of each process is progressive,
whereby animals of 4 months of age appear to be in a transitional period, with reduced
levels of partial occupancy occurring alongside increased levels of degenerative
markers. Specific ultrastructural analysis of NMJs from 4 month old Wlds preparations
confirmed that markers of both piecemeal withdrawal (partial occupancy with retained
membranes and organelles) and classical degeneration (swollen and disrupted
mitochondria) could be detected, sometimes at the same NMJ (Figure 4.9b, 4.10 and
4.1 la). Occasionally, a nerve terminal bouton with retained ultrastructure was observed
only a couple of micrometres away from a bouton with degenerative characteristics
(Figure 4.1 lb). This situation could arise for a number of reasons. It is possible that the
degenerating mitochondrial profiles simply represent normal levels of mitochondrial
turnover (-20% in control preparations; Winlow and Usherwood, 1975). This
explanation would be acceptable in boutons containing low numbers of mitochondria
(such as in Figure 4.1 lb), where out of one or two mitochondria profiles either, or both,
were degenerating (thereby giving a value of 50-100% of degenerating mitochondria,
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classifying the bouton as 'degenerating'). The large numbers of degenerating
mitochondria in most terminals however (such as in Figures 4.10 and 4.11a), suggests
that this explanation could not apply to the majority of NMJs examined. A more
feasible explanation for differing levels of mitochondrial degeneration at the same NMJ
could be that the regulation of degenerative mechanisms is controlled on a local (i.e.
/mis) level. This could be conceivably be achieved by a selective trafficking of
'synaptic maintenance' factor(s) into nerve terminal boutons (see below). Furthermore,
the findings that mitochondria appear to be the only degenerative marker occurring in
axotomised 4 month old Wlds nerve terminals may suggest that mitochondria are the
most susceptible of terminal organelles to degeneration, supported by findings in
previous studies that mitochondrial swelling and lysis is one of the earliest signs of
wild-type terminal degeneration (Manolov, 1974; Winlow and Usherwood, 1975).
Moreover, it seems apparent that the progression of wild-type degeneration at nerve
terminals occurs independently of mitochondrial damage; nerve terminals with
degenerating mitochondrial profiles (i.e. 4 month Wlds axotomised preparations) do not
inevitably proceed to a complete degenerative processes, indicated by the lack of any of
the other classical markers of Wallerian degeneration (reduced synaptic vesicle
densities, terminal membrane fragmentation and phagocytosis by the terminal Schwann
cell).
Ultrastructural quantification of NMJs in Wlds mice revealed further significant
differences in the degenerative processes occurring at different ages. There was a clear
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accumulation of neurofilament in nerve terminal boutons from 4 and 7 month old Wlds
mice, 3 days after axotomy, compared to controls (Figure 4.15 and 4.16). This
distinctive accumulation in 4 and 7 month Wlds nerve terminals was very similar in
distribution to that seen in 2 month old Wlds mice at 3 days post axotomy (cf. Figure
3.20), and the levels of NF were not significantly higher (P=0.0619 and P=0.6287
respectively; Mann Whitney test). These findings suggest that NF accumulation is not a
characteristic specific to withdrawing nerve terminals. Indeed, it is to be expected that
nerve terminals that have persisted for a couple of days following axotomy should
contain NF accumulation, as slow axonal transport has been shown to persist in severed
distal nerve stumps, leading to an accumulation of NF at the proximal and distal
extremities (see Chapter 3 discussion; Watson et al., 1993). Furthermore, intra-terminal
NF accumulations have been previously described by Manolov (1974) in the few nerve
terminals remaining at twenty hours or more following axotomy in wild-type rats.
Whilst NF accumulation has been shown to occur in Wlds mice of all ages following
axotomy, variations in synaptic vesicle populations, packing densities and localisation
were detected in mice of different ages. For example, synaptic vesicle levels observed
in 2 and 4 month Wlds nerve terminals, at 3 days post axotomy, show no reduction
compared to control levels (Figure 4.17a and 4.18a). Indeed, the packing density of
SVs was significantly higher in both 2 and 4 month preparations than in controls. The
most likely cause for this increase in packing densities is the invasion of neurofilament.
Because NF accumulation reduces the area available for SVs within a nerve terminal,
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added to the fact that there is no reduction in the overall density of SVs, this results in a
compression of the vesicles into a smaller area. Subsequent analysis of the number of
'docked' synaptic vesicles (Figure 4.19) in 2 and 4 month old Wlds FDB muscle
preparations showed that there was no increase in these levels. This supports the
hypothesis, raised in Chapter 3, that the maximal level of vesicle docking is achieved in
control preparations. These results are dissimilar to those gained from 7 month Wlds
preparations at 3 days after axotomy. Synaptic vesicles were scarce in these
preparations (Figure 4.17 and 4.18a). This data closely resembles the findings of
Manolov (1974) and Winlow and Usherwood (1975), who showed a similar reduction
of SVs in wild-type preparations within 3-24 hours of axotomy, providing further
evidence that the loss of nerve terminals in 7 month Wlds mice occurs by a process
more akin to classical 'Wallerian-like' degeneration than piecemeal withdrawal.
Furthermore, significant reductions in the packing density and number of 'docked'
vesicles were detected in 3 day axotomised 7 month Wlds preparations compared to
controls (Figure 4.8b and 4.9). Interestingly, the mean levels of synaptic vesicles at 3
days post axotomy were still almost half of that seen in controls, whereas Manolov
(1974) and Winlow and Usherwood (1975) describe an almost total loss of SVs in wild-
type terminals within a couple of days of axotomy. It is possible that the majority of
nerve terminals in 7 month Wlds axotomised NMJ preparations do undergo a similar
level of synaptic vesicle loss as observed in wild-type preparations, but that this is
masked to a certain extent by the way that the current data was collected. This can be
explained by the presence of a few persistent nerve terminals, which have retained
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ultrastructure and organelles in 7 month Wlds preparations at 3 days after axotomy,
possibly protected by a retention of the Wlds phenotype (see above). That these
terminals remain, and their retained synaptic vesicles are included in the analysis,
somewhat biases the data. Alternatively, it is possible that the degenerative process
observed at axotomised NMJs from 7 month old Wlds mice occurs by a less severe
process as than that of Wallerian degeneration in wild-type preparations, and as a result,
the effect on the synaptic vesicle population is not so striking.
Finally, evidence for a transition in the nature of terminal loss is provided by analysing
vacant endplates with no overlying nerve terminal. At the majority of vacant endplates
observed in 7 month Wlds preparations (96.30%), cellular profiles, presumably of
terminal Schwann cells (cf. Miledi and Slater, 1968), were in close contact with the
postsynaptic folds (Figure 4.13b). This is in contrast to 2 month Wlds preparations
where only 30.04% of vacant endplates were contacted by a cellular profile. Retention
of terminal Schwann cell processes at vacant NMJs has been shown to occur following
wild-type nerve terminal degeneration in frog and rat muscle (Birks, Katz and Miledi,
1959; Birks, Katz and Miledi, 1960; Miledi and Slater, 1968; Miledi and Slater, 1970).
By contrast, studies of processes which involve withdrawal of nerve terminals, such as
synapse elimination in reinnervated sternomastoid muscle, suggest that Schwann cells
are removed from the endplate alongside motor nerve terminals (Culican et ah, 1998).
This provides further evidence to support the hypothesis that 7 month Wlds terminals
are lost by a 'Wallerian-type" process whereas 2 month Wlds terminals are lost by a
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separate and distinct withdrawal mechanism, thereby suggesting that synaptic
compartments contain more than one mechanism capable of producing synaptic
degeneration.
4.4.4 Possible Mechanisms Underlying an Age Related
Decline in the Wlds Phenotype
One of the most logical explanations for a reduction in the effectiveness of the Wlds
phenotype with age would be a concurrent reduction in the expression of the Wlds gene.
Molecular studies from the lab of Dr M.P. Coleman in Cologne have demonstrated that
this is not the case however. A western blot showing the continued expression of the
Wld protein as well as the Ube4b protein in Wlds mice of up to a year old is shown in
Figure 4.22. This suggests that the increased rate of loss of motor nerve terminals in
older Wlds mice may be controlled by other mechanisms. More specifically, it may be
due to the action of a 'synaptic maintenance factor', the levels of which decline with
age. It is possible that such a factor may be responsible for initiating the withdrawal,
rather than degeneration, of nerve terminals under conditions such as disuse or
axotomy. Furthermore, it could be envisaged that a 'synaptic maintenance factor' may
be responsible for initiating many of the withdrawal processes which occur in vivo,
such as synapse elimination. Synapse elimination occurs normally in Wlds mice
(Parson et al., 1997), thus I am not suggesting that the mechanisms of synapse
withdrawal are in any way abnormal in these mice. In this model, selective trafficking
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Fig. 4.22 Wlds Protein Expression in Brain.
(A) Western blot showing the continued expression of the Wld protein and Ube4b
protein in brains of Wlds mice of 3 months and 1 year of age. Unpublished data






of such a factor into 'winning' nerve terminals at competing polyinnervated endplates
would lead to a subsequent loss of the 'maintenance' factor in 'losing' terminals,
leading to their elimination via a process of withdrawal. Similarly, in my young Wlds
preparations, it is possible that, in the absence of Wallerian degeneration (which
normally masks synapse specific events), axotomy leads to a reduction in the production
of, and places a physical barrier to stop the trafficking of, such a factor from the cell
body. Thus, when the residual amount of factor left in the distal stump is consumed,
terminals withdraw from the endplate. If the levels of expression of such a 'synaptic
maintenance' factor decline with age then it is possible that in older Wlds mice,
insufficient levels are present to neither retain synaptic terminals nor cause their
withdrawal from the endplate following axotomy, therefore allowing separate,
Wallerian-like degenerative mechanisms to remove nerve terminals. This hypothesis
seems plausible when the fact that age has significant effects on both the physical and
functional properties of neurones is considered, whereby in older animals both
myelinated and unmyelinated nerve fibres are lost, many remaining fibres have
deteriorating myelin sheaths and axons often appear atrophied (for review see Verdu et
al., 2000).
This 'synaptic maintenance' factor hypothesis also provides a possible explanation for
the preservation of a small sub-set of motor nerve terminals following axotomy in 7
month old Wlds preparations as well as the appearance of intermediate characteristics of
withdrawal and degeneration in 4 month old Wlds preparations. If the switching off of
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such a factor occurs asynchronously in different motor neurones, then it is possible that
some will still retain the Wlds phenotype, even at 7 months of age. However, there is
one other possible explanation for the retention of some nerve terminals in older mice in
light of the 'synaptic maintenance' factor hypothesis. It is possible that a few motor
axons have been subjected to some form of injury whilst in vivo. It has been shown that
piecemeal nerve terminal withdrawal occurs from polyinnervated endplates established
as a result of nerve injury in adult mice (Taxt, 1983; Rich and Lichtman, 1989a; Barry
and Ribchester, 1995; Culican et al., 1998), which may suggest that the 'withdrawal'
phenotype, controlled by such a factor, may be upregulated in neurones following
injury.
The existence of both withdrawal and degeneration characteristics at the same NMJs in
4 month old Wlds mice (partial occupancy and terminal retention alongside
mitochondrial degeneration; Figure 4.9, 4.10 and 4.11) can also be explained by the
presence of a 'synaptic maintenance' factor. If the levels of such a factor are only just
enough to produce the retention and withdrawal of nerve terminals, it remains possible
that individual boutons which are not getting quite enough of the factor start to show
signs of classical degeneration (mitochondrial swelling and lysis). These could happily
coexist with other boutons of the same nerve terminal which, either due to slightly
better trafficking or retention, show no signs of degeneration. Therefore, the sudden
increase in Wallerian-like characteristics between 4 and 7 months of age may represent
a critical point in the life of a neurone, when the levels of such a factor are no longer
188
high enough to have a protective effect, and as a result, Wallerian-type characteristics
prevail at axotomised motor nerve terminals. It would be very interesting to study
differences in the molecular characteristics of individual boutons at a nerve terminal, to
examine their dependence or independence on other boutons under normal and
destabilising conditions such as axotomy or synapse elimination.
The findings of an age related phenotypic expression in the Wlds mouse suggest that
one way to identify a molecule which could be responsible for maintaining synapses
could be to search for neuronal proteins whose expression declines with age. For
example, by using a combination of micro-array (gene chip) and 2D gel electrophoresis
techniques on neuronal tissue, it would be possible to search through thousands of
candidate mRNA or protein molecules. This could be undertaken in a way in which
those molecules which are expressed in an age-dependent manner, or even have
undergone age-related post-translational modifications, could be detected. Furthermore,
an expansion of this 'synaptic maintenance factor' hypothesis could be attained by
introducing computational modelling of the mechanisms of action of such a factor, in a
similar fashion to that which has been previously undertaken with regard to the
competition for neurotrophic factor in the development of nerve connections (van
Ooyen and Willshaw, 1999).
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4.4.5 Summary
The data presented in this chapter unequivocally demonstrate that, at least in the stock
supplied by Harlan-olac and maintained or bred in Edinburgh, both the rate and nature
of nerve terminal loss following axotomy in Wlds mice changes with age. The decline
in the phenotypic expression of the Wlds mutation results in a transition from piecemeal
withdrawal of nerve terminals following axotomy in young (2 month old) Wlds mice, to
classical 'Wallerian-like' degeneration of terminals in animals of 7 months and older,
with characteristics of both present in 4 month old Wlds NMJs. The probable difference
in the effect of age on axons and motor nerve terminals provides further evidence to
support the hypothesis that nerve terminals are lost by mechanisms distinct from that of
axons and soma. Moreover, my data suggest that even in old Wlds mice, the mechanism
of nerve terminal degeneration, whilst not being the same responsible for nerve terminal
loss in young Wlds mice, is still separate and independent of axon degeneration.
Furthermore, the current data provides evidence indicating the existence of a 'synaptic
maintenance factor', responsible for initiating the withdrawal of nerve terminals under
conditions such as axotomy or disuse, the levels of which decline with age. It still
remains unclear however, as to what molecular component in the Wlds genotype is





5. Responses of Ube4b/Nmnat (Wlds) Transgenic Mice
Motor Nerve Terminals to Axotomy
5.1 Background
The molecular genetics underlying the Wlds mutation remained a mystery until fairly
recently. Initial studies showed that the Wlds mutation is controlled by a single
autosomal dominant gene, which maps on to the distal end of mouse chromosome 4, the
region homologous with human chromosomal region Ip34-lp36 (Perry et al., 1990b;
Lyon et al., 1993). Subsequent analysis showed that the Wlds locus consists of an 85-kb
tandem triplication within the candidate region (Coleman et al., 1998), containing the
exons of three genes within the repeat sequence (Conforti et al., 2000). Two of these
genes, Ube4b, a ubiquitination factor, and Nmnat, a key enzyme in the synthetic
pathway of NAD+ (Magni et al., 1999), have been shown to span the proximal and
distal boundaries of the repeat unit, forming a chimeric Ube4b/Nmnat gene which
expresses a 43kDa fusion protein (see Figure 1.3; Conforti et al., 2000). The third gene,
a retinol binding protein, Rbp7, is not expressed in the nervous system and is now
considered not to exert any influence on the Wlds phenotype (Conforti et al., 2000).
Whilst the Ube4b/Nmnat chimeric gene (hereafter referred to, tentatively as 'wallerin')
is a strong candidate for producing the Wlds phenotype, in order to test the hypothesis
that the chimeric gene is both necessary and sufficient to explain the Wlds phenotype,
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transgenic mice expressing the chimeric gene have been generated and the effect of
axotomy on motor nerve terminals has been assessed. The characterisation of the
wallerin gene is part of an ongoing team effort, and the results in this chapter represent
my contribution to this enterprise. Evidence is presented that expression of the wallerin
gene, under the action of the (3-actin promoter, results in a manifestation of the Wlds
phenotype, thereby preserving disconnected axons and motor nerve terminals following
axotomy. Furthermore, the data show that a similar kind of axotomy-induced piecemeal
retraction of motor nerve terminals seems to occur following axotomy, appearing much
the same as described previously at young Wlds mutant mice NMJs (Chapter 3;
Mattison et ah, 1996; Ribchester et ah, 1999). This provides strong evidence to suggest
that slow synapse withdrawal is not unique to the Wlds mouse, but rather that it reflects
a secondary degeneration process inherent in the synaptic compartment that is revealed
only when Wallerian degeneration of axons is blocked.
Immunocytochemical and electron microscopic data are presented regarding the
morphological and ultrastructural characteristics of NMJs in 1 month old transgenic
mice at 2, 3 and 5 days post axotomy. Qualitative and quantitative examination of such
preparations provided an overview of the temporal and morphological aspects of motor
nerve terminal loss in these mice. Comparison with data from control and 2 month
Wlds preparations, generated in previous chapters, allowed for an accurate assessment
of the level of expression of the Wlds phenotype in Ube4b/Nmnat transgenic mice.
Parallel biochemical studies (T. Mack and M.P. Coleman) and electrophysiological
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The majority of experiments contained within the current chapter were undertaken using
methods previously described in Chapter 2. The following section contains details of
methods which are specific to this chapter.
5.2.1 Generation of Ube4b/Nmnat Transgenic Mice
The production of Ube4b/Nmnat transgenic mice was undertaken by Dr M.P.
Coleman's laboratory in Cologne (Figure 5.1). Appendix 1 contains the description of
how these mice were generated by Dr Coleman and colleagues.
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Fig. 5.1 Transgene Construct for Ube4b/Nmnat Transgenic Mice
(A) The transgene construct. The chimeric cDNA was expressed with non-coding exon
1 of P-actin under the control of a human (3-actin promoter and terminated with the
SV40 polyadenylation signal.
(B) Southern blot showing the incorporation of the Ube4b/Nmnat transgene in the
4839, 4830 and 4836 lines of transgenic mice and a non-transgenic control mouse. The
4836 line shows the strongest incorporation of the transgene and is the line used for all
experiments in the current study.

















5.2.2 Processing of Ube4b/Nmnat Transgenic Mouse
Tissue for Immunocytochemistry and Electron
Microscopy
All experiments utilising Ufd2/Nmnat transgenic mice were carried out on isolated FDB
or 4th deep lumbrical muscle preparations obtained from young (2 months or under)
mice from the breeding colony maintained in Dr M.P.Coleman's lab in Cologne.
Muscle preparations were dissected in Cologne, and fixed immediately for either
immunocytochemistry (4% paraformaldehyde) or electron microscopy (4%
paraformaldehyde/2.5% glutaraldehyde). Tissue for immunocytochemical analysis was
taken by courier to Edinburgh (along with living preparations for physiological
experiments) in phosphate buffer or HEPES buffered physiological saline. I carried out
the remainder of the immunocytochemical protocol and fluorescence/confocal
microscopic analysis in Edinburgh (see Chapter 2). Tissue for electron microscopic
analysis was washed in 0.1M phosphate buffer and post-fixed in 1% osmium in
Cologne before being mailed to Edinburgh, where I carried out standard EM processing,
observation and analysis (see Chapter 2).
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5.3 Results
5.3.1 Morphological Preservation and Partial Occupancy
at NMJs in Ube4b/Nmnat Transgenic Mice following
Axotomy
Immunocytochemically labelled NMJs (NF, SV2 and a-BTX) from 2 day (n=86, N=l),
3 day (n=81, N=l) and 5 day (n=318, N=2) axotomised 1 month old wallerin transgenic
mice 4th deep lumbrical muscles were individually assessed as to their level of
occupancy. All of the nerve terminals observed at all time points post axotomy showed
retained pre- and postsynaptic architecture (Figure 5.2). At 2 days post axotomy, in
remarkable contrast to wild-types (see Chapter 3), all Wallerin transgenic endplates
were still occupied. This prevalence decreased to 97.53% at 3 days and 90.03% ±2.83
SEM at 5 days after axotomy (Figure 5.3). These muscles reportedly twitched in
response to cutting the nerve when they were dissected, and synaptic potentials were
recorded from the impaled FDB muscle fibres (D. Thomson and R.R. Ribchester,
personal communication).
Evidence for partial occupancy of endplates following axotomy was found in all
wallerin transgenic preparations, ranging from only one or two terminal boutons
missing through to retraction bulb formation (Figure 5.4 and 5.5). Quantification of this
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phenomenon showed that the occurrence of partially occupied endplates did not
increase much above the level observed in controls (see Chapter 3) until 5 days post
axotomy, when 22.25% ±12.51SEM of endplates were partially occupied (Figure 5.6).
5.3.2 Ultrastructural Evidence for Preservation of NMJs in
Wallerin Transgenic Mice following Axotomy
Qualitative ultrastructural analysis of NMJ profiles from 5 day axotomised wallerin
transgenic FDB muscle preparations confirmed that nerve terminals were retained
without any degenerative changes (i.e. intact mitochondria, synaptic vesicles and
terminal membranes; Figure 5.7). Occasionally, examples of nerve terminals with
neurofilament invasion and/or a paucity of synaptic vesicles were observed (Figure 5.8).
Quantification of NF levels (Figure 5.9) revealed that there was a significant increase
(P=0.0015; Mann Whitney test) in 5 day axotomised wallerin transgenic mice nerve
terminals (6.32% +F68SEM; n=20, N=2) compared to controls (1.42% ±0.33; n=34,
N=4). However, the levels of NF accumulation were significantly less than those
observed in 2 month old Wlds mice preparations at 5 days post axotomy (17.32% ±2.63;
P=0.0047; n=26, N=4).
Qualitative analysis, suggesting that some terminals from 5 day axotomised wallerin
transgenic mice preparations had a paucity of synaptic vesicles, was supported by
quantitative analysis (Figure 5.10). Synaptic vesicle densities were significantly
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reduced in 1 month transgenic preparations at 5 days post axotomy (39.51 SV//rm2
±4.81SEM), by almost 50% compared to control (78.31 SV//xm2 ±6.04; P=<0.0001,
unpaired t test) and 2 month old, 5 day axotomised Wlds (78.75 SW/rm2 ±5.72;
P=<0.0001) preparations. Furthermore, even though many wallerin transgenic nerve
terminals contained accumulations of NF (see above), the packing density of synaptic
vesicles (21.21% ±3.35) were significantly reduced compared to both control (28.25%
±1.95; P=0.0168, Mann Whitney test) and 2 month, 5 day axotomised Wlds (41.40%
±2.18; P=<0.0001) preparations.
Qualitative analysis of electron micrographs of NMJs from 5 day axotomised wallerin
transgenic mice FDB muscles suggested that the subcellular localisation of synaptic
vesicles was altered (Figure 5.11a). Quantitative analysis of the numbers of 'docked'
vesicles (classified as vesicles within 125nm of an active zone; see Chapter 2 for
explanation) showed a significant reduction in wallerin transgenic mice FDB muscle
nerve terminals, with levels of 3.17 ±0.24SEM (n=48, N=2), compared to both control
(5.04 ±0.18; P=<0.0001, unpaired t test; n=75, N=4) and 2 month, 5 day axotomised
Wlds(5.25 ±0.17; P=<0.0001; n=55, N=4) muscles.
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Fig. 5.2 Morphology of Axotomised NMJs in Ube4b/Nmnat Transgenic
Mice.
(A) Stereo pair of confocal micrographs of five NMJs from a 1 month old
Ube4b/Nmnat homozygote transgenic mouse 4th deep lumbrical muscle (NF, SV2 and
a-BTX) 5 days post axotomy. All NMJs have intact axons and motor nerve terminals,
showing no signs of fragmentation. Scale bar = 20/xm.
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Fig. 5.3 Morphological Quantification of Motor Nerve Terminal
Preservation in Ube4b/Nmnat Transgenic Mice Following Axotomy.
(A) Graph of the percentage of occupied endplates (both fully and partially occupied)
against days post axotomy in Ube4b/Nmnat homozygote transgenic mice 4th deep






Fig. 5.4 Morphological Evidence for Partial Occupancy at Endplates of
Ube4b/Nmnat Transgenic Mice Following Axotomy (1).
(A) Confocal micrograph of four NMJs from a 1 month old wallerin homozygote
transgenic mouse 4th deep lumbrical muscle (NF, SV2 and oc-BTX) 5 days post
axotomy. Two endplates are partially occupied, with areas of endplate not contacted by
overlying nerve terminal boutons (arrows). Note the intensity of neurofilament staining
in the axon branches. Scale bar = 20jUm.
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Fig. 5.5 Morphological Evidence for Partial Occupancy at Endplates of
Ube4b/Nmnat Transgenic Mice Following Axotomy (2).
(A) 'Stereo pair' confocal image of four NMJs from a 1 month old Ube4b/Nmnat
homozygote transgenic mouse 4th deep lumbrical muscle (NF, SV2 and a-BTX) 5 days
post axotomy. The endplate second from the left is only contacted by a retraction bulb
(characterised by a thin axonal process terminating in a bulbous swelling). The other
three NMJs have intact axons and motor nerve terminals, showing no signs of
fragmentation or degeneration. Scale bar = 20/rm.
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Fig. 5.6 Morphological Quantification of Partial Occupancy at Endplates of
Ube4b/Nmnat Transgenic Mice Following Axotomy.
(A) Graph of the percentage of partially occupied endplates against days post axotomy
in Ube4b/Nmnat homozygote transgenic mice 4th deep lumbrical muscle preparations,




Fig. 5.7 Ultrastructural Preservation of Motor Nerve Terminals at
Axotomised NMJs in Ube4b/Nmnat Transgenic Mice.
(A) Electron micrograph of a NMJ from a 1 month old Ube4b/Nmnat homozygote
transgenic mouse FDB muscle 5 days post axotomy. The nerve terminal appears to
have normal levels and distribution of synaptic vesicles and mitochondria alongside
well preserved membranes. Scale bar = ljum.
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Fig. 5.8 Ultrastructural Alterations in Subcellular Organelles in
Ube4b/Nmnat Transgenic Mice Axotomised NMJs.
(A) Electron micrograph of a NMJ from a 1 month old Ube4b/Nmnat homozygote
transgenic mouse FDB muscle 5 days post axotomy. The nerve terminal appears to
have a small NF accumulation in the centre of the terminal and a paucity of synaptic
vesicles. Scale bar = l|U.m.
(B) Electron micrograph of a NMJ from a 1 month old Ube4b/Nmnat homozygote
transgenic mouse FDB muscle 5 days post axotomy. Whilst no mitochondria or
discernable NF are present, a paucity of synaptic vesicles is apparent. Scale bar = 1/rm.
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Fig. 5.9 Ultrastructural Quantification of Neurofilament Levels in
Axotomised Motor Nerve Terminals from Ube4b/Nmnat Transgenic
Mice.
(A) Bar chart showing the percentage of nerve terminal occupied by neurofilament in
control FDB muscle, 2 month Wlds FDB muscle 5 days post axotomy and
Ube4b/Nmnat homozygote transgenic FDB muscle 5 days post axotomy. Significant
accumulations of NF were detected in transgenic nerve terminals compared to control
preparations (P=0.0015; Mann Whitney test). The levels of NF were significantly less








Fig. 5.10 Ultrastructural Quantification of Synaptic Vesicle Densities and
Packing Densities in Axotomised Motor Nerve Terminals from
Ube4b/Nmnat Transgenic Mice.
(A) Bar chart showing the density of synaptic vesicles in nerve terminals from control
FDB muscle, 2 month Wlds FDB muscle 5 days post axotomy and Ube4b/Nmnat
homozygote transgenic FDB muscle 5 days post axotomy. Transgenic motor nerve
terminals contained significantly reduced SV densities compared to both control and 2
month Wlds preparations (P=<0.0001 for both; unpaired t test). Error bars = SEM.
(B) Bar chart showing the packing density of synaptic vesicles in nerve terminals (see
chapter 2 for explanation) from control FDB muscle, 2 month Wlds FDB muscle 5 days
post axotomy and Ube4b/Nmnat homozygote transgenic FDB muscle 5 days post
axotomy. Transgenic motor nerve terminals contained significantly reduced SV
packing densities compared to both control and 2 month Wlds preparations (P=0.0168
and P=<0.0001 respectively; Mann Whitney test). Error bars = SEM.
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Fig. 5.11 Qualitative and Quantitative Assessment of Synaptic Vesicle
Localisation in Axotomised Motor Nerve Terminals from
Ube4b/Nmnat Transgenic Mice.
(A) Electron micrograph of a NMJ from a Ube4b/Nmnat homozygote transgenic FDB
muscle 5 days post axotomy. Whilst the pre- and postsynaptic architecture appear
intact, the numbers of vesicles clustered around active zones are reduced. Scale bar =
0.5/im.
(B) Bar chart showing the number of synaptic vesicles within 125nm of active zones
('docked' vesicles) in nerve terminals from control FDB muscle, 2 month Wlds FDB
muscle 5 days post axotomy and Ube4b/Nmnat homozygote transgenic FDB muscle 5
days post axotomy. Transgenic motor nerve terminals contained significantly reduced
numbers of 'docked' synaptic vesicles compared to both control and 2 month Wlds










In this chapter, the role of the wallerin chimeric gene in producing the axotomy-induced
phenotype observed in Wlds mice was assessed. Both immunocytochemical and
electron microscopic studies on axotomised neuromuscular preparations from
transgenic mice expressing the wallerin gene demonstrate that this chimeric gene
confers a phenotype that strongly resembles the Wlds phenotype. Not only were motor
nerve terminals preserved in these mice after axotomy, but examples of partially
occupied endplates supplied by thin axon collaterals with occasional accumulations of
NF were identified, very similar in appearance to those observed in young Wlds mice
muscle preparations following axotomy. Furthermore, these findings strongly suggest
that the unmasking of synapse-specific events, such as axotomy-induced synapse
withdrawal, is not unique to the Wlds mouse. However, my EM data suggest that the
response of motor nerve terminals in Wlds and wallerin transgenic mice were not quite
the same. The possible reasons for the discrepancies are discussed, but they do not
detract from the conclusion that transgenic expression of the chimeric wallerin gene
profoundly inhibits both axonal and synaptic degeneration.
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5.4.1 Comparison of Synaptic Events Following Axotomy
at NMJs in Wallerin Transgenic and Wlds Mutant
Mice
The preservation of motor nerve terminals for up to 5 days post axotomy in wallerin
transgenic preparations showed that the axotomy-induced Wlds phenotype was present
in these mice (Figure 5.2 and 5.3). A comparison with the levels of nerve terminal
retention observed in young Wlds mice (Figure 3.10) at similar time points following
axotomy suggested that transgenic mice motor nerve terminals were more protected
against degeneration than Wlds nerve terminals (with levels of 97.53% occupancy
versus 90.03% at 3 days post axotomy and 95.31% versus 74.05% at 5 days post
axotomy). Whilst the numbers of transgenic preparations assessed (4 muscles in total)
were lower than those from 2 month old Wlds mice (19 muscles in total) due to a
limited availability of transgenic tissue, these findings suggested that the expression, or
effectiveness, of the Wlds phenotype may be enhanced in the former. To be certain of
such a conclusion however, it would be necessary to extend the current transgenic study
in the parameters of both the numbers of muscle preparations assessed and the number
of time points following axotomy (i.e. extend to 7 and 10 days post axotomy). These
experiments will hopefully become feasible when the transgenic breeding colony in
Cologne is more strongly established and/or a sub-colony is founded in Edinburgh.
Another possibility is that the differences between nerve terminal preservation in
wallerin transgenic mice and Wlds mutant mice following axotomy may occur as a
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result of the genetic background on which the transgenic was bred (the transgenics were
produced from a 75% C57B1/6J and 25% CBA line rather than a pure C57B1/6 line) to
the Wlds phenotype. Strain-specific differences have previously been shown to
contribute to alterations in the sensitivity of peripheral nerves to spontaneous age-
related changes (including degeneration; Tabata et al., 2000). Thus, axons and motor
nerve terminals from different mice strains might also differ in their sensitivity to
degenerative signals.
Whilst the morphological characteristics associated with partial occupancy (areas of
unoccupied postsynaptic receptors next to occupied regions with intact nerve terminal;
see Chapter 3) were present in both wallerin transgenic and Wlds mice following
axotomy, differences in the incidence of partial occupancy of endplates were observed
(compare Figures 5.4, 5.5 and 5.6 with Figures 3.12, 3.13 and 3.14). The lower
incidence of partial occupancy at 5 days post axotomy in transgenic mice compared to 2
month old Wlds mice (22.25% and 54.58% respectively) suggested that the onset of
nerve terminal withdrawal was delayed in transgenic mice. This conclusion was
supported by the findings that the overall preservation of nerve terminals was higher in
transgenic mice compared to Wlds mice at the same time point following axotomy (see
above). Additional evidence to support this hypothesis comes from the experimental
data which showed that the levels of partial occupancy at wallerin transgenic mice
endplates did not increase much above the basal levels, attributed to remodelling
processes (see Chapter 3), seen in non-axotomised preparations, until 5 days post
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axotomy. To test this hypothesis fully however, further experiments would need to be
undertaken, extending the time points in the wallerin transgenic mice study to 7 and 10
days post axotomy, in order to assess whether or not the time course of nerve terminal
loss progresses in a similar fashion to that observed in Wlds mice, albeit delayed in its
onset. Unfortunately, this will not be possible until the transgenic mice become more
readily available. Finally, my findings could also be explained by the 'synaptic
maintenance factor' hypothesis proposed in Chapter 4. It is possible that differences in
the expression or effectiveness of such a factor between various species of mice may
account for the increased retention and delayed withdrawal of nerve terminals observed
in the transgenic compared to Wlds mutant mice.
Taken together, the findings that nerve terminal preservation and partial occupancy of
endplates occur in wallerin transgenic mice after axotomy provides further evidence to
support the hypothesis that the withdrawal of motor nerve terminals occurs via a
synapse specific form of degeneration, independently of axonal degeneration. The data
also suggest that both nerve terminal retention and piecemeal withdrawal following
axotomy are not features unique to axotomy in the Wlds mouse, but implies that they
can be elicited in other strains of mouse when axonal degeneration is delayed. The
further implications of these findings are considered in the final discussion.
Ultrastructural analysis of NMJs in wallerin transgenic mice showed that nerve terminal
preservation following axotomy was conferred by the wallerin chimeric gene, thereby
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confirming its ability to regulate expression the Wlds phenotype. Nerve terminal
profiles from wallerin transgenic preparations, 5 days after axotomy (Figure 5.7 and
5.8), often appeared very similar to those from 2 month old Wlds preparation at the
same time following axotomy (Figure 3.11, 3.18, 3.20 and 3.22), showing no signs of
classical degeneration: with retention of terminal membranes, intact mitochondria and
no invasion of terminal Schwann cell processes into the synaptic cleft. Quantification
of NF levels showed a significant accumulation in wallerin transgenic mice nerve
terminals at 5 days post axotomy compared to control preparations (Figure 5.9).
Interestingly, the levels of NF accumulation were significantly less than observed in 2
month old Wlds nerve terminals at 5 days post axotomy. This could have occurred as a
result of a reduced rate of slow axoplasmic flow in the severed transgenic mice distal
nerve stumps. It would be interesting therefore, to measure the rate of transport of NFs
within severed axons from wallerin transgenic mice, as well as to compare the spatio-
temporal aspects of NF accumulation in the synaptic compartments of wallerin
transgenic and Wlds mutant mice.
Qualitative and quantitative differences in the numbers of synaptic vesicles were also
apparent between wallerin transgenic mice nerve terminal profiles, and similar profiles
from control and 2 month old Wlds preparations. Thus, mean synaptic vesicle densities,
mean packing densities and the mean number of 'docked' SVs were all significantly
reduced in transgenic mice 5 days after axotomy (Figure 5.10 and 5.11). Interestingly, a
few nerve terminal profiles had a density and distribution of SVs that was above the
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mean value observed in control and 2 month Wlds preparations at 5 days post axotomy.
This led to the conclusion that the reduction in SVs was not an artefact of tissue
processing, and was supported by electrophysiological findings (from Mr D. Thomson
and Dr R.R. Ribchester, personal communication). Whilst the morphological data
showed a clear retention of motor nerve terminals in wallerin transgenic mice following
axotomy, intracellular recordings detected a much lower level of functional nerve
terminal preservation. This could be accounted for by the reduction in the overall
numbers of, and numbers of 'docked', SVs in the majority of transgenic nerve
terminals.
Whilst the reasons for the reduction in synaptic vesicle numbers remain unclear, it is
possible that motor nerve terminals in the transgenic strain of mice have synaptic
vesicle recycling machinery which is more susceptible to axotomy induced changes
(reduction of synaptic vesicles occurs in wild-type preparations following axotomy;
Miledi and Slater, 1970; Manolov, 1974; Winlow and Usherwood, 1975) than in Wlds
mutant mice. It is possible that the mechanisms responsible for producing synaptic
vesicle recycling, such as clathrin-mediated endocytosis (Maycox et al., 1992; De
Camilli and Takei, 1996) and/or 'kiss and run' endocytosis (Klingauf et al., 1998), are
impaired following axotomy. For example, alterations in the activity of proteins such as
the clathrin adaptor API80 and a-adaptin have previously been shown to alter the
number of synaptic vesicles in drosophila synapses (Zhang et al., 1998; Gonzalez-
Gaitan and Jackie, 1997). Thus, it is possible that such proteins may be more
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vulnerable to a loss of function following axotomy in the transgenic than in the Wlds
mice. Whatever the reasons for this decline in SV numbers however, these findings
show that a reduction in the numbers of SVs, as in the case of degenerating
mitochondria (see Chapter 4), does not inevitably lead to degeneration of the nerve
terminal.
5.4.2 Possible Mechanisms Underlying the Wlds
Phenotype
Whilst the current study has provided a qualitative and quantitative description of the
synaptic events which occur at axotomised wallerin transgenic and Wlds mouse NMJs,
little is still known as to the underlying mechanisms responsible for producing delayed
axonal degeneration as a result of the Wlds phenotype. Previous studies of the Wlds
mutant mouse phenotype have resulted in a proposed hypothesis that the cell body of a
neurone may provide a maintenance factor which is transported to the extremities of the
cell via axoplasmic transport and inhibits the initiation of Wallerian degeneration (Glass
et al., 1993; Buckmaster et al., 1995). The Wlds mutation may cause either a
stabilisation of such a factor, or may impair the axonal machinery responsible for its
transport or breakdown, thereby prolonging the initiation of Wallerian degeneration
following separation from the cell body.
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The hypothesis that the Wlds phenotype may be due to the impairment or failure of
axonal transport was examined by Glass and colleagues (Glass and Griffin, 1991;
Watson, Glass and Griffin, 1993; Glass and Griffin, 1994), but refuted with the
demonstration that bi-directional transport of neurofilaments continues at a normal rate
for up to 14 days post axotomy. Tsao et al (1994) also found no abnormalities in
neurofilament phosphorylation and stability. A number of studies have addressed the
possibility that an altered regulation of Ca2+ ions within the nerve causes the Wlds
phenotype. For instance, both Glass et al (1994) and Buckmaster et al (1995)
demonstrated that degeneration in Wlds axons, as in wild type axons, is calcium
dependent. Their data also suggest that calcium dependent Wallerian degeneration
associated proteases are present in Wlds axons, but that these may require higher levels
of calcium for their activation than in normal axons. However, Tsao et al (1994) found
that the levels of calcium-activated proteases in Wlds axons were normal and Glass et al
(1998) found no evidence for a defect in the m-calpain 80kD subunit. The calpain
system of neurofilament degradation therefore appears to be functioning normally, but
the possibility that calpain activation by calcium is impaired in the Wlds mouse has not
been ruled out.
Recent evidence in support of the hypothesis that calcium ions may play a pivotal role
in the regulation of the Wlds phenotype was provided by experiments examining the
role of NAD on intracellular Ca2+regulation. Both cyclic ADP-ribose (cADPR) and
nicotinic acid adenine dinucleotide phosphate (NAADP), derivatives of NAD and
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NADP respectively, initiate release of Ca2+ from intracellular stores (Lee, 1999;
Ziegler, 2000; Podesta et al., 2000). This has led to the suggestion that NAD
derivatives are endogenous modulators of intracellular Ca2+(White et ah, 2000) and may
also have a role in the modulation of neurotransmitter release from pre-synaptic nerve
terminals (Mothet et al., 1998). This hypothesis is noteworthy given the identification
of Nmnat in the Wlds genotype (Conforti et al., 2000).
Intriguingly, a recent study by Benavides et al (2000) suggests that the elevation of
intracellular Ca2+ in Wlds hippocampal neurones following depolarisation is
significantly less than in control preparations. They suggest that this is evidence for
abnormal calcium ion entry into Wlds neurones. However, if the mutation produces
abnormal calcium buffering, perhaps via its effects on NAD levels, this could perhaps
explain their findings.
Finally, proteins targeted by ubiquitin (Laney and Hochstrasser, 1999) may play a
critical role in the Wlds phenotype. It is possible that the fragment of Ube4b expressed
in the chimeric Wlds protein may act to competitively inhibit the action of native Ube4b
(a "dominant-negative" effect), or alternatively increase the overall levels of active
ubiquitin within a neurone. Furthermore, alterations in the level of ubiquitin have been
shown to change the growth and function of synapses; whereby antagonisation of the
ubiquitination pathway produces synaptic outgrowth and dysfunction (DiAntonio et
al.,2001). Thus, it will be interesting to discover therefore whether the mutation in the
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Wlds mouse affects the degradation of all, some or none of the constituent proteins of
the axon and motor nerve terminal. This could perhaps be examined by creating
transgenic animals in which the Ube4b fragment or Nmnat are independently expressed.
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5.4.3 Summary
The data presented in the current chapter strongly suggest that the wallerin chimeric
gene is responsible for producing the Wlds phenotype. Furthermore, current findings
demonstrate that a delay in axonal degeneration unmasks an independent mechanism of
synapse specific degeneration, separate and distinct from axonal and somatic
degeneration. Moreover, the data presented show that the synapse specific degeneration
(withdrawal) process can be unmasked wherever and whenever axonal degeneration is
delayed, and is not unique to the Wlds mouse. However, I concede that further
experiments are required to make more assured conclusions with regard to the temporal
characteristics of nerve terminal withdrawal at axotomised wallerin transgenic mice
NMJs, and these should be undertaken as soon as more of the transgenic mice become
available.
Taken together with data from previous chapters, the current findings strongly support
the hypothesis that nerve terminals are lost by a compartmentalised mechanism of
degeneration, separate from those which underlie the degeneration of axons and cell
bodies. This hypothesis is addressed fully in the final discussion, and a





Nerve section in wild-type rodents normally results in the rapid removal of distal axons
and motor nerve terminals, via Wallerian degeneration. This thesis supports and builds
upon previous studies which have shown that this process is delayed in the Wlds mutant
mouse, whereby disconnected axons and motor nerve terminals are preserved for days
or weeks, rather than hours (Lunn et al., 1989; Ribchester et al., 1995). Furthermore,
previous studies have suggested that, whilst axons retain their structural and functional
properties, motor nerve terminals appear to be lost from the endplate via a process of
synapse withdrawal (Mattison et al., 1996; Ribchester et al., 1999; Mattison, 1999,
PhD Thesis, University of Edinburgh). The current study supports these hypotheses by
providing novel morphological data to demonstrate that axotomised nerve terminals in
Wlds mice of 2 months and younger undergo a withdrawal from the endplate, as
evidenced by the increased incidence of partially occupied NMJs. Moreover, this study
unequivocally demonstrates that axotomised Wlds nerve terminals are capable of being
removed from the endplate by more than one mechanism. The regulation of these
mechanisms is dependent upon the age of the animal, but both processes appear to be
distinct from that of classical Wallerian degeneration. Experiments utilising transgenic
mice expressing the Ube4b/Nmnat ('wallerin') chimeric gene (the candidate Wlds gene;
Conforti et al., 2000), as well as demonstrating that the wallerin gene confers the Wlds
phenotype, showed that these synapse specific forms of degeneration are not unique to
the Wlds mouse, and that they can be observed in NMJ preparations from other strains
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of mouse where axonal degeneration is similarly delayed. Taken together, the results
from the current study suggest that synapses have their own, compartmentalised
mechanisms of degeneration following disconnection from their cell body, separate and
distinct from that of axonal degeneration. Thus, this discussion attempts to place the
current findings in the context of previous notions with regard to a physical and
functional compartmentalisation of the neurone, and culminates in a proposed model of
the neurone pertaining to neurodegeneration.
6.1 Compartmentalisation of Neurodegeneration -
Morphology and Function
It is now widely accepted that a neurone is a highly polarised cell, containing many
separate sub-cellular domains or compartments (the cell body and dendrites, the axon
and the synaptic terminals), each dedicated to performing specific functions within the
cell. From a purely morphological point of view, the cell body is clearly defined as it
contains the nucleus and major cytoplasmic organelles such as the endoplasmic
reticulum (Peters et ah, 1991). In contrast, the dendritic tree emanating from the cell
body is distinct from the latter due to the scarcity of major cytoplasmic organelles,
replaced by a complex array of cytoskeletal proteins such as microtubules and
neurofilaments (Zigmond et ah, 1999). Similarly, the axon has a paucity of major
organelles, instead containing very high levels of cytoskeletal proteins such as
neurofilaments and microtubules, extending into the axon from bundles in the cell body
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(Peters and Jones, 1984; Peters et al., 1991). Interestingly, in many instances the
synaptic compartment of the neurone is not acknowledged as being separate from the
somatic and axonal domains (for example, see Zigmond et al., 1999), even though it is
morphologically distinctive. The large numbers of synaptic vesicles, nerve terminal
mitochondria and specialised combinations of membranous and cytoskeletal networks
(for example the 'active zone material' localised to active zones on the presynaptic
membrane, Palay, 1956; Harlow et al., 2001) not found extra-synaptically, alongside a
reduction in the levels of regular axonal cytoskeletal proteins (Palade and Palay, 1954;
Yee et al., 1988), strongly suggest that synaptic terminals should be considered as a
distinct morphological unit, separate from the axon and cell body.
The distinctive functional properties of synaptic terminals provide further, compelling
evidence that they should be regarded as a distinct domain with respect to a
compartmentalisation of the neurone. The ability to release neurotransmitter in both an
activity dependent and independent fashion is a property largely exclusive to the nerve
terminal. Thus, the molecular machinery for producing the synaptic vesicle cycle is
uniquely concentrated within the nerve terminal (Betz and Angleson, 1998): whereby
proteins such as synaptophysin and synaptobrevins (Elferink and Scheller, 1993),
Synapsins I and II (Sudhof and Jahn, 1991) and the Vesicular Ach transporter (Erickson
et al., 1994) are all present. Similarly, the distribution of ion channels within nerve
terminals is unique, to provide the necessary regulation required for sensitive yet
controlled synaptic vesicle release; P-type calcium channels, voltage-gated potassium
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and voltage-gated calcium channels are all heavily localised within nerve terminal
membranes (Uchitel et ah, 1992; Robitaille et ah, 1993; Day et al., 1997).
Similar compartmentalisation of function can be found in the axonal domain,
specialised to propagate action potentials along its length, allowing the transmission of
electrical impulses over long distances. Once again, the precise distribution of ion
channels within the membrane of the compartment confers these specialised properties
(Hille, 1992), but interactions with other cell types such as Schwann cells also play a
key role in axonal function. For example, in myelinated neurones sodium channels are
tightly clustered around the nodes of Ranvier (interspersed ~200/rm-2mm throughout
the length of the axon; Nicholls et al, 1992) whilst potassium channels are sequestered
in the paranodal region (England et al., 1996; Rasband et al., 1998), an arrangement
brought about due to the pattern of myelination by Schwann cells (England et al., 1996).
This arrangement of insulating myelin and highly specific distribution of ion channels
leads to a large increase in the conduction velocity of the axon (via the process of
'saltatory conduction'; Huxley and Stampfli, 1949; Bostock and Sears, 1978), thereby
enhancing its function. The cell body too, is clearly compartmentalised with regard to
function. Whereas the axon and synaptic terminals are specialised for the conduction
and transmission of nerve impulses, the cell body is adapted for protein synthesis. The
nuclei of most neuronal cells are large compared to other cell types, consistent with
their function of creating and maintaining a large cellular volume (Peters et al., 1991).
Furthermore, the molecular machinery for protein synthesis and distribution is highly
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concentrated in neuronal cell bodies (Nissl substance, Sanford et al., 1955), facilitating
transcription of the many different genes required for neuronal function and subsequent
high levels of protein production.
6.2 Compartmentalisation of Neurodegeneration -
Pathophysiology
Whereas the structural and functional compartments of the neurone are relatively well
defined and are readily exposed via experimental investigation, there has been little
debate of a possible compartmentalisation of the neurone with regard to
pathophysiology. Thus, it is only in the last few years that evidence has been provided
to suggest that the mechanisms of axonal (Wallerian) degeneration are separate and
distinct from those which underlie somatic degeneration.
There are numerous cellular and molecular degenerative mechanisms by which cells,
including neurones, can be destroyed. The two best understood processes are 'classical'
necrosis and 'classical' apoptosis. Necrosis is a term used to describe the major form of
pathological degeneration, usually occurring following injury (Ankarcrona et al., 1995;
Martin, 2001). Whilst necrosis of cells involves a gross destruction of the cellular
ultrastructure, resulting in an inflammatory response (Zigmond et al., 1999), apoptosis
(a form of programmed cell death common during CNS development, Oppenheim,
2001) occurs by a more discreet pathway, whereby degenerating cells are packaged into
membrane bound apoptotic bodies (Kerr et al., 1972). The phagocytosis of cells
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undergoing apoptosis by in situ macrophages or adjacent cells acting as temporary
macrophages (such as glial cells) results in the removal of the degenerating cell without
an inflammatory response (Zigmond et ah, 1999). At an ultrastructural level, the
process of apoptosis occurs with a retention of sub-cellular organelles (although
mitochondrial alterations such as membrane depolarisation, oxyradical accumulation
and calcium overload occur, Mattson et ah, 1998a) and a shrinkage of the cell, whilst
necrotic cell death involves a swelling of the cell, rupture of cell membranes and
disruption of organelles (Roy and Sapolsky, 1999; Zigmond et ah, 1999; Martin,
2001). Historically the two processes of necrosis and apoptosis have been deemed to be
distinct (Kerr et al., 1972; Kerr et ah, 1995). Recent evidence suggests that the two
may be the extremes of an apoptosis-necrosis cell death continuum however, whereby
mitochondrial function and calcium-dependent enzymes alongside growth factor
expression and gene expression (e.g. Bcl-2 and Bax) are critical factors in regulating the
pathway of degeneration (Martin, 2001; Ankarcrona et al., 1995; Choi, 1996; Bennett
and Huxlin, 1996; Roy and Sapolsky, 1999; Yuan and Yanker, 2000). Analysis of
neuronal cell body degeneration reveals many of these markers of 'classical' apoptosis.
For example, in the majority of instances somatic degeneration is accompanied by DNA
degradation (Kerr et al., 1972; Kerr et al., 1995).,4£Linhibited by neuronal growth
factors and by over-expression of genes such as Bcl-2 (Dubois-Dauphon et al., 1994;
Deckwerth and Johnson, 1994; Sagot et al., 1995; Burne et al., 1996), and is dependent
on the presence of caspases (particularly caspase-3, Janicke et al., 1998; Woo et al.,
1998; Keramaris et al., 2000). It has been shown that apoptosis is not the only
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mechanism of cell death present in cell bodies however. Oppenheim et al. (2001) have
shown that when apoptosis is prevented during development by the genetic deletion of
caspases, normal levels of cell death occur, but via a non-apoptotic pathway of
degeneration (see below).
Evidence for the existence of different degenerative mechanisms in separate domains of
the neurone becomes apparent when comparing the process of apoptotic somatic
degeneration with that of axonal Wallerian degeneration. The theory that apoptosis and
necrosis form the extremes of a cell death continuum (Martin, 2001) appears to be
supported by such a comparison, whereby Wallerian degeneration occurs by
mechanisms which display markers of both necrosis and apoptosis. For example, the
production of ovoid bodies during Wallerian degeneration of the axon (see Chapter 1)
appear very similar to apoptotic bodies formed during apoptosis. Furthermore, both
apoptosis and Wallerian degeneration are calcium dependent phenomena, reliant on the
action of calpains and calcium-dependent proteases (Schlaepfer and Hasler, 1979b;
Croall and DeMartino, 1991; Glass et al., 1994; Squier et al., 1994; Chan and
Mattson, 1999). Wallerian degeneration can not include all aspects of apoptosis (e.g.
DNA degradation, Kerr et al., 1972; Kerr et al., 1995) because axotomised distal
stumps do not include motoneurone cell bodies. This does not rule out the possibility
that apoptotic-like processes are occurring however, as it has previously been shown
that apoptosis can occur in the absence of RNA or protein synthesis (Martin, 1993) and
in cells lacking nuclei (Ellerby et al., 1997; Jacobson et al., 1994). Thus, the suggestion
229
by a number of authors that axonal degeneration might be viewed as a form of
'cytoplastic apoptosis' (Ribchester et al., 1995; Buckmaster et al., 1995; Alvarez et al.,
2000), appears plausible. The possibility that Wallerian degeneration occurs primarily
by apoptotic-like mechanisms is not as plausible however. The swelling and lysis of
sub-cellular organelles such as mitochondria and cytoskeletal proteins (Vial, 1958;
Honjin et al., 1959; Ballin and Thomas, 1969; Donat and Wisniewski, 1973;
Schlaepfer and Hasler, 1979a), alongside the invasion of foreign macrophages in an
inflammatory response (Lunn et al., 1989; Perry et al., 1990c), suggest that necrotic
pathways are also a major mechanistic presence during Wallerian degeneration.
Molecular studies of axon degeneration have also demonstrated that non-apoptotic
pathways are responsible, at least in part, for producing Wallerian pathways. For
example; firstly, over-expression of the anti-apoptotic gene Bcl-2 has been shown to
protect cell bodies, but not axons, from degeneration in models of injury and motor
neurone disease (Burne et al., 1996; Sagot et al., 1995); and secondly, application of
the apoptotic insult amyloid (3-peptide has been shown to activate caspases in cell
bodies, but not in axons (Mattson et al., 1998b; but see Ivins et ah, 1998). Similarly
Finn et al. (2000) demonstrated that caspase-3 is not activated during Wallerian
degeneration, prompting the authors to suggest that a neurone contains more than one
mechanism for self-destruction. However, the initial evidence for an independent
mechanism of degeneration in axons was provided in an elegant study by Deckwerth
and Johnson (1994). In their study of sympathetic neurones from the superior cervical
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ganglion of Wlds mice in culture, these authors demonstrated that when NGF was
removed from the culture solution, axons survived whilst cell bodies underwent
apoptosis, thereby showing that Wallerian degeneration can occur independently of
growth factor regulation. Wallerian degeneration has also been shown to utilise
molecular mechanisms distinct from those present during apoptosis, for example;
Tumour Necrosis Factor-alpha (TNF-a) has been shown to play a major role in the
recruitment of foreign macrophages (Liefner et al., 2000) during Wallerian
degeneration. Finally, the demonstration that the wallerin chimeric gene is sufficient
and necessary to produce the Wlds phenotype (current study; Conforti et al., 2000;
Mack et al., 2001), demonstrates that Wallerian degeneration is under the control of
genetic influences, separate from those which control somatic apoptosis.
The demonstration by current experiments, supported by data from previous studies
(Mattison et al., 1996; Ribchester et al., 1999; Mattison, 1999, PhD Thesis, University
of Edinburgh), that axotomised nerve terminals are removed from the endplate by more
than one mechanism, both distinct from the process of axonal Wallerian degeneration,
suggests that synaptic terminals also have separate compartmentalised mechanisms of
neurodegeneration. The retraction of nerve terminal boutons in young Wlds
preparations bears many hallmarks of classical apoptosis; firstly, sub-cellular
organelles such as mitochondria and synaptic vesicles are preserved throughout the
process; secondly, there is a general preservation of nerve terminal architecture and
terminal membranes; and thirdly, there is no leakage of degenerating cytological
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elements from the nerve terminal into the extra-cellular space, and hence no
inflammatory response. It would therefore be of interest to ascertain whether other
markers of apoptosis are present during this process. For example, it would be possible,
using serial EM reconstruction techniques, to undertake measurements of nerve terminal
volume during the retraction process, to examine if there is any shrinkage or swelling of
the compartment. However, the withdrawal of nerve terminals does not, and can not,
involve all the mechanisms which underlie classical apoptosis because of the lack of a
nucleus. As a result I tentatively suggest the term 'synaptosis' to describe this series of
events.
Similar 'synaptotic' processes can be observed throughout the nervous system under
varying conditions, thereby suggesting that 'synaptosis' is not simply a secondary
process only associated with delayed axonal degeneration. For example, blocking fast
axonal transport with batrachotoxin, causes nerve terminals to retract from endplates
within 18 hours; but they then grow back (Hudson et al., 1984). Nerve terminals also
retract in a reversible, "non-Wallerian" fashion following a single subcutaneous
injection of the organophosphate sarin (Kawabuchi et al., 1991). Furthermore, Rich and
Lichtman (1989) observed comparable, reversible nerve terminal withdrawal from
degenerating muscle fibres and nerve terminals have also been shown to retract in
piecemeal fashion in a mouse model of myasthenia gravis, suggesting a role for the
postsynaptic cell in the withdrawal process (Rich et al., 1994).
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The best understood example of the retraction of nerve terminals occurs during the
process of synapse elimination however, an essential step in the formation or
reformation of normal neuromuscular innervation patterns that takes place in postnatal
development or following reinnervation (see Chapter 1). Thus, nerve terminals
undergoing withdrawal during synapse elimination are removed from the endplate
bouton-by-bouton, ending with the formation of a characteristic 'retraction bulb'
(Brown et al., 1976; Riley, 1977; Riley, 1981; Balice-Gordon et al., 1993; Gan and
Lichtman, 1998). A direct comparison of immunocytochemical data from the current
and previous studies utilising the Wlds mouse (Mattison et al., 1996; Parson et al.,
1998; Ribchester et al., 1999) with similar immunocytochemical data from neonatal
mice NMJs undergoing synapse elimination (Balice-Gordon et al., 1993; Balice-
Gordon and Lichtman, 1993; Gan and Lichtman, 1998; Sanes and Lichtman, 1999)
suggested that these two events have very similar morphological and temporal
characteristics. Moreover, when the ultrastructural characteristics of nerve terminal
withdrawal during synapse elimination and following axotomy in young Wlds mutant
and wallerin transgenic mice are compared, many similarities prevail. Both processes
occur with no apparent degeneration of nerve terminals, whereby the incidence of
markers such as mitochondrial disruption and lysis, terminal membrane fragmentation
and terminal Schwann cell phagocytosis are rare (current study; Korneliussen and
Jansen, 1976; Riley, 1977; Riley, 1981; Bixby, 1981). This suggests that the
withdrawal of nerve terminals during synapse elimination may also be occurring via a
process of 'synaptosis'. Moreover, it would be of great interest to study the
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ultrastructural characteristics of synapse withdrawal phenomena in preparations such as
those described above (following the blockade of fast axonal transport, Hudson et ah,
1984; following the application of sarin, Kawabuchi et ah, 1991; following the
degeneration of the postsynaptic cell, Rich and Lichtman, 1989; and in a mouse model
of myasthenia gravis, Rich et ah, 1994) to assess if degenerative characteristics are
similarly absent.
The findings from the current study, that axotomised nerve terminals from older Wlds
mouse preparations are removed by a process more akin to classical Wallerian
degeneration than 'synaptosis', yet still distinct from axonal degeneration, confirms that
the synaptic compartment contains more than one mechanism of degeneration. Nerve
terminal loss in the older Wlds mice displays many more signs of necrosis than
apoptosis. For example; sub-cellular organelles such as mitochondria undergo swelling
and lysis, synaptic vesicle densities are reduced and terminal membranes become
fragmented. It has previously been shown that degenerating nerve terminals in wild-
type preparations are phagocytosed by the terminal Schwann cell (Miledi and Slater,
1970; Manolov, 1974; Winlow and Usherwood, 1975), and a similar process appears
to be occurring in preparations from old Wlds mice. It would be of interest to establish
whether or not foreign macrophages are involved in this synaptic degeneration process,
as they are during axonal degeneration (Lunn et al., 1989; Perry et ah, 1990c), or
whether the phagocytotic process occurs by adjacent cells and without an inflammatory
response, more characteristic of apoptosis.
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The occurrence of nerve terminal 'synaptosis' at young Wlds mice NMJs, and
Wallerian-like degeneration at old Wlds mice NMJs following axotomy are not isolated
examples of one degenerative process being unmasked by the disruption of another.
Thus, after genetic deletion of caspase-3 and caspase-9 in developing mouse postmitotic
neurones, normal neuronal cell loss occurs, but by a mechanism separate and distinct
from the classical apoptotic pathways observed in wild-type preparations (Oppenheim
et al., 2001). This suggests that all neuronal compartments may have more than one
mechanism of degeneration capable of bringing about removal of that segment of the
neurone, although a secondary mechanism of degeneration has yet to be described in
axons. It should be noted however that the current study provides novel evidence for
independent mechanisms of synaptic degeneration in the peripheral nervous system but
offers no insights concerning such events in the central nervous system. Thus, whilst
axon preservation has been demonstrated in the CNS of Wlds mice (Perry et al., 1990a;
Ludwin and Bisby, 1992), it has not been established whether or not synaptic
connections are also preserved following nerve lesion. It would therefore be of great
interest to establish whether or not synaptic terminals in the CNS of young Wlds mice
are not only retained, but are also retracted from postsynaptic cells following axotomy.
And furthermore, to assess whether age has a similar effect on the regulation of which
mechanism(s) is/are to be responsible for synaptic terminal degeneration. It is possible
to speculate that synaptic withdrawal processes may occur following nerve lesion in the
CNS of young Wlds mice, as synaptic withdrawal mechanisms have previously been
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shown to occur at young CNS synapses. For example, during developmental
reorganisation (synapse elimination) in mammalian autonomic ganglia, the withdrawal
of supernumerary inputs have been demonstrated using both morphological and
electrophysiological techniques (Johnson and Purves, 1981; Lichtman, 1977; Lichtman
and Purves, 1980).
Taken together, the findings discussed above suggest that, alongside morphological and
functional characteristics, the neurone is compartmentalised with regard to
neurodegeneration. This hypothesis is demonstrated in the model of neurodegeneration
shown in Figure 6.1, which proposes that the cell body, axon and synaptic terminal
domains of the neurone each have at least one independent mechanism of degeneration,
regulated by the action of different genes. Whilst these mechanisms are illustrated as
being independent in the proposed model, the notion that apoptosis and necrosis are
extremes on a cell death continuum (Martin, 2001) suggests that all the proposed
pathways of neurodegeneration may also be part of the same continuum. Furthermore,
the demonstration that multiple methods of degeneration are present in some neuronal
compartments, and that the detection of their presence depends upon the level of
masking by another mechanism, suggests that it is the expression of each mechanism
which is regulated independently in different domains of the neurone rather than
different mechanistic machinery being present per se.
236
Fig. 6.1 Model of the Compartmental Organisation of Degeneration
Mechanisms in the Neurone.
(A) Genes regulating cell body degeneration by apoptosis (blue) and axon degeneration
(magenta) are given in parentheses. The genes controlling synaptic degeneration
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6.3 Compartmentalisation of Neurodegeneration -
Molecular Mechanisms
The molecular mechanisms which regulate synapse specific degeneration, in any of the
circumstances described above, remain unknown. However, recent molecular studies
have provided evidence to support the hypothesis that synaptic degeneration can be
regulated independently of axonal and somatic degeneration. Experiments utilising
CNS neurones have shown that activation of apoptotic pathways by exposure to
amyloid (3-peptide does not produce caspase activation in axons, but does produce
caspase activation in cortical synaptosomes (Mattson et al., 1998b). Similar evidence
for 'synaptic apoptosis' was provided by experiments which showed that apoptotic
biochemical cascades are selectively triggered at synaptic sites (Mattson et al., 1998a, b;
Mattson, 2000; Guo and Mattson, 2000). For example, exposure of cortical
synaptosomes to levels of the apoptotic stimuli Fe2+ and staurosporine which induce
apoptosis in primary cultured hippocampal and cortical neurones resulted in
mitochondrial alterations (membrane depolarisation, oxyradical accumulation and
calcium overload), a loss of membrane phospholipid asymmetry and caspase activation
(Mattson et al., 1998a). Further evidence that the synaptosomes were undergoing
apoptotic-like degeneration was produced by demonstrating that these apoptotic
processes could be prevented by the administration of the caspase inhibitor zVAD-fmk
(Mattson et al., 1998a).
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Following the demonstration that synapses contain their own molecular machinery to
instigate compartmental degenerative processes, it is possible to speculate that such
apoptotic-like molecular mechanisms are also activated during 'synaptosis'. It should
be possible to address this question by repeating the Wlds axotomy experiments detailed
in the present study, but this time in conjunction with the sub-cutaneous administration
of apoptosis-blocking agents such as zVAD-fmk. If these experiments reveal any effect
on the morphological or temporal aspects of nerve terminal retraction in axotomised
young Wlds preparations, it would provide strong evidence that 'synaptosis' occurs by
mechanisms similar to classical apoptosis. Furthermore, it would be interesting to
examine possible differences in the molecular machinery active in synaptic
compartments of young and old Wlds neurones following axotomy, to assess to what
extent apoptotic and necrotic processes are being expressed, independently or in
conjunction with one another. Moreover, it is plausible to suggest that the intermediate
characteristics of axotomised nerve terminals in Wlds mice of ~4 months of age,
whereby markers of both apoptotic and necrotic cell death are apparent, is evidence for
a transition on the apoptosis-necrosis cell death continuum. A molecular investigation
of the degenerative processes occurring in Wlds mice of a transitional age may therefore
shed light on the mechanisms which regulate the expression of apoptotic versus necrotic
cell death.
The discovery of the molecular genetics underlying the Wlds phenotype, advanced by
data from the current study, provide some indicators as to possible underlying molecular
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mechanisms. It was originally thought that the identification of Nmnat in the Wlds
genotype (Conforti et al., 2000) would provide insights into the molecular mechanisms
which underlie the axotomy-induced phenotype. Nmnat has been identified as the
enzyme responsible for the synthesis of NAD within neurones (Emanuelli et al., 2001),
and evidence that NAD can regulate intracellular calcium levels via the release of
intracellular calcium stores has recently been provided (Lee, 1999; Ziegler, 2000;
Podesta et al., 2000). It was therefore suggested that expression of the wallerin
chimeric gene may up-regulate the production of NAD, which would in turn act as a
maintenance factor, possibly even the 'synaptic maintenance factor' discussed
previously. This hypothesis has been somewhat refuted however by recent experiments
from Dr M.P. Coleman's laboratory which have shown that NAD levels are normal in
Wlds neurones (personal communication).
The identification of an N-terminal fragment of Ubiquitination factor E4B (Ube4b) in
the Wlds genotype (Conforti et al., 2000) suggests that the ubiquitin system may be
altered in these mice. The ubiquitin system of intracellular proteolysis is crucial for the
control of protein activity, localisation and selection for degradation, thereby regulating
processes such as apoptosis (Hochstrasser, 1996; Hershko and Ciechanover, 1998;
Laney and Hochstrasser, 1999). It has been demonstrated that the yeast homologue of
Ube4b, whilst not being essential for cell viability (Johnson et al., 1995), is a
conjugation factor involved in the multi-ubiquitination of proteins, whereby in the
absence of Ubiquitination factor E4, ubiquitination is initiated but does not proceed to
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proteosomal degradation in vivo (Koegl et al., 1999). Furthermore, E4 Ubiquitination
factors have been linked to cell survival under stress conditions (Koegl et al., 1999). As
the Wlds protein only contains 70 of the 1173 amino acids of Ube4b, it is unlikely that
this confers full multi-ubiquitination or cell survival properties on the Wlds protein, but
it may have a related role which could feasibly alter the function of the ubiquitin system
(Mack et al., 2001).
Altered function of the ubiquitin system of intracellular proteolysis has previously been
implicated in the pathogenesis of diseases such as Alzheimer's and Parkinson's. For
example, it has been shown that impairment in substrate recognition or the supply of
free ubiquitin leads to accumulation of unwanted proteins in neurones (for review see
Layfield et al., 2001). Alterations in the selection of axonal proteins for degradation
could therefore lead to the preservation of specific cytoskeletal proteins such as NF in
the distal nerve stump following lesion in Wlds mice. Moreover, ubiquitin-dependent
mechanisms have been shown to regulate synaptic growth and function at the
Drosophila NMJ. For example, expression of the yeast de-ubiquitinating protease
UBP2, producing antagonisation of the ubiquitination pathway in neurones, leads to an
elaboration of the synaptic branching pattern (including a significant increase in the
numbers of synaptic boutons) and a severe reduction in presynaptic transmitter release
(DiAntonio et al., 2001). The authors of this study concluded that "a balance between
positive and negative regulators of ubiquitination controls the structure and function of
a synapse". These findings suggest that the control of synapse specific morphology and
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degeneration, including the withdrawal of motor nerve terminals at axotomised young
Wlds and wallerin transgenic mice NMJs, may be regulated, in part, by the ubiquitin
system.
The findings that age has an effect on the expression of the Wlds phenotype at
axotomised nerve terminals suggests that whatever the underlying molecular machinery
is, it is altered with age. The hypothesis that a, as yet unidentified, 'synaptic
maintenance factor' may be responsible for controlling the preservation and
degeneration of nerve terminals appears feasible however, and as a result it will be
interesting to discover whether certain proteins in the neurone are differently regulated
with increasing age. Whilst the expression of the Wlds protein does not decline with
age, it is possible that such a maintenance factor has an altered susceptibility to
ubiquitination or other cell regulation mechanisms in older animals. However, it is also
important that the actions of retrograde factors on neuronal structure and function are
not overlooked. For example, a recent study by Snider and colleagues showed that
sustained postnatal subcutaneous administration of the retrograde factor glial cell line
derived neurotrophic factor (GDNF) is capable of producing a "state of continuous
synaptic remodelling" (Keller-Peck et ah, 2001). These findings suggest that GDNF is
capable of regulating both the sprouting and withdrawal of nerve terminal boutons in
vivo, and therefore may exert some effects on the fate of axotomised Wlds motor nerve
terminals. However, evidence that the expression of GDNF and its receptors in the
peripheral nervous system do not decline with age (Golden et al., 1999), and in some
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cases increase with age (Ming et al., 1999), suggests that whilst GDNF may exert some
influence over the retention and plasticity of synaptic terminals, it does not fulfil the
criteria for an age-dependent regulatory mechanism as is present in the Wlds mouse.
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6.4 Conclusion
The current study provides evidence that mechanisms of degeneration within neurones
are highly compartmentalised (Figure 6.1), whereby cell bodies (apoptosis), axons
(Wallerian degeneration) and synaptic terminals (synaptosis) all have their own,
independently regulated degenerative pathways. These findings offer a re-assessment
of the current accepted model of neurodegeneration. The implications for
understanding neurodegenerative diseases such as Parkinson's and Alzheimer's could
be significant. For example, synapse-specific forms of degeneration could play an
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The following appendix contains methodological and experimental data produced by
others to support the findings of the current study concerning the generation and
characterisation of the Ube4b/Nmnat (Wallerin) transgenic mice.
A.1 Generation of the Ube4b/Nmnat Transgenic Mouse
The production of Ube4b/Nmnat transgenic mice was undertaken by Dr M.P.
Coleman's laboratory in Cologne (see Figure 5.1 for transgene construct). The
following description of how these mice were generated is taken from a collaborative
paper by Drs. Coleman and Ribchester, of which I am a co-author (Mack et ah, 2001).
"Chimeric Ube4b/Nmnat cDNA was amplified by RT-PCR from Wlds brain using
Platinum Pfx polymerase (Gibco-BRL) and BamHI and 7/m<iIII-tagged primers, before
cloning into plasmid pH(lAPr-l (kindly supplied by Tom Vogt, University of
Princeton). The human (3-actin promoter drove expression of chimeric cDNA with the
first (non-coding) exon of P-actin, thus mimicking the ubiquitous expression in WlcF
mice. DNA sequencing confirmed the absence of errors and a 6 kb fragment containing
the promoter, cDNA and polyadenylation signal was released by Ndel/EcoRl double
digestion and gel-purified in the absence of ethidium bromide using QIAquick
extraction (Qiagen). The transgene was injected into pronuclei of CBA X C57 F1
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single-cell embryos by the service of Dr. George Kollias, Pasteur Institute, Athens.
Nine founders were identified from 62 pups and eight were analysed.
DNA was prepared from a 5 mm tail biopsy or from spleen taken post mortem using the
Nucleon HT kit (Amersham Pharmacia). Presence or absence of the 1.1 kb transgene
coding region was determined using alkaline Southern blotting of a BamHL/Hindlll
double digest onto Hybond N+ filters (Amersham Pharmacia) followed by hybridisation
with a 32P-labelled probe of the full length chimeric gene coding sequence."
A.2 Electrophysiological Studies on Ube4b/Nmnat
Transgenic Mice
The preservation of functional axons and motor nerve terminals following axotomy in
Ube4b/Nmnat transgenic mice was shown using intracellular recording techniques from
FDB muscle preparations, undertaken by Mr D. Thomson and Dr R.R. Ribchester in our
laboratory. Some results from this study are shown in Figure A.l.
A.3 Molecular Studies on Ube4b/Nmnat Transgenic Mice
The preservation of distal axons following axotomy in Ube4b/Nmnat transgenic mice
was also demonstrated by producing western blots of NF levels in axotomised sciatic
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nerve, undertaken in Dr M. Coleman's laboratory in Cologne. The results of these
experiments are shown in Figure A.2.
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Fig. A.l Functional Preservation of Motor Axons and Motor Nerve
Terminals in Ube4b/Nmnat Transgenic Mice Following Axotomy
(A) An electrophysiological trace taken from a sample of muscle fibres in a
homozygous 4836 Ube4b/Nmnat mouse FDB muscle preparation 3 days after sciatic
nerve section. This figure shows the occurrence of both endplate potentials (EPPs) in
response to nerve stimulation and spontaneous activity (random, uniquantal MEPPs) in
these muscle fibres, demonstrating the persistence of neuromuscular transmission in
these preparations.
(B) Graph of the percentage of fibres showing activity against days post axotomy.









Fig. A.2 Preservation of Neurofilaments in Ube4b/Nmnat Transgenic Mice
Sciatic Nerves Following Axotomy
(A) A western blot showing the retention of NF proteins in axotomised Wlds and
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